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Abstract 
 
A large number of cell surface proteins contain an SH3 type 5 domain (SH3_5) responsible for the 
cell wall binding of these proteins to peptidoglycan. SH3_5 domains are involved in the 
recognition of peptidoglycan in different pathogenic bacteria including methicillin-resistant 
Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecalis (VRE). This work 
sought to elucidate the mechanisms underpinning the recognition of peptidoglycan by SH3_5 
proteins. As a model system, we focused on the C-terminal SH3_5 domain from the lysostaphin 
enzyme. Lysostaphin is a bacteriolytic enzyme produced by S. simulans that cleaves the 
pentaglycine crossbridge in S. aureus peptidoglycan. This potent enzyme can efficiently lyse 
MRSA strains and disrupt biofilms. The lysostaphin enzyme contains an N-terminal catalytic 
domain with glycylglycil endopeptidase activity and a C-terminal SH3_5 cell wall targeting 
domain. Nuclear Magnetic Resonance (NMR) titrations, X ray crystallography, and mutational 
analyses, revealed how this SH3_5 domain efficiently recognises S. aureus peptidoglycan. Our 
NMR titrations showed that the pentaglycine crossbridge and the peptide stem are recognized 
by two independent binding sites located on opposite sides of the SH3_5 domain. The 1.4 Å 
crystal structure of the SH3_5 domain, in complex with a synthetic peptidoglycan fragment, 
revealed a dual SH3_5 binding mechanism whereby the G5 ligand from a monomeric fragment 
was recognized by one SH3_5 domain and the P4 peptide was bound to another SH3_5 protein. 
We propose that this binding mechanism leads to a synergistic and structurally dynamic binding, 
which induces clustering of the SH3_5 domains and increases the local concentration of the 
enzyme resulting in its potent bacteriolytic activity. We propose that this research will serve as a 
framework for understanding how bacteria control the enzymatic activity of PG hydrolases and 
will contribute to the development of antimicrobial approaches.  
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CHAPTER I 
Introduction 
 
1.1 The cell wall of Gram-positive bacteria  
Gram-positive bacteria lack an outer membrane and their cell wall constitutes the outermost 
layer of the cell envelope (Rogers, 1980; Vollmer, 2008a). As a result, it plays a pivotal role in 
their interaction with the environment. The cell wall is a complex structure made of 
peptidoglycan (PG) and covalently attached anionic polymers such as teichoic acids (TAs), 
polysaccharides, and surface proteins (Fig. 1.1) (Dramsi  S., 2008; Neuhaus, 2003; Vollmer, 
2008a).  
 
1.1.1 Peptidoglycan  
Peptidoglycan (PG) is an essential element of the bacterial cell wall ensuring cell shape and 
viability by withstanding the turgor pressure (Rogers, 1980; Turner, 2014; Vollmer, 2008a). PG is 
intimately involved in cell growth and division, as well as protective, physiological, and adaptative 
processes. In Gram-positive bacteria, it serves as a scaffold for both the covalent and non-
covalent anchoring of polymers and surface proteins (Desvaux, 2018; Dramsi  S., 2008; 
Shockman, 1983).  
 
1.1.1.1 Peptidoglycan composition 
PG is a porous net-like macromolecule made of linear glycan chains crosslinked by short peptides. 
The glycan chains are formed of repeating disaccharide units of N-acetylglucosamine (GlcNAc) 
and N-acetylmuramic acid (MurNAc) linked by β 1-4 bonds (Rogers, 1980). The D-lactoyl group of 
each MurNAc is substituted by a short peptide stem constituted by amino acids with L- and D- 
configurations, most often: L-Alanine, D-Glutamate or iGlutamine, L-Lysine or -meso-
Diaminopimelic acid (m-A2pm), D-Alanine and D-Alanine (Fig.1.2) (Schleifer, 1972; van 
Heijenoort, 2001) 
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Figure 1.1. Schematic representation of a Gram-positive cell envelope (CE). The cell envelope 
of Gram-positive bacteria is constituted of the cytoplasmic membrane (CM) acting as a selective 
permeable  barrier and the cell wall  ensuring cell shape and viability. Lipoproteins in Gram-
positive bacteria are anchored into the outer leaflet of the CM. The inner wall zone (IWZ) is a 
narrower zone of low density and devoid of cross-linked PG, the IWZ is not bound by two 
biological membranes like the case of Gram-negative bacteria and therefore is not considered as 
a periplasm although it presents some analogies (Desvaux, 2018). The cell wall is constituted of 
peptidoglycan (PG) which serves as a scaffold for the anchor of wall teichoic acids (WTA); wall 
polysaccharides (WPs); and surface proteins (SP). Lipoteichoic acids (LTA) are anchored to the 
CM and protrude from the cell wall. Adapted from (Silhavy, 2010). Created by BioRender.com. 
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The composition of the disaccharide glycan strands is highly conserved. However, the majority of 
bacterial species have developed modifications to their glycan units which are critical for cell 
shape, division, and pathogenesis (Vollmer, 2008b). In most bacterial species, glycan units 
become modified after insertion into the assembled cell wall. In Gram-positive bacteria the most 
common modifications are: (i) N-deacetylation of GlcNAc and MurNAc (Boneca, 2007; Vollmer, 
2000), (ii) N-glycolylation of MurNAc (Raymond, 2005), (iii) O-acetylation of MurNAc and GlcNAc 
(Clarke, 2007; Sychantha, 2018), and (iv) attachments of surface polymers such as wall teichoic 
acids (WTA) and other highly diverse heteropolysaccharides like capsular and rhamnose 
polysaccharides (RhapWPs) (Brown, 2013; Deng L, 2000; Vollmer, 2008b). These alterations have 
been implicated in bacterial resistance to β-lactam antibiotics and host defence factors as in the 
case of lysozyme hydrolysis (Brown, 2013; Smith, 2019; Vollmer, 2008b).  
Another important modification of the glycan strands is their average chain length (glycan chain 
length - GCL) which varies between species. Noticeably the GCL does not correlate with the 
thickness of the PG layer (Vollmer, 2008a). Bacillus subtilis was estimated to have long glycan 
chains of over 100 disaccharide units (Matias, 2005), whereas Staphylococcus aureus has a GCL 
of between 3-10 disaccharide units. A model across bacteria has been proposed in which initial 
PG is formed of dense stiff regions that undergo remodelling  by PG hydrolysis. This allows the 
enlargement of the cell surface area with a more flexible PG. This model is independent of the 
specific mechanism of monomer insertion and mode of hydrolysis (Wheeler, 2011) 
The stem peptides of PG can also be modified. The N-terminal L-Ala amino acid is conserved in 
most bacteria, however in the Corynebacterium and Mycobacterium genera Gly or L-Ser 
substitutions have been described (Hesse L, 2003; Mahapatra, 2000; van Heijenoort, 2001). In 
Gram-positive bacteria the -carboxyl of the D-glutamic acid is often amidated (D-iGln) and L-
Lysine is often present in position 3, the exceptions being Mycobacterium, Bacillus, and 
Clostridium  genera where A2pm is found instead (van Heijenoort, 2001; Vollmer, 2008a). The 
two C-terminal D-Alanine residues are highly conserved. D-Ala at position four is present in all 
bacteria. In vancomycin-resistant Enterococci strains the D-Ala at position five is substituted by 
a D-Lactate (D-Lac) or a D-Serine (D-Ser) (Healy VL, 2000).   
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Figure 1.2. Disaccharide pentapeptide subunit (monomer) of most Gram-positive bacteria. The 
PG building blocks consist of disaccharide units of alternating β-1-4 linked N-acetylglucosamine 
(GlcNAc) and N-acetylmuramic acid (MurNAc) residues. The pentapeptide stem is covalently 
linked via a lactyl group to MurNAc. In most Gram-positive bacteria the epsilon-amino group of 
the side chain of the third amino acid is attached to a lateral chain of variable length and 
composition. In S. aureus the lateral chain is comprised of a pentaglycine peptide chain. 
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In most Gram-positives including pathogenic cocci, the ε-NH2 of the L-Lysine is substituted by a 
lateral chain of variable length and composition (Fig. 1.2). Different L- and D- amino acids have 
been identified: Gly, L-Ala, L- or D-Ser, D-Asx, L- or D-Glu, among others. For instance, in S. aureus 
the lateral chain is made of five glycines, whereas in Enterococcus faecalis it is composed of two 
L-Ala residues (Boniface A, 2006; Schleifer, 1972; Vollmer, 2008a).  
 
1.1.1.2 Peptidoglycan biosynthesis  
The study of PG biosynthesis started nearly 70 years ago (Park, 1952) and a general overview of 
the biochemical pathway has been generated after the study of its different steps in various 
Eubacteria (van Heijenoort, 2001). PG biosynthesis is generally divided into a two-stage process: 
(i) assembly of the monomer unit and (ii) polymerization of the lipid II substrate (Fig.1.3). The 
assembly of the monomer unit can be further divided into a cytoplasmic, and cell membrane 
stage.  
The characteristic features of the PG building blocks highlight the specificity and complexity 
involved during each step of the first-stage process. For instance, the unusual presence of 
muramic acid, the formation of a γ-linkage between D-iGln and a diamino acid (instead of the 
usual α-carboxylic group), and the alternating L- and D- amino acid conformations.     
Monomer assembly can be divided into four sequential reactions: (i) formation of UDP- GlcNAc, 
(i) formation of UDP- MurNAc, (iii) formation of UDP- MurNAc -pentapeptide, and (iv) formation 
of the lipid intermediates. Steps (i) to (iii) occur in the cytoplasm whilst step (iv) occurs at the cell 
membrane. 
The first step involves the conversion of fructose-6-P into UDP- GlcNAc by the GmlS/M/U 
transferases. The amidotransferase GlmS is responsible for the transformation of fructose-6-P to 
an intermediate glucosamine-6-P; this step is followed by the interconversion of glucosamine-1-
P by the phosphoglucosamine mutase GlmM. During the last step, the bifunctional GlmU 
synthase transforms glusosamine-1-P into UDP-GlcNAc by two consecutive reactions: first the 
GlmU C-terminal domain acetylates the glucosamine-1-P molecule into  
6 
 
 
Figure 1.3. Peptidoglycan synthesis in S. aureus. The two-stage pathway is illustrated: ① 
assembly of the monomer unit and ② polymerization of the PG precursor lipid II. Cytosolic and 
membrane-associated enzymes lead to the synthesis of the lipid II-Gly5. Four successive groups 
of reactions are considered: formation of UDP-N-acetylglucosamine (UDP-GlcNAc) by GlmS, 
GlmM, and GlmU; formation of UDP-N-acetylmuramic acid by MurA and MurB; formation of the 
UDP-MurNAc-pentapeptides by MurC to MurF and Alr/Ddl; and formation of the lipid 
intermediates by MraY and MurG. The FemX transferase catalyses the addition of the fist Glycyl 
residue of the lateral chain; the second and third glycyl residues are added by FemA and the 
fourth and fifth by FemB. Lipid II is flipped across the cytoplasmic to the outer leaflet in the inner 
wall zone (IWZ) by a flippase (MurJ/FtsW), where it is used as a substrate by glycosyltransferases 
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(Gtases) and DD-transpeptidases (DD-TPases). Peptides are trimmed by DD- and LD-
carboxypeptidases (CPases). Adapted from (Egan, 2020; Typas, 2011). 
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N-acetylglucosamine-1-P, and finally its N-terminal domain catalyses the uridylation of UDP- 
GlcNAc. In Gram-positive bacteria, UDP-GlcNAc is an essential precursor for PG synthesis and 
GlcNAc containing polymers like teichoic acids and polysaccharides (Fig. 1.3) (Pooley, 1994; van 
Heijenoort, 2001). 
The transformation of UDP-GlcNAc to UDP-MurNAc is a two-step process catalysed by the MurA 
and MurB enzymes. First, the transferase MurA places enolpyruvate from phosphoenlovyruvate 
(PEP) in position 3 of the GlcNAc residue yielding a UDP-GlcNAc-enolpyruvate intermediate. Next, 
the MurB reductase catalyses (in an NADPH and FAD-dependent reaction) the reduction of the 
enolpyruvate moiety into D-Lactoyl, to form the UDP- MurNAc precursor (Benson TE, 2001; 
Brown ED, 1995; Farmer, 1996).  
The assembly of the UDP-MurNAc-pentapeptide is carried out by the consecutive addition of L-
Ala, D-Glu, L-Lys or m-A2pm, and the D-Ala dipeptide onto the D-lactoyl group of MurNAc by the 
Mur C-F synthases. Mur C to F synthases are a family of highly specific cytoplasmic ADP/peptide-
forming ligases  (van Heijenoort, 2001). They all share a similar catalytic mechanism, driven by 
the hydrolysis of ATP into ADP, which promotes the formation of a peptide bond, and the loss of 
inorganic phosphate. The MurC ligase adds the first amino acid into the peptide stem. As 
mentioned in previous sections, MurC displays a preferential binding to L-Ala, and in rare cases 
Gly or L-Ser have been identified (Emanuele, 1996; Mahapatra, 2000). In Mycobacterium spp the 
substitution of Gly for L-Ala has been associated to specific growth conditions (Mahapatra, 2000). 
The next amino acid at position two is added by the MurD ligase. MurD has proven to be highly 
specific, since only D-Glu has been identified as the substrate for this enzyme. As such, most 
amino acid variations occur at the third position. Depending on the organisms L-Lys or m-A2pm 
are commonly found. However, other residues such as ornithine, diaminobutyric acid, 
homoserine, lanthionine, or 3-hydroxy-A2pm have been identified (Bertrand, 1997, 2000). 
Although MurE accepts a larger range of substrates, it has been shown that in most cases it can 
efficiently discriminate between different amino acids, and catalyse  the addition of a specific 
residue into the peptide stem (Boniface A, 2006; Gordon E., 2001; van Heijenoort, 2001). The 
alanine racemase Alr catalyses the conversion of L-Ala to D-Ala which is then polymerised into 
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the dipeptide D-Ala-D-Ala, by the Ddl ligases (Fig. 1.3). This dipeptide is then added to the UDP-
MurNAc-tripeptide by MurF. The specificity of MurF towards the D-Ala-D-Ala substrate has been 
studied using various analogues in different in vivo systems (Duncan K., 1990; Vollmer, 2008a). 
Although D-Ala is predominantly found at the fourth position in all bacterial species, the fifth D-
Ala can be replaced by D-Lac or D-Ser which has little impact in transpeptidation reactions as 
observed in Vancomycin-resistant Gram-positive organisms (Bugg, 1991). 
The final stage of assembly for the monomeric unit is the formation of the lipid intermediates I 
and II (Fig. 1.3). For these steps, the transferases MraY and MurG are involved. MraY is a 
transferase or translocase that catalyses the transfer of phospho-MurNAc-pentapeptide from the 
UDP-MurNAc-pentapeptide to the membrane acceptor-undecaprenyl phosphate resulting in the 
formation of the lipid I intermediate (MurNAc-pentapeptide-pyrophosphoryl undecaprenol). 
Subsequently, MurG, a N-acetylglucosamine transferase, catalyses the addition of UDP-GlcNAc 
into Lipid I, yielding the GlcNAc-MurNAc-pentapeptide-pyrophosphoryl undecaprenol (Lipid II) 
(Ikeda, 1991; van den Brink-van der Laan, 2003; van Heijenoort, 2001).  
In most Gram-positive bacteria cross-linking between PG peptide stems occurs via a lateral 
peptide chain. Two enzyme families responsible for the ‘branching’ of interpeptide bridges have 
been described: the Fem transferases (for L-amino acids and glycine) and the ATP-grasp family 
enzymes (for D-amino acids) (Galperin, 1997; Mainardi, 2008; Vollmer, 2008a). Fem transferases 
are a family of non-ribosomal peptide bond-forming enzymes involved in the branching of 
aminoacyl-transfer ribonucleic acids (aa-tRNA). The aa-tRNAs are amino acids delivered to the 
ribosome for translation and they also participate as substrates for cell wall synthesis (Vollmer, 
2008a). Gly and L-amino acids are activated as aa-tRNA and their amino acid moiety is transferred 
by the Fem transferases to the third amino acid in the pentapeptide stem of the lipid precursors 
to form branched peptide chains that will be linked during PG polymerization. The peptide bridge 
composition, and the precursor used by these enzymes, varies between bacterial species. It has 
been shown that lipid II is the precursor substrate for S. aureus Fem enzymes, whereas UDP- 
MurNAc-pentapeptide and lipid II are both substrates for E. faecalis Fem transferases, which are 
also known as BppA1 and BppA2 (Bouhss, 2002; Schneider, 2004). D-amino acids are 
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incorporated by the ATP-grasp family. These enzymes activate the amino acids as acyl 
phosphates at the expense of an ATP molecule and catalyse the ligation of the activated carboxyl 
group to different chemical groups, in this case an amino nitrogen (Aliashkevich, 2018; Bellais, 
2006; Veiga, 2006). 
The second stage in PG synthesis is the polymerization of the monomeric units, which requires 
the translocation of the lipid II located at the inner leaflet of the cytoplasmic membrane to the 
outer leaflet where is utilized as a substrate by PG synthases (Fig. 1.3). Owing to the recent 
development of dedicated enzymatic assays, the details of the PG synthesis regulation are being 
uncovered, particularly for the second stage of the pathway (Caveney NA., 2018; Egan, 2020).  
The identity of the protein responsible for transporting or ‘flipping’ lipid II from the inner to the 
outer leaflet has remained elusive for decades. The coordination of proteins from two integral 
membrane protein families, FtsW and RodA from SEDS (shape, elongation, division and 
sporulation), and MurJ member of the MOP (multidrug, oligosaccharide-lipid, polysaccharide)  
transporter family have been suggested to fulfil this role (Egan, 2020; Liu, 2018). RodA and FtsW 
are two essential proteins for PG growth during elongation and division, respectively. The model 
rod-shaped B. subtilis possesses a third SEDS protein, SpoVE, involved in spore cortex synthesis. 
FtsW was shown to be responsible for transporting lipid II across a synthetic membrane when 
incorporated into proteoliposomes (Mohammadi T, 2011). From this, the authors assumed that 
the FtsW homologues, RodA and SpoVE, are also likely to participate in the translocation of lipid 
II during cell elongation and spore PG synthesis in B. subtilis. Moreover, no in vitro flippase activity 
was detected for MurJ in their synthetic system. However, neither FtsW nor RodA were 
implicated in the transport of lipid II in an in vivo assay in which colicin M (ColM) was added to 
cells to digest only the flipped (periplasmic) lipid II of E. coli (Sham, 2014). The protection of lipid 
II from ColM cleavage upon MurJ inactivation suggested that either lipid II is not flipped or that 
inhibiting MurJ somehow interferes with ColM import or activity. The results in both studies are 
not necessarily in opposition since key caveats, described below, remain for each set (Egan, 
2020). 
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Recently, a high-resolution structure of MurJ was determined revealing different inward-facing 
and outward-facing conformations (Kuk, 2017). This alternate access configuration and the 
movement of the MurJ cargo seemed to be driven by the proton motive force (PMF) and the 
binding and release of Na+ (Kuk, 2017; Kumar, 2019). For the in vitro experiment the absence of 
PMF in the artificial membranes could explain the lack of flipping activity by the MurJ proteins 
(Mohammadi T, 2011). For the in vivo study where FtsW and RodA did not appear to contribute 
to flipping, ColM might be a biased tool to explore this process as it inhibits PG biosynthesis by 
interfering with lipid carrier recycling (Harkness, 1988). Whether one of these proteins has a 
more direct involvement in the flipping activity of the lipid II, like the MurJ transition from an 
inward-open conformation to an outward-open conformation caused by substrate binding, it is 
likely that both MurJ and FtsW are required for transportation to occur. It has been suggested 
that the recruitment of MurJ at mid-cell during division requires both the presence of the 
precursor lipid II and functional FtsW, and that this cooperative activity might be necessary to 
fulfil the high demand for PG synthesis (Liu, 2018).  
PG polymerisation is carried out by membrane-associated enzymes called Penicillin binding 
proteins (PBPs) (Goffin, 1998). PBPs can be divided into three groups: (i) Class A PBPs, which are 
bifunctional enzymes acting as glycosyltransferases (GTases) and DD-transpeptidases (TPases) 
for the polymerisation of glycan strands and cross-linking the stem peptides, (ii) Class B PBPs with 
monofunctional TPase activity, and (iii) Class C PBPs, a group of low molecular weight 
carboxypeptidases (Sauvage, 2008; Vollmer, 2008a). One of the difficulties in studying PG 
synthesis is the large number of PBPs with apparent redundancy: for example in both S. 
pneumoniae and E. coli, class A PBPs (PBP1A and PBP1B) have been described as partially 
redundant, as the bacterial cell only requires one of these for growth (Egan, 2020; Hoskins, 1999; 
Yousif, 1985). However, S. aureus PBP2 is the only bi-functional PBP (Pinho, 2001) and in E. 
faecalis all class A PBPs are dispensable, with deletions of all three enterococcal class A PBPs 
having a minor effects in PG cross-linking (Arbeloa, 2004).  
PBP2 (class B) is required for PG cross-linkage during the elongation process and its interaction 
with PBPA1 stimulates the GTase activity of the latter (Egan, 2020). SEDS proteins are another 
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type of monofunctional GTases and a recent study has shown that their function as PG 
polymerases requires the presence of its cognate PBP class B (Taguchi, 2019).  
In many species, PBPs produce most of the crosslinkage in the PG. The pentapeptides are used 
as donors in DD-transpeptidation by catalysing peptide bond formation between the D-Alanine 
in position 4 (donor stem) and the amino group of a residue in position 3 (acceptor stem) 
(Vollmer, 2008a). PBP activity is inhibited by β-lactams and glycopeptides, two of the most 
clinically relevant antibiotics (Arbeloa, 2004; Boneca, 2003; Stapleton, 2002; Tipper, 1965). Class 
C PBPs are monofunctional enzymes with D,D-carboxypeptidase and endopeptidase activities 
involved in cell separation. These enzymes hydrolyse the D-Ala4-D-Ala5 bond in the pentapeptide 
stem and the D-Ala4-L-Lys3 bond of cross-linked PG, respectively (Vollmer, 2008c). 
Finally, D-Ala is not the only possible acyl donor during the cross-linkage reaction. LD-
transpeptidases (LDTs) use the carboxyl group of the amino acid at position 3 as donor to form 
3-3 cross-links (Hugonnet, 2016; Wietzerbin, 1974). In most species L-D cross-links are of low 
abundance but increase during stationary phase or in β-lactam resistant strains (Hugonnet, 2016; 
Vollmer, 2008a). In the Mycobacterium and Clostridium genera, 3-3 cross-links are the most 
abundant type (Baranowski, 2018; Egan, 2020; Vollmer, 2008a; Wietzerbin, 1974), and some 
strains of E. faecium can bypass the need for DD-transpeptidation by exclusively performing LD-
transpeptidation in the presence of  β-lactams (Fig. 1.4) (Mainardi, 2005) 
PG hydrolases play a key role in sculpting the shape, size, and thickness of the newly synthesized 
and matured sacculus, and contribute towards  interbacterial interactions (Vollmer, 2008a). PG 
hydrolases can have redundant roles, and it has been shown that no single hydrolase knockout 
prevents growth or cell separation (Typas, 2011; Vollmer, 2008c). The major classes of PG 
hydrolases are N-acetylmuramidases, that hydrolyse the bond between GlcNAc and MurNAc 
residues and release a MurNAc residue at the reducing end; N-acetylglucosaminidases, cleaving 
between MurNAc and GlcNAc residues releasing a GlcNAc residue at the reducing end; 
transglycosylases, that cleave the same bond as N-acetylmuramidase but do not use a water 
molecule during cleavage; amidases, that cleave the bond between MurNAc and the N-terminal 
L-Ala residues of the stem peptide; and peptidases which are divided into endopeptidases, and 
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Figure 1.4. Peptidoglycan cross-linking in C. difficile. (A) Reactions catalysed by penicillin-binding 
proteins (PBPs) lead to the formation of 3-4 bonds; class C (low molecular weight) PBPs display 
D,D carboxypeptidase activity to hydrolyse the D-Ala4-D-Ala5 bond in the pentapeptide stem. (B) 
Reactions catalysed by L,D-transpeptidases (LDTs) lead to the formation of 3-3 bonds. LDTs can 
also display L,D-carboxypeptidase activity and can exchange the C-terminal amino acid in position 
4.  
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Figure 1.5. Cleavage sites of the different PG hydrolases. Hydrolysis of glycosidic, amide, and 
peptide bonds in E. coli or B. subtilis PG. N-acetylmuramidases (MurNAses) and N-
acetylglucosaminidaseses (GlcNAses) cleave the glycosidic bonds between GlcNAC and MurNAC 
glycan chains. N-acetylmuramyl-L-alanine amidases (Ami) hydrolyse the amide bonds between 
the lactyl group of MurNAc and the L-alanine of the stem peptide. The anhAmi specifically cleaves 
at 1,6-anhydroMurNAc residues. Endopeptidases (DD-EPase, LD-EPase,  DL-EPase) cleave amide 
bonds within the peptide stem or the cross bridges when present. The cleavage sites for LD-or 
DL-endopeptidases are indicated in a dimeric (cross-linked) peptide, but monomeric units can be 
hydrolysed. Carboxypeptidases (DD-CPase, LD-CPase, DL-CPase) cleave peptide bonds to remove 
C-terminal D-or L-amino acids (Adapted from Vollmer, 2008c) . 
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carboxypeptidases. Endopeptidases cleave the bond within the peptide stem or cross bridge and 
carboxypeptidases remove the C-terminal D-or L-amino acids of peptide stems (Fig. 1.5)(Typas, 
2011; Vollmer, 2008c). 
 
1.1.2. Anionic polymers 
The cell wall of Gram-positive bacteria is densely decorated by linked heteropolymers. Teichoic 
acids and other diverse heteropolysaccharides such as capsules and rhamnopolysaccharides 
(RhapWPs) are intimately involved in cell division, cell shape (particularly in rod-shape 
microorganisms), resistance to host immune defences, and the modulation of resistance to 
cationic antibiotics and β-lactams (Brown, 2013; Desvaux, 2018; Percy, 2014; Smith, 2019).  
 
1.1.2.1 Teichoic acids.  
Teichoic acids (TAs) are a diverse family of cell surface glycopolymers containing phosphodiester-
linked polyol repeat units (Ward, 1981). There are two types of TAs: (i) lipoteichoic acids (LTA) 
anchored in the cytoplasmic membrane and (ii) wall teichoic acids (WTA) covalently attached to 
PG (Brown, 2013; Caveney NA., 2018; Percy, 2014).  
WTAs are covalently attached to PG via a phosphodiester bond to the C6 hydroxyl of MurNAc 
(Neuhaus, 2003; Ward, 1981). WTAs can be divided into two components: the disaccharide 
linkage unit and the main chain polymer. The disaccharide linkage unit is highly conserved across 
species and it is made of N-acetylmannosamine (ManNac) and GlcNAc linked by a β 1-4 bond, 
with one to two glycerol-3-phosphate (GroP) units attached to the C4 oxygen of ManNAc (Brown, 
2013; Caveney NA., 2018). The anomeric phosphate of GlcNAc from the linkage unit forms the 
covalent bond with MurNAc in the PG. The main chain, made of phosphodiester-linked polyol 
repeats, extends from the GroP end of the linkage units (Ward, 1981). The two best-characterized 
WTA structures are comprised of repeating 1,5-D-ribitol-phosphate (RboP) or 1,3-L-α-glycerol-
phosphate (GroP) units. However, WTA monomer structures can be highly diverse (Brown, 2013; 
Endl J, 1983). It has been shown that members of the same species display differences in their 
WTA composition.  In B. subtilis, strains 168 and W23 contain GroP and RboP, respectively 
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(Brown, 2013), whilst in E. faecalis, the WTA repeating units of the clinical isolate 12030 were 
composed of D-glucose, D-galactose, 2-acetamido-2-deoxy-D-galactose, 2-acetamido-2-deoxy-D-
glucose, D-ribitol, and phosphate in a molar ratio 1:2:1:1:1:1 (Theilacker, 2012). These 
modifications may represent adaptions to environmental pressure. It has been shown that WTAs 
are required for survival; a cell lacking WTAs has gross defects in cell division and cell morphology. 
WTAs comprise up to 60% of the cell wall mass (Brown, 2013). In B. subtilis and S. aureus, it has 
been estimated that every ninth PG MurNAc residue contains an attached WTA polymer made 
of 40 to 60 polyol repeats (Bera, 2007; Kojima, 1985). WTAs are also involved in biofilm 
formation, virulence, and antimicrobial resistance (Brown, 2013).  
LTAs are defined as alditolphosphate-containing polymers which are linked via a lipid anchor to 
the cytoplasmic membrane. LTAs have been grouped into five different types based on their 
chemical structures. The best-characterized LTA structure is the polyglycerol phosphate, or type 
I LTA, which are the most common LTAs in Firmicutes. They have an unbranched 1–3 linked GroP 
backbone structure linked to the cytoplasmic membrane via a glycolipid anchor, which is often a 
diglucosyl-diacylglycerol (Glc2-DAG) unit. Type II to V LTAs have more complex structures which 
often contain glycosyl residues. In S. pneumoniae, type IV LTAs are decorated with 
phosphocholine (Percy, 2014). LTAs and WTAs are often modified with sugar moieties and D-Ala 
esters, that introduce positive charges to the negatively charged phosphate polymers. LTAs play 
an important role for bacterial growth and physiology, and contribute to membrane homeostasis 
and virulence (Percy, 2014; Reichmann, 2013, 2011). 
1.1.2.2 Wall polysaccharides 
Wall polysaccharides (WPs) are complex structures with various compositions e.g. capsule, 
RhapWPs, or teichuronic acids. The composition of WPs often varies and can be strictly strain 
specific. Capsules contribute to pathogenesis through specific interactions with 
opsonophagocytic antibodies. The capsular polysaccharide (CPS) is variable and non-ubiquitous, 
in E. faecalis V583 is made of diheteroglycan glucose and galactose and is involved in resistance 
to phagocytosis (Guerardel, 2020). The anchoring of CPs remains unclear, however, in S. 
pneumoniae, it has been shown to be covalently linked to the GlcNAc residues (Larson, 2017).  
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CPSs and RhapWPs are major virulence factors  in many microorganisms (Geiss-Liebisch S, 2012; 
Teng, 2002; Thurlow, 2009). In Enterococci, the presence of these heteropolysaccharides allows 
bacteria to escape detection and clearance by the host immune system (Guerardel, 2020; Smith, 
2019). The enterococcal polysaccharide antigen (EPA) has been associated with invasion of host 
tissues (Teng, 2002) and biofilm formation (Mohamed JA, 2005). The genes responsible for EPA 
production are encoded by a complex locus (epa) that contains 18 genes (epaA to epaR) (Palmer, 
2012; Smith, 2019). Recent studies revealed that the decorations of the EPA polymer, encoded 
by genetic loci that are variable between isolates, underpin the biological activity of this surface 
polysaccharide by contributing to resistance towards phagocytosis and charged antimicrobials 
(Smith, 2019). The complete structure of E. faecalis strain V583 has been recently determined 
(Guerardel, 2020). The rhamnan backbone of EPA is composed of a hexasaccharide repeat unit 
of C2- and C3-linked rhamnan chains, partially substituted in the C3 position by α-glucose (α-Glc) 
and in the C2 position by β-N-acetylglucosamine (β- GlcNAc). The EPA decorations consist of 
phosphopolysaccharide chains corresponding to teichoic acids covalently bound to the rhamnan 
backbone. As previously mentioned, the composition of these complex heteropolysaccharides 
differs between species and it is likely to be strictly strain specific as determined for other E. 
faecalis  EPA-containing strains (unpublished-Davis, J., Smith RE). 
  
 1.1.3 Architecture 
PG is a single complex macromolecule that does not display a crystalline structure (Vollmer, 
2008a). Different studies combining biochemical analyses and atomic force microscopy (AFM) on 
isolated PG from B. subtilis led to architectural models where the PG network is oriented parallel 
to the short axis of the cell (Hayhurst, 2008; Turner, 2014; Vollmer, 2010). A more recent study 
used high-resolution AFM of S. aureus and B. subtilis living cells and PG sacculi  imaged in liquid 
(Pasquina-Lemonche, 2020).  It showed that the mature cell wall is a disordered, mesh-like 
hydrogel with large (up to 60 nm diameter) and deep (up to 23 nm) pores. The cell wall thickness 
has been estimated at ~20 nm which implies that some pores could extend across most of the 
wall (Vollmer, 2010). It was also determined that the inner PG layer is mainly constituted of 
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recently synthesized PG. This surface appeared much denser with less than 7 nm of glycan strands 
spacing and it displayed two distinct architectures that are thought to be location dependent.  
 
The two distinct inner surface architectures were attributed to different synthesis regimes. First, 
a highly ordered structure formed of circumferentially oriented glycan strands was proposed to 
be constituted of nascent septal material. The observations of long concentric rings  support the 
key role of PG hydrolases in cell wall remodelling during growth and maturation. It was 
hypothesised that this material was deposited at the leading edge of the constricting cell 
membrane forming the post-synthesis core. The second inner architecture extends across the 
division septa to constitute the cytoplasm-facing side of the wall. This inner surface is the densest 
region with substantially smaller pores and randomly oriented material. These observations were 
consistent in S. aureus and B. subtilis, apart from the presence of concentrically oriented strands 
at the cylinder attributed to elongasome-associated PG synthesis in the latter (Pasquina-
Lemonche, 2020; Turner, 2014).  
 
It has been proposed that PG remodelling results in the reorientation of the glycan strands from 
the septal rings (S. aureus) or the cylinder (B. subtilis) to produce a porous surface architecture 
(Pasquina-Lemonche, 2020). The distinct architectural arrangements observed across the PG 
contribute to our understanding of this macromolecule as an elastic and dynamic structure. PG 
serves as a scaffold for the attachment of complex polymers likely protruding from its pores, as 
well as the transport and interaction of different surface proteins. It also controls the turgor 
pressure within the cell to prevent plasmolysis which requires a closer and denser PG structure 
of the inner, smoother surface.  
 
1.2. Cell surface proteins of Gram-positive bacteria  
Bacterial surface proteins play a key role during cell growth and division. They interact with the 
host immune system, and in some cases, they are involved in the competition with other bacteria 
for a given ecological niche. The study of bacterial surface proteins dates back to the late 1950s 
with initial efforts to characterize predominant antigens in Staphylococci and Streptococci strains 
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(Jensen, 1958; Lancefield, 1962). Cell wall-associated proteins are classified into two main 
classes: (i) proteins covalently attached to PG and (ii) proteins non-covalently bound to either PG 
and/or cell wall associated polymers (Table 1.1).  
 
1.2.1  Cell surface proteins covalently bound to PG  
 
1.2.1.1 Cell wall sorting mechanism   
The covalent binding of proteins to PG is conserved in Gram-positive bacteria and is one of the 
best characterised surface protein anchoring mechanisms (Dramsi  S., 2008; Fischetti, 1990; 
Navarre, 1999; Schneewind, 1995). It involves the recognition of a C-terminal cell wall sorting 
signal (CWS) characterised by  a charged tail of a few residues followed by an LPXTG motif. LPXTG 
proteins are covalently linked to PG by a family of enzymes named sortases (Dramsi  S., 2008). 
LPXTG proteins are present in all known Gram-positive bacteria and have been identified as 
colonising factors, toxins, proteases, amongst others (Navarre, 1999). S. aureus protein A has 
been the main subject of study to unravel the cell wall sorting mechanism (Navarre, 1999; 
Schneewind, 1995).  
 
The C-terminal CWS is comprised of a highly conserved LPXTG motif, where X denotes any amino 
acid, followed by a hydrophobic domain and a positively charged tail (Figure 1.6) (Dramsi  S., 
2008; Fischetti, 1990). It has been determined that all elements from the CWS are necessary for 
the correct protein attachment to the cell wall. The hydrophobic domain and the charged tail are 
necessary for protein translocation where they are thought to hold the protein at the cytoplasmic 
membrane whilst the rest of the LPXTG protein is transported via the secretory pathway to the 
outer leaflet of the cell membrane (Dramsi S., 2017). Here the LPXTG sequence is recognized by 
sortase enzymes that attach the LPXTG protein on the nascent PG by cleaving between the T and 
G residues. Depending on the PG nature, sortases anchor this motif into the NH2 group of the 
amino acid at position 3 in the PG peptide stem (Budzik JM, 2008) or on the N-terminal residue 
of the lateral chain (Marraffini, 2005).  
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a
 Other names found in the literature. Name and abbreviation given in the first two columns are 
the most common.  
Table 1.1 Domains involved in protein attachment to the Gram-positive cell wall.  
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b
 Member databases used to construct the Interpro entry, i.e. Pfam (PF), SMART (SM), Conserved 
Domain Database (CD), Prosite (PS), Prints (PR), SuperFamily (Fischer et al.). 
c 
Accession number of structures available in the PDB. 
d 
CW, cell wall; PG, peptidoglycan; LTAs, lipoteichoic acids; WTAs, wall teichoic acids; WPs, wall 
polysaccharides; n.d., not determined. Choline residues are found in WTAs and LTAs. 
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Figure 1.6. Covalent anchoring of surface proteins by SrtA. Most proteins covalently bound to 
PG have a C-terminal sorting signal comprised of: (i) the LPXTG sorting motif, where X denotes 
any amino acid, (ii) a hydrophobic sequence and  (iii) a positively charged tail of 5-12 amino acids. 
The N-terminal sequence directs the full-length polypeptide (step 1) through the Sec system and, 
upon translocation, is cleaved by signal peptidases. The product of this reaction (step 2) is 
retained within the secretory pathway via its C-terminal hydrophobic domain (blue box) and 
positively charged tail (+). The sortase, a membrane-associated enzyme with an active cysteine 
group, cleaves the substrate between the threonine and glycine residues to form an acyl-enzyme, 
in which cysteine from the active site interacts with the carboxyl group of threonine. The carbonyl 
group of the threonine residue is then attached to the amine group of the last glycine residue of 
the lateral chain on a lipid II precursor. The attached protein to lipid II (step 3) reaches the cell 
surface at the lipid precursor and is polymerized into the existing network. (Adapted from BPS 
Bioscience, Inc).  
 
  
23 
 
There are six classes of sortases classified from A to F (Dramsi S., 2017). All sortase enzymes 
possess a similar structure, with an N-terminal signal peptide and a catalytic TLXTC motif. 
However, they display specific recognition patterns related to the chemical structure of PG and 
the variability within the LPTXG motif (Dramsi S., 2017; Siegel, 2017). Sortase A anchors a wide 
range of LPXTG proteins, whereas sortase B recognizes a related motif NP(Q/K)TN. The sortase 
class C is involved in pilus assembly whilst class D enzymes, predominantly identified in Bacilli, 
have been associated with the anchoring of sporulation proteins to the cell wall. Class E and F 
have been identified in Actinobacteria, but their functions remain unknown (Desvaux, 2018; 
Dramsi S., 2017; Siegel, 2017). 
 
1.2.2 Cell surface proteins non-covalently bound to PG  
In Gram-positive bacteria, most surface proteins have a multi modular organization, with two or 
more domains. Many surface proteins are PG hydrolases with a general architecture consisting 
of a catalytic domain linked by its N- or C- terminal end to one or more cell wall binding modules 
(Vollmer, 2008c). Most cell wall binding domains consist of 30 to 100 amino acids that form non-
covalent bonds enabling weak and dynamic interactions by the formation of hydrogen bonds, 
ionic bonds, van der Waals forces and/or hydrophobic interactions (Desvaux, 2018).  
 
The discovery and classification of cell wall associated proteins has dramatically increased thanks 
to the availability of sequencing data and bioinformatic analyses. These data have highlighted 
the great structural and functional diversity of the cell wall binding domains (Table 1.1). 
 
1.2.2.1 LysM domains 
Lysin motif (LysM) domains are highly conserved carbohydrate-binding molecules present across 
all kingdoms (Buist, 2008; de Jonge, 2009; Kaku, 2006; Radutoiu, 2003). According to Pfam 
(June,2020) there are 28,700 LysM bacterial sequences from over 6,400 specie (El-Gebali, 2019). 
LysM domains consist of approximately 45 amino acids  that adopt a βααβ fold with the two 
helices packing onto the same side of an anti-parallel beta sheet (Fig. 1.7 A) (Bateman, 2000; 
Mesnage, 2014; Wong, 2015). Up to 12 LysM domains can be found in a single protein  
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Figure 1.7. Structure of E. faecalis LysM AtlA module bound to GlcNAc5. (A) Cartoon 
representation of the NMR structure of the first AtlA LysM module. β-Sheets are formed of 
residues T4-V8 and G42-V47; α-helices of L14-Y21 and V25-N32. (B,C) Model of interaction 
between one LysM domain to E. faecalis PG, including the peptide stem. Glycan strands MurNAc-
(GlcNAc-MurNAc)2 are depicted in blue.  The peptide stem (pink) is represented in two possible 
orientations interacting with either the residue G11/K16 or L38 (Adapted from Mesnage, 2014).  
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and they are often separated by flexible linkers that are rich in S, T, and N residues (Mesnage, 
2014). 
 
LysM-carbohydrate interactions are highly diverse, and it has been shown that the binding 
mechanism varies within LysM domains. In eukaryotes, LysM proteins can form quaternary 
structures requiring posttranslational modifications involving the formation of disulphide bonds, 
that are necessary for carbohydrate recognition (Lefebvre, 2012; Radutoiu, 2007). In bacteria, 
LysM domains generally do not contain cysteine residues and have been shown to bind PG  in a 
non-covalent manner via a cooperative binding mode (Mesnage, 2014). 
 
Bacterial LysM domains bind to PG by interacting with GlcNAc polysaccharides (Mesnage, 2014). 
E. faecalis AtlA, an autolysin involved in cell division, is constituted of six C-terminal LysM repeats 
that recognise the GlcNAc -x- GlcNAc motif. One essential attribute of this LysM-PG interaction is 
the presence of a hydrogen bond network that creates a contact surface with four carbohydrates 
that are the minimal PG binding motif. It has been determined that the multiple AtlA LysM 
domains displayed an additive binding to either short PG polysaccharides or intact PG sacculi. 
Interestingly, AtlA binds to chitooligosaccharides (GlcNAc-containing oligomers) with a higher 
affinity, which highlights the adaptability of carbohydrate recognition across kingdoms 
(Mesnage, 2014). The optimal ligand for LysM appears to be a GlcNAc pentasaccharide (GlcNAc)5 
(Koharudin LM, 2011; Mesnage, 2014). 
 
The crystal structure of a single fungal LysM module from the MoCVNH3 lectin of Magnaporte 
oryzae was determined in its apo form and as a (GlcNAc)3- and (GlcNAc)4-bound protein 
(Koharudin LM, 2011). It was shown that the binding site is comprised of two loop regions that 
connect the secondary structures, i.e.  the loop between β1-α1 and the loop between α2-B2. 
Conformational changes caused by ligand recognition form a shallow groove that can 
accommodate the carbohydrates. These changes were especially pronounced for residues in the 
loop region connecting helix α2 and strand β2. It was also determined by NMR titrations that LysM 
domains can accommodate long GlcNAc chains in different fashions. These observations are in 
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agreement with the LysM structure from the putative NlpC/P60 D,L endopeptidase from Thermus 
thermophilus bound to a (GlcNAc)6 polysaccharide (PDB, 4UZ3) where several alternative 
conformations were found for the last two GlcNAc oligomers (Wong, 2015). No dimerization of 
MoCVNH3 via its LysM domain was observed upon binding to GlcNAc6, unlike multiple eukaryotic 
LysM domain-containing proteins (Koharudin LM, 2011; Wong, 2015). 
 
A recently determined co-crystal structure of E. faecalis AtlA bound to a GlcNAc pentasaccharide 
(GlcNAc)5 (Galley N., F. Vincent, Mesnage S., unpublished) confirmed the published model made 
with the NMR structure of AtlA, docking the LysM-GlcNAc5 oligosaccharide on the first LysM 
module (Mesnage, 2014). AtlA LysM exhibits the typical βααβ fold connected by two loops 
between β1-α1 and β2-α2. NMR titrations with PG fragments  (β-1,4− GlcNAc -MurNAc-peptide 
polymer) located the interaction site within the protein loops (Fig. 1.7 B). They formed a 
contiguous surface in accordance with the interaction shown with chitin  (Koharudin LM, 2011; 
Wong, 2015). Moreover, it was suggested that LysM from AtlA has evolved to bind PG since NMR 
titrations indicated residues that only interacted in the presence of GlcNAc-MurNAc ligands 
containing both the lactoyl group and peptide stem (Fig. 1.7 B).  
 
1.2.2.2 WxL domains 
The C-terminal WxL family domain is comprised of two highly conserved sequences containing 
the Trp-x-Leu (WxL) motifs. The first WxL motif is followed by a well-conserved 
YXXX(L/I/V)TWXLXXXP distal motif at the last 120 to 190 amino acid residues of the protein  
(Brinster, 2007; Siezen, 2006). WxL proteins have been identified in over 220 species of Gram-
positive bacteria (June,2020) (El-Gebali, 2019), mainly in the orders of Lactobacillales and 
Bacillales (Brinster, 2007; Dumas, 2008; Galloway-Peña, 2015; Toh, 2013). To this date there are 
no structures available in the protein data base. WxL domains were shown to bind PG (Brinster, 
2007). However, the PG binding motif has yet to be identified. In E. faecalis, recombinant fusion 
proteins including an N-terminal nuclease reporter and a C-terminal WxL domain were made 
from two WxL-containing proteins found in the V583 strain. These proteins were shown to bind 
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the bacterial cell wall of whole cells and isolated PG by Western Blot analyses. Moreover, 
deletions of the WxL domains proved to abolish binding to PG (Brinster, 2007).   
 
It has been shown that WxL proteins are encoded by genes organised in clusters and from 
bioinformatic and transcriptome data in L. plantarum and E. faecium it has been hypothesized 
that these loci are likely to form cell surface protein complexes involved in virulence or 
colonization-related functions (Brinster, 2007; Galloway-Peña, 2015; Siezen, 2006). Further 
biochemical and structure-function analyses are required to elucidate the architectural and 
biological properties of these proteins.  
 
1.2.2.3 Sporulation-related domain (SPOR) 
The sporulation-related (SPOR) domains are PG binding proteins found in a large number of 
bacteria. Amongst Gram-positive bacteria these domains are mainly found in Firmicutes, 
especially in the Clostridiales and Bacillales orders (Alcorlo, 2019; Yahashiri, 2017).  Currently, the 
Pfam database includes 4127 bacterial species harbouring SPORs and five structures have been 
determined (June,2020) (El-Gebali, 2019). One to five SPOR domains can be found in a single 
protein (Mishima, 2005).  They are approximately 70 amino acids long ,constituted of two 35-
residue repeats.  Overall, SPOR proteins share low sequence similarity, with less than 20% amino 
acid identity. However, at a structural level they share a conserved fold made by a four stranded 
antiparallel β-sheet flanked on one side by two α-helices. These domains have been classified as 
part of the ribonucleoprotein (RNP) fold superfamily which are also present in eukaryotic 
proteins, although RNP folds are not associated with the recognition of a particular ligand 
(Yahashiri, 2017).  
 
 Originally, SPOR domains were found in proteins associated with sporulation (Mishima, 2005). 
The identification of the first C-terminal SPOR protein was in the B. subtilis CwlC amidase, which 
is involved in PG hydrolysis of the mother cell that allows the release of the spore. SPOR proteins 
are quite diverse and are also involved  in the remodelling of PG,  primarily acting as PG septal  
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Figure 1.8. Structural basis of denuded glycan recognition by P. aeruginosa RlpA SPOR domains. 
(A) Top, scanning-electron micrograph showing  the  P. aeruginosa daughter-cell 
separation process. Inset shows a schematic cartoon  representing the cell-division septum and 
coordinated processes involved in cell-envelope constriction. (B) Diagram of the division site 
(corresponding to the blue boxed area in (A), showing the coordinated action of PG amidases 
(purple) and the glycosylation of RlpA catalytic domain (gray) upon recognition of the denuded 
glycan chains by its SPOR domain (yellow). OM, outer membrane; IM inner membrane. The 
protein has a covalently attached lipid at the amino terminus. (C) Crystal structure of the SPOR-
RlpA in complex with (MurNAc-GlcNAc)2 (compound 1) and tetrasaccharide containing 
anhMurNAc at position 1 (compound 3). The structure of compound 1 (blue sticks) is 
superimposed (protein omitted for clarity). (D) Model to represent the steric clashes of PG 
peptide stems in the SPOR-RlpA:1 complex. The peptide conformation is according to PDB 6FCS. 
The modelled peptide stems are in orange for the carbon atoms. Adapted from (Alcorlo, 2019; 
Gray, 2015). 
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targeting domains that recruit proteins to the cell division site (Ursinus, 2004; Yahashiri, 2017, 
2015). SPOR proteins bind ‘denuded’ PG, i.e. PG devoid of peptide stems (Gerding, 2009; Ursinus, 
2004; Yahashiri, 2015). Denuded glycan strands are located at septal PG and are generated by 
amidases to allow the separation of the daughter cells (Fig. 1.8 A-B) (Alcorlo, 2019; Vollmer, 
2008c; Yahashiri, 2017). 
 
According to Pfam, these domains are present in multiple domain organizations associated with 
proteins involved in different cellular functions. In a simplified overview of the domain 
organization the most abundant architecture, around 60% of the SPOR sequences, is associated 
with proteins containing an N-terminal transmembrane anchor with a large unstructured linker 
region of low sequence complexity. The best-studied proteins from this group are the E.coli FtsN, 
DamX, and DedD proteins, which are all part of the apparatus that remodels PG during cell 
division (Yahashiri, 2017; Yang, 2004).  Previous  observations using GFP-SPOR fusions of the 
mentioned proteins (FtsN, DamX, and DedD) showed no binding to isolated PG sacculi from an 
E.coli mutant lacking the three main amidases responsible for daughter-cell separation 
(ΔamiABC) (Heidrich C, 2001; Priyadarshini, 2007). As mentioned above, these enzymes remove 
peptide stems from glycan strands, so denuded glycans presumably are absent in the 
ΔamiABC mutant. This suggested that, not only do SPORs bind denuded PG, they are incapable 
of binding to a ‘complete’ monomeric PG unit. Although it is likely that SPOR domains share an 
overall similar PG recognition, regardless of their modular organization, a structure of the SPOR-
glycan complex of cell-division proteins is necessary, in addition to the existing biophysical studies 
(Mishima, 2005; Williams, 2013; Yang, 2004) to confirm the nature of their binding mode as for 
the recently solved co-crystal structure of the SPOR RplA PG hydrolase (Fig. 1. 8) (Alcorlo, 2019).  
 
The second most abundant domain architecture found in SPORs (~20%) corresponds to SPOR- 
containing PG hydrolases, e.g. CwlC in B. subtilis and RlpA in E.coli and Pseudomonas aeruginosa. 
RplA is a lytic transglycosylase needed for the efficient separation of daughter cells and the 
maintenance of rod shape (Alcorlo, 2019). A solved structure of the RlpA SPOR domain in complex 
with synthetic tetrasaccharide (MurNAc - GlcNAc)2 ligands corroborated that the peptide stems 
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in the monomeric PG unit abrogate binding. The PG-binding site in the SPOR domain is located 
within the concave face of the β-sheet forming a cavity where the tetrasaccharide sits in an 
extended conformation (Fig. 1.8 C-D). It was proposed that the minimal ligand was constituted 
of two disaccharide (MurNAc-GlcNAc)2 units devoid of their peptide stems. Although all four 
glycans directly interact with the protein, the strongest polar interactions were with the 
carboxylate moieties of the MurNAc rings, highlighting their crucial involvement in binding. These 
carboxylate moieties become available only after the removal of the peptide stems by the actions 
of PG amidases. The exposed D-lactyl group of MurNAc 1 interacts with a conserved Q residue 
identified in previous studies, and a positively charged patch made of three R residues, whereas 
the second D-lactyl group interacts with an F residue.  These interactions create a bent 
conformation of the glycan chain.  
 
SPOR proteins were also capable of binding modified polysaccharides (containing the 
anhMurNAc residues) which suggests that SPORs are able to bind at the end of the glycan chains 
(peripheral PG) (Fig. 1.8 C). However, fewer polar interactions were observed between the lactyl 
carboxylate and the Q and R residues. Computationally modelled complexes with O-acetylated 
glycans allowed these interactions, whereas N-deacetylated glycan chains seemed unfavourable 
for binding. The ligand did not remain in the binding pocket since the N-deacetylated PG was not 
able to form a hydrogen bond with the conserved Q residue compared to other tolerated 
modifications.  
The remaining SPOR domain architectures are found in proteins that fall into different categories, 
most of which have unknown functions.  
 
1.2.2.4 Clostridial hydrophobic repeat (ChW) 
The ChW (clostridial hydrophobic W (tryptophan)) domains are approximately 50 amino acids 
long and contain a highly conserved Gly–Trp dipeptide motif. A single protein can harbour up to 
12 domains but there are no structures yet available. They were originally identified in 
Clostridium acetobutylicum and proposed to be involved in cell wall binding based on 
bioinformatic assignment (Desvaux, 2005; Nölling, 2001). Although they are mainly associated 
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with  Clostridia,  they  are  present  in  some  Gram-positive  bacteria,  including  E. faecalis,               
S. agalactiae and some members of the phyla Actinobacteria, specially Streptomycetes (Desvaux, 
2018). ChW domains are mostly found in bacteriophage endolysins where they could be involved 
in targeting the cell wall, and very little is known about their structure or function (Oliveira, 2013).  
 
1.2.2.5 Choline binding proteins (CBD)  
The choline-binding proteins (CBD) are comprised of conserved regions of approximately 20 
amino acids long. This conserved motif is also known as the cell wall binding repeat type 1 
(CWB1). CBDs are commonly found in tandem or in association with other PG binding domains 
(Galán-Bartual, 2015; García, 1998; Varea J, 2000). They have been primarily described as TA 
binding modules in Streptococci, as well as in some of their associated bacteriophages (Eldholm, 
2009; Fernández-Tornero, 2001; Maestro, 2016). The TA polymers (WTAs and LTAs) from the 
members of the Mitis group in the Streptococcus genus (including S. pneumoniae) are decorated 
with phosphatidyl choline (P-Cho) groups. In S. pneumoniae, P-Cho moieties appear essential for 
several physiological functions such as colonization of the upper respiratory tract in mice models 
(Kharat AS, 2006).  
 
LytA is the major autolysin in S. pneumoniae. It is made of an N-terminal N-acetylmuramoyl l-
alanine amidase domain with six C-terminal choline binding repeats (Fig. 1.9 A) (Fernández-
Tornero, 2001; Maestro, 2016). CBDs bind to the TAs at the cell wall and their deletion from LytA 
prevents the localization of the amidase at the cell surface and therefore the autolysis of 
pneumococcal cells (Giudicelli, 1984). The overall shape of the six terminal repeats is 
approximately cylindrical. Each repeat encompasses two structural units: a β-hairpin formed by 
two antiparallel β-strands, and an 8-10-residue connecting loop. The six β-hairpins adopt a 
solenoid fold that stack to form a left-handed superhelix with a boomerang-like shape (Fig. 1.9 
A). LytA CBDs bind to choline groups at hydrophobic cavities present in the protein surfaces (Fig. 
1.9 B)  (Fernández-Tornero, 2001). The choline binding sites (ChBS) are formed by the interface  
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Figure 1.9. Structure of S. pneumoniae LytA CBD proteins in complex with choline residues. (A) 
Cartoon representation of the six C-terminal LytA CBD domains. β-hairpins (‘hp’) are colored cyan, 
whereas the loops connecting them are colored yellow. (B) Partially transparent protein surface 
of the choline binding sites in a crystallized CBD-LytA dimer. Monomers are highlighted in different 
colors: yellow and cyan. CBD binding site (ChBS) 1 and 2 of monomer ‘a’ (yellow) are occupied by 
DDAO molecules from crystallization solutions. ChBS3 of monomer ‘b’ (cyan) is occupied by the 
(2,2′:6′,2′′-terpyridine)-platinum(II) used for MAD phasing. The hydrophobic components of 
choline (labeled ‘cho’), DDAO (labeled ‘ddao’) and terpyridin (labeled ‘tpy’) molecules, 
schematized as CPK, occupy small hydrophobic cavities on the surface of the protein. (C) Enlarged 
image of ChBS4, where choline is highlighted in orange. The side chains of the hydrophobic 
conserved residues forming the cavity are shown in the ‘ball-and-stick’ format. The 2Fo – Fc omit 
map (green) of the choline molecule was contoured at 1.0 σ. (Adapted from  Fernández-Tornero 
C, 2001). 
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between consecutive β-hairpin pairs, i.e. hairpins 1 and 2 form the first ChBS (ChBS1), followed 
by hairpins 2 and 3 (ChBS2), hairpins 3 and 4 (ChBS3), and hairpins 4 and 5 (ChBS4) (Fig. 1.9 C) 
(Fernández-Tornero, 2001).  
 
Other structures of CBD proteins bound to choline or analogues shared a similar binding mode. 
The CDB repeats from the Cpl1-1 bacteriophage endolysin bind to the choline groups in the 
pneumococcal cell wall between its C-terminal hairpin 1-2, and 2-3 of the superhelical domain 
(Hermoso, 2003).  
 
1.2.2.6 PASTA domains  
PASTA domains (penicillin-binding protein and serine/threonine kinase-associated domains) 
have been described in PBPs and serine/threonine kinases (STPK) of Firmicutes and 
Actinobacteria (Mir, 2011; Ogawara, 2016; Pares, 1996). They exhibit a modular structure 
comprised of 1 to 5 modules. Each module consists of approximately 70 amino acids. Although 
PASTA domains share low sequence similarity (<25%) they display a strong structural 
conservation (Ogawara, 2016). 
 
PASTA domains in PBPs have a globular fold consisting of three β-strands and an α-helix, with a 
loop region of variable length between the first and second strands (Gordon, 2000; Yeats, 2002). 
They were first identified in the C-terminus of PBP2x proteins in S. pneumoniae (Pares, 1996). 
The solved structure showed van de Waals interactions between the β-lactam ring of the 
cephalosporin cefuroxime to one of the two PASTA domains present in the protein. The structural 
similarities of the cefuroxime β-lactam ring to D-Ala-D-Ala dipeptides in the PG led to the 
proposed binding recognition of PASTA domains to uncrosslinked  PG (Yeats, 2002). The 
localization of PBP2x in the mid-cell was shown to be dependent on PASTA domains which in turn 
is reliant on the presence of its substrate (PG precursors) (Jones, 2006; Peters, 2014). However, 
their biological function is still in debate since other PASTA domains do not seem to bind PG. In 
M. tuberculosis, PBP PonA2 which has a single PASTA domain does not bind muropeptides nor β-
lactams, or polymeric PG (Calvanese, 2014). In B. subtilis, PASTA domains are only present in two 
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of the sixteen different PBPs expressed, of them: PBP2b which has 2 PASTA domains and SpoVD 
which has only one. The PASTA domain in SpoVD however, is not essential for the endospore 
cortex PG assembly (Bukowska-Faniband, 2015).  
 
PASTA domains are also present in serine/threonine protein kinases (STPKs) (Ruggiero, 2011). 
The STPK in S. pneumoniae  (StkP) is comprised of an N-terminal phosphatase PhpP and four C-
terminal PASTA domains (Osaki, 2009). Since the StkP PASTA domains were shown to bind PG 
and β-lactams, uncrosslinked PG are thought to act as signals for StkP localization at the division 
site. The activation of StkP in response to the binding of PASTA domains is proposed to cause the 
phosphorylation of the cell-division proteins DivIVA and FtsZ (Maestro, 2011).  
 
The PknB STPK in M. tuberculosis is another example of a PASTA-containing kinase that binds to 
muropeptides (Mir, 2011).  It regulates many aspects of mycobacterial physiology and is a key 
component of a signal transduction pathway that regulates cell growth, cell shape, and cell 
division via phosphorylation of targeted proteins like the DivIVA ortholog Wag31 (Barthe P, 2010; 
Kang, 2005; Ogawara, 2016). PknB contains four C-terminal PASTA domains for which their 
binding to PG is dependent on the presence of both D-iGln and m-A2pm at the second and third 
position in the peptide stem, and on the presence of the MurNAc sugar moiety. A proposed 
model suggested that PG fragments produced at the mid-cell and cell poles act as signalling 
molecules for the PknB localization via their PASTA domains (Barthe P, 2010; Mir, 2011). 
Moreover, a close homologue of PknB, PknC in B. subtilis, induces germination of dormant spores 
through interactions with its PASTA domains (Shah, 2008). 
 
PASTA domains from PBPs and STPK display different structural arrangements following ligand 
binding. In S. pneumoniae PBP2x, the two PASTA domains interact with each other to form a 
compact globular structure (Yeats, 2002), compared to the linear organization of the four PASTAs 
in the PknB NMR structure (Mir, 2011). The presence of a β’/β brace in the place of a α-helix 
prevents the interaction between the individual PASTA domains and the formation of a compact 
structure in a single PknB protein. In PBP2x the close configuration of its two C-terminal domains  
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Figure 1.10. Model of M. tuberculosis PknB activation promoted by PASTA-PG binding. In this 
model, the PknB C-terminal PASTA domains bind to PG precursors or PG hydrolysed fragments 
produced at the mid-cell and poles. This interactions lead to PknB phosphoryl kinase activation. 
Authors depicted two PASTA domains in two possible arrangements following ligand binding. Rpf, 
resuscitation promoting factor (Adapted from Mir M, 2011). 
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were shown necessary for ligand binding. A model of the activation of the PknB kinase based on 
the binding of PASTA domains to muropeptides acting as signalling molecules was proposed (Fig. 
1.10). This model works on the basis that the mid-cell and poles are active sites of PG synthesis 
and hydrolysis, and that the high local PG concentration would result in the localization of the 
PknB PASTA domains. The accumulation of PknB proteins would then lead to dimerization of the 
kinase domains and its activation, which in turn causes the phosphorylation of cell-division 
proteins and cell wall synthesis at the cytoplasm. Further functional and structural analyses are 
needed to corroborate the aforementioned model and to determine whether the number of 
domains present in a single protein is necessary for PG recognition.  
 
1.2.2.7 SH3 domains  
SH3 [(src) homology 3] domains were first identified in eukaryotic proteins involved in cell 
signalling, division, and migration. The core ~60-residue region is present in many proteins such 
as the Src kinase family, the Crk adaptor protein, and phospholipase C-γ (Mayer, 1998; Yu, 1994). 
Eukaryotic SH3 proteins have been characterized as protein-protein interaction modules involved 
in the recognition of proline-rich sequences, PxxP being defined as the minimal consensus target 
for binding. Based on the relative positioning of a positively charged residue (R,K), two classes of 
peptide ligands have been described: class I peptide ligands with the consensus sequence 
(R/K)xxPxxP and class II ligands xPxxPx(R/K) with the consensus sequence in the opposite 
orientation.  The existence of a negatively charged pocket in the SH3 binding surface defines the 
orientation of the Class I and II ligands (Feng, 1994; Fernandez-Ballester, 2004; Kaneko, 2008). 
 
The evolution of the protein data base has allowed the identification of a large subset of 
structurally related SH3-like proteins in bacteria and viruses (Ponting, 1999; Whisstock, 1999). 
However, they share low sequence similarity to eukaryotic domains .Their sequence and 
structural conformation will be described in detail below. According to Pfam (May 2020), the SH3 
clan is present in 8,500 species, and contains 36 families and a total number of 121, 150 domain 
sequences (Table 1.2) (El-Gebali, 2019). 
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SH3 families with members proposed to bind bacterial CW are highlighted in blue. 
a 
Resolved structures in PDB (protein data bank). Only unique protein sequences were considered. 
Table 1.2. Lineage distribution of the SH3 domain families.  
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To date, around thirty bacterial SH3 structures have been determined, and in several families 
their function remains unknown. Twenty SH3 families have been found in bacteria, five of which 
have been identified as protein domains involved in non-covalent binding to the cell wall of 
different species:  SH3_3, SH3_5, SH3_6, SH3_7, and GW (SH3_8).  
 
The canonical SH3 structure comprises five β-strands arranged into two antiparallel β-sheets or 
in a β-barrel. β-strands are connected by three loops: the RT, Src, and distal loops, and a short 
310 helix. These play important roles in the recognition of binding partners (Fig. 1.11) (Kaneko, 
2008; Kurochkina, 2013). In eukaryotes, PxxP peptides bind to a relatively flat hydrophobic 
groove made of three shallow pockets flanked by the RT loop and the distal 310 helix. The Src loop 
is at the margin of the substrate binding groove (Fig. 1.11 A) (Feng, 1994; Fernandez-Ballester, 
2004; Kurochkina, 2013). 
 
The five -strands which represent the protein core are relatively conserved in bacterial SH3 
domains. The most pronounced structural differences are in the RT loop. Bacterial SH3 have long 
insertions of amino acids that form secondary structures. Most bacterial SH3 domains have two 
extra -strands in the RT loop and, in some cases, additional α-helices are also present (Fig. 1.11 
B). The additional -strands form -sheets with the five conserved strands. In many bacterial SH3 
structures, strands 2 and 6 interact by hydrogen bonds between the main chain atoms giving 
the RT loop a more closed conformation. This greatly reduces the accessible surface and creates 
a geometric incompatibility for the recognition of PxxP ligands (Fig. 1.11) (Kamitori, 2015; Lu JZ, 
2006). 
 
There are also other subtle differences between regions in the SH3 cell wall targeting domains 
that alter the recognition of PxxP ligands. The distal loop is slightly tilted away from the RT loop 
in prokaryotes when compared to the canonical position in eukaryotes. The extended position of 
strands 4 and 5 causes the tip of the Src loop to be positioned nearly 180 degrees away from 
its site in SH3_1 proteins. These conformational changes have formed surface regions that allow 
for interactions with common features of the bacterial cell wall (Fig. 1.11).  
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Figure 1.11. Structure and topology of eukaryotic and bacterial SH3 domains. (A) Cartoon 
representation of the eukaryotic SH3 type 1 domain, c-CRK (PDB entry 1CKA) (left) and the 
bacterial SH3 type 8, InLB distal C-terminal domain (PDB entry 1M9S) (right). Secondary 
structures are labelled: β-strands are numbered and rainbow coloured according to the position 
in the sequence from N- to C-terminus; 310 helices are coloured in dark pink.  (B) Topology of the 
canonical eukaryotic SH3 proteins (Kelley et al.) and a general representation of the topology of 
bacterial SH3 families (bottom). Secondary structures and loops are depicted.  
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Despite their structural similarities, eukaryotic and prokaryotic SH3 proteins show low sequence 
identity (>30%). A multiple sequence alignment between various cell wall binding SH3 proteins 
(from families 3 to 8) with a eukaryotic SH3_1 domain is shown in Figure 1.12. In eukaryotic 
domains, the open conformation of the binding groove is caused by hydrophobic contacts 
between the highly conserved F7, F9, W35, P49, and Y52 residues (Kaneko, 2008; Kurochkina, 
2013). These residues are rarely conserved in bacterial SH3 domains. Glycine 46 is the most 
conserved residue in eukaryotic and prokaryotic proteins and is part of the Gly-Trp sequence that 
gives name to the GW (SH3_8) domains. Whilst there is a high diversity between bacterial SH3 
proteins, there are conserved regions in bacterial families that allow favourable contacts with PG 
peptide structures as shown by the results obtained in this study. 
 
1.2.2.7.1 Structural comparison of SH3 domains targeting bacterial cell walls  
The secondary and tertiary structural arrangements of five families of SH3 domains targeting 
bacterial cell walls are shown in Figure 1.13. This section provides an overview of the structure-
function relationship between these families as described in the literature. The topology of the 
described SH3 structures was created using the sequence display mapped in the PDB data base.  
 
1.2.2.7.1.1 SH3_3 domains  
SH3_3 domains were first described as part of bacteriophage endolysins. Endolysins are 
expressed in the final stage of a lytic cycle. One of the best characterised endolysins harbouring 
an SH3_3 protein is the Psm enzyme encoded by the episomal phage phiSM101. Psm displays a 
specific muramidase activity against Clostridium perfringens strains (Nariya, 2011).  
 
Psm harbours an N-terminal catalytic domain belonging to the glycoside hydrolase family 25 and 
two C-terminal tandem repeats corresponding to the SH3_3 family domain (Tamai, 2014). The 
structures of these two SH3_3 modules are highly similar, despite sharing only 51% sequence 
identity. Both domains are formed of seven β-strands and the strands β2 and β3 are inside the   
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Figure 1.12. Multiple amino acid sequence alignment between cell wall targeting SH3 bacterial 
domains (SH3-3,5,6,7,8) with a eukaryotic SH3 domain (c-Crk). c-CrK, Mouse (PDB entry 1CKA); 
AvPCP, Anabaena variabilis (PDB entry 2HBW ); NpPCP, Nostoc punctiforme (PDB entry 2FG0 ); 
BcYkfc, B. cereus (PDB entry 3H41); DVU-0896, Desulfovibrio vulgaris (PDB entry 3M1U); Ale-1, S. 
capitis (PDB entry 1R77); Lysostaphin, S. aureus (PDB entry 6RK4); phiSM101, Clostridium 
perfringens type A strain SM101(PDB entry 4KRT); InlB, Listeria monocytogenes (PDB entry 
1M9S). Conserved residues among all proteins are highlighted in black and residues in light grey 
indicate conservative substitutions. The positions of β-strands and helices are shown by arrows 
and cylinders, respectively. β-strands are numbered and coloured in rainbow; 310 helices are 
coloured in dark pink; the red start represents either a loop or a 310 helix. The position of 
conserved hydrophobic amino acid residues (F7, F9, W35, P49, and Y552) among eukaryotic SH3 
protein is indicated by a (*). 
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Figure 1.13. Structural similarities of cell wall binding SH3 domain families. One protein from 
each of the five SH3 domain families targeting bacterial cell walls is described; from top to 
bottom:  (A) SH3 type 3, Psm endolysin (PDB entry 4KRT); (B) SH3 type 5, Lss  endopeptidase (PDB 
entry 6RK4); (C) SH3 type 6, YkfC endopeptidase (PDB entry 3H41); (D) SH3 type 7, YkfC 
endopeptidase (PDB entry 3H41) both domains (SH3_6 and SH3_7) are found in the same PBD 
structure from the YkfC endopeptidase; (E) SH3 type 8, Atl autolysin (PDB entry 4EPC). The 
topology map of each protein structure is shown on the left side. Secondary-structure elements 
and loops are depicted as indicated in the key below the structures. The coloured codes of β-
strands and 3
10 
helices are in agreement with Figure 1.11. The corresponding cartoon 
representation of each protein is shown on the right side. Three dimensional images of folds were 
prepared with PyMOL (DeLano, 2002) and the graphical representation of the protein 
architecture was built based on sequence entries as reported in UniProtKB.  
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RT loop. The topology and structure of the first SH3_3 domain is shown in Figure 1.13 A. A closed 
hydrophobic RT loop. The topology and structure of the first SH3_3 domain is shown in Figure 
1.13 A. A closed hydrophobic surface is formed by β2 and the distal 310 helix which extends to a 
positively charged cavity between strands β2 and β6 (Fig.1.14). Although the motif recognized by 
the SH3_3 domains has not been identified, the presence of acetic (ACT) and malonic (MLA) acid 
from crystallization solutions within the positive cavity of each SH3_3 repeat has been reported 
(Tamai, 2014). The ACT was bound to the SH3N and MLA to SH3C, both efficiently forming salt-
bridge interactions with R224 and R290, respectively (Fig. 1.14). These positively charged cavities 
have been proposed to accommodate a negatively charged PG peptide sidechain, which is likely 
to be D-Glu since in C. perfringens the L-L-diaminopimelate in position 3 is amidated. C. 
perfringens PG is crosslinked by the L,L-diaminopimelate in position 3 through a glycine 
interpeptide bridge to a D-alanine in position 4 (Leyh-Bouille, 1970). 
 
1.2.2.7.1.2 SH3_5 domains  
SH3 _5 domains are formed of 60 to 100 amino acids adopting a characteristic SH3 fold. The 
SH3_5 domains from lysostaphin (Lss) and its close homologue Ale-1 have been extensively 
studied. These domains are found in hydrolases that display  specific glycylglycine endopeptidase 
activity against members of the Staphylococcus genus, including methicillin-resistant S. aureus 
(MRSA). These C-terminal SH3_5 or SH3b domains have been proposed to drive a preferential 
binding to the PG pentaglycine cross-links which would confer the specificity of the bacteriolytic 
enzyme (Gründling, 2006; Lu JZ, 2006). Despite being discovered in 1964 (Schindler, 1964), the 
recognition of the PG by the Lss SH3_5  domain has not yet been fully characterized. The 
elucidation of this binding mechanism is the focus of Chapter IV.  
 
SH3_5 domains comprise 7 to 9 β-strands connected by the RT, Src and distal loops. Amongst the 
SH3_5 domains from staphylococcal hydrolases, additional conserved residues at the N-terminus 
form a unique β-strand (β1) and the additional N-terminal part of β2 (Fig.1.13 B) (Lu JZ, 2006). 
This region has been identified as interacting with the pentaglycine cross-bridges (Lu JZ, 2006; 
Sabała, 2014) (Fig. 1.14). The SH3_5 domains from Lss and Ale-1 share 84% sequence identity and  
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Figure 1.14. Hydrophobicity and surface charge of cell wall binding SH3 domain families. One 
protein from each of the five SH3 domain families targeting bacterial cell walls is shown in 
hydrophobic (red) to non-hydrophobic (white) gradient in a surface and cartoon representation, 
and on the right their surface electrostatic potential ; from top to bottom: (A) SH3 type 3, Psm 
endolysin (PDB entry 4KRT) with the presence of malonic acid (MLA) located in the proposed 
binding groove; (B) SH3 type 5, Lss endopeptidase (PDB entry 6RK4) bound to a pentaglycine 
peptide (G5); (C) YkfC endopeptidase (PDB entry 3H41) made of two N-terminal SH3 proteins, an 
SH3_6 domain (1), an SH3_7 domain (2), and a C-terminal NlpC/P60 domain (3). The proposed 
binding pocket for the L-Ala-iQ ligand is located at the SH3_6-NlpC/P60 interface; (D) SH3 type 8, 
Atl autolysin (PDB entry 4EPC). The two subunits, R2a and R2b, that form the SH3_8 domain are 
shown. Their proposed binding grooves are indicated by arrows. No ligand has been identified for 
any of the SH3_8 domains.  
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their structures are almost identical. The Lss SH3_5 domain is comprised of two β-sheets packed 
at right angles against each other. β-sheet I is built from strands β5- β7 and the N-terminus of β2, 
whereas β-sheet II is made from β3-β4, β8 and the C-terminus of β2. Strands β3 and β4 are inside 
the RT loop, in contrast with SH3_5 proteins from the Streptococcus, Enterococcus, and 
Lactococcus genera that exhibit the canonical insertion of β2 and β3 strands in their RT-loop. In 
the staphylococcal SH3_5 domain there is a relatively long loop called the ‘extra loop’ between 
strands β7 and β8 in the place occupied by a short 310 helix in eukaryotic SH3 domains (Fig. 1.13-
1.14). 
 
The structure of the Lss SH3_5 domain in complex with a pentaglycine peptide has been 
determined (Mitkowski, 2019). As previously suggested the pentaglycine (G5) ligand sits in a 
groove built by the side chains of the N-terminal extra conserved residues (β1- β2) (Hirakawa, 
2009; Lu JZ, 2006). The bound G5 adopts an extended conformation between these strands to 
the RT loop side (Fig. 1.14). Based on distance, the geometry of the binding site is not compatible 
with backbone hydrogen bond formation. Instead the G5 interacts with the side chains of 
residues from both β1 and β2 and from the RT loop. The carbonyl oxygen atom of the first G from 
G5 accepts a hydrogen bond (donor-acceptor distance 3.1 Å) from the side chain carboxamide of 
residue N405, located at the end of β1.  
 
Many staphylococcal SH3_5 domains have been described in the literature, however most SH3_5 
domains are found in Lactococcus, Streptococcus, and Enterococcus genera (El-Gebali, 2019). The 
Staphylococcus genus only represents 10% of the species harbouring SH3_5 domains. There are 
six unique structures available in Pfam and four of them are Staphylococcus related proteins. 
Further structural and functional studies are required to determine what is the consensus and 
the specificity across different SH3_5 domains.    
 
1.2.2.7.1.3 SH3_6 and SH3_7 domains  
The presence of two distinct N-terminal tandem SH3 domains, previously named SH3_51 and 
SH3_52, in a family of -D-glutamyl-L-diamino acid endopeptidases has been described (Xu, 
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2010). These SH3 domains are structurally related and have been identified as SH3 type 6 and 
type 7, respectively. These two domains (SH3_6 and SH3_7) are found in the YkfC endopeptidase 
from Bacillus cereus (Fig. 1.13 C-D and Fig. 1.14), in its ortholog (BcYkfC) from Bacillus subtilis, 
and in a putative -D-glutamyl-L-diamino acid endopeptidase from Desulfovibrio vulgaris strain 
Hildenborough (PDB 3M1U). In all three enzymes the N-terminal SH3 domains are linked to a C-
terminal NlpC/P60 cysteine peptidase that has been proposed to cleave the linkage between D-
Glu and m-A2pm (Xu, 2010). 
 
Although these domains adopt a typical SH3 fold with a similar five stranded core, they display 
much larger structural differences. The SH3_6 domains are approximately 90 amino acids long; 
they conserve the structural insertion of β2 and β3 in the RT loop region but lack the typical β-
hairpin motif compared to other members of the bacterial SH3 clan. Instead, Bacillus 
endopeptidases have 30 additional amino acids forming a novel helical insertion (α1-3) between 
strand β2 and β3 (Fig.1.13 C), whilst Desulfovibrio vulgaris also presents a long insertion in the 
RT loop but no additional secondary structures. 
  
The SH3_7 domain, composed of 60 amino acids, has a more conserved SH3-like structure with 
seven β-strands. Strands β2 and β3 are inserted in the RT but no other significant insertions are 
present. SH3_7 sits between the SH3_6 and the catalytic domain (Fig.1.13 D). They are arranged 
in a triangular shape such that each of them interacts with the other two (Fig. 1.14). The interface 
between the two SH3 domains is mostly hydrophobic and is centred on interactions between the 
RT and Src loops of SH3_6 and the β3-β4 strands and the distal 310 helix of SH3_7. 
 
The presence of an SH3_6 domain has also been reported in two -D-glutamyl-L-diamino acid 
endopeptidases from cyanobacteria. Anabaena variabilis (AvPCP) and Nostoc punctiforme 
(NpPCP) (Xu, 2009) AvPCP and NpPCP have almost identical structures and share 80% sequence 
similarity. These proteins have N-terminal SH3 domains with the characteristic 30 amino acid 
insertion forming three helical structures in the RT loop. The SH3_6 domain from the YkfC 
endopeptidase is located at an equivalent position to the SH3_6 domains from cyanobacterial 
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AvPCP and NpPCP proteins. However, SH3_6 is linked to the catalytic NlpC/P60 peptidase by a 
long loop occupying the space of the SH3_7 in YkfC.  
No ligand has been identified for any of the SH3 domains. However, SH3_6 has been suggested 
to recognize the PG crossed-linked stem peptide. In YkfC, the active site is located at the SH3_6–
NlpC/P60 interface providing a favourable pocket for the binding of L-Ala where the carbonyl 
group of E83 and the side chain of a conserved Y residue (Y118 in YkfC and Y64 in AvPCP) are 
predicted to form hydrogen bonds with the amino group of L-Ala (Xu, 2015) (Fig. 1.14). 
 
The function of SH3_7 is unknown. In YkfC, this domain is distal to the active site. It has been 
proposed that the nonessential SH3_7 domain was evolutionarily lost over time in the 
cyanobacterial endopeptidases (Xu, 2010). 
 
1.2.2.7.1.4 GW (SH3_8) domains  
The SH3_8 family is one of the best studied bacterial SH3 families. The SH3_8 domains, better-
known as GW domains, are cell wall binding modules of about 80-90 amino acids named after a 
conserved Glycine-Tryptophan (GW) dipeptide (Braun, 1997). Over the last 20 years a large 
number of GW domains have been described. In prokaryotes, these domains are mainly found in 
Firmicutes of the Lactobacillus, Bacillus, Enterococcus, Listeria, and Staphylococcus genera.  
 
In S. aureus and S. epidermidis, the autolysin Atl plays a major role in cell separation. The Atl 
enzymes from both species have the same modular organization: signal peptide (SP), pro peptide 
(PP), N-acetylmuramyl-L-alanine amidase (Ami), three major repeats (R1-R3, each one built of 
two subunits (a) and (b)) which have been identified as GW domains, and an N-
acetylglucosaminidase (GlcNAse). Following cleavage of the SP, external Atl is proteolytically 
cleaved at two positions, after the PP and after repeat R2, leading to the formation of the mature 
AM-R1-R2 and R3-GL enzymes (Heilmann, 1997; Zoll, 2012).  
 
The crystal structure of the R2 domain has been determined by X-ray crystallography (Zoll, 2012). 
Each subunit carries a conserved GW motif exhibiting the typical SH3 fold (Fig.1.13 E and Fig. 
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1.14)). Both domains resemble a half-open β-barrel formed by a semi-circular β-sheet made of 
strands β1, β3-β5 of R2a and strands β1, β4- β6 of R2b. Their loops were named in accordance 
to the SH3 nomenclature, except for an extra loop named the SU loop. The most conserved 
residues from both subunits are located around the GW motif. However, these regions exhibit 
significant structural differences. In R2a the conserved cluster around the GW motif is centre 
around a wide and shallow hydrophobic groove formed with the RT loop (Fig. 1.14). Both RT loops 
are especially prominent. In R2a it adopts a parallel orientation relative to the central β-sheet 
which creates the shallow cavity. R2b presents a deep cavity on the opposite side of the protein 
which is formed between the tip of its RT loop and the conserved GW motif (R2a, amino acids 
762 to 763; R2b, amino acids 838 to 839) (Fig. 1.14). 
 
GWs are often part of multi modular proteins with additional enzymatic domains which exhibit 
PG hydrolytic activity. The internalin protein B (InlB) from Listeria monocytogenes is an exception. 
InlB mediates the entry of endothelial, epithelial, and hepatocytic cells. InlB contains three C-
terminal GW domains. A search for homologous proteins using the DALI server (Holm, 2008) 
identified the GW domain of L. monocytogenes InlB as the closest homologue of the S. aureus 
and S. epidermidis  AtlA R1ab and R2ab repeats (Zoll, 2012). 
 
The LTA cell wall polymers have been implicated as the binding receptors for the GW domains 
(Jonquières, 1999; Zoll, 2012). In both studies, based on L. monocytogenes and S. aureus, 
respectively, InlB and AtlA were proposed to recognise LTA polymers by their GW domains using 
fixed purified polymers in ELISA experiments. Binding to LTA polymers has also been suggested 
based on experimental data using fluorescent-labelled GW repeats on the surface of S. aureus 
WT cells and the LTA-deficient strain (RN4220) (Zoll, 2012). However, the initial S. aureus 
experiments indicated a direct interaction between AtlA GW repeats and isolated PG (Biswas). In 
this study the AtlA Ami-R1abR2ab and the R1ab-R3ab repeats were incubated with WT PG, PG 
lacking O-acetylation, and PG lacking WTA. Both recombinant proteins (Ami-R1abR2ab and R1ab-
R3ab) displayed a dose-dependent binding to all isolated PG sacculi with no evidence of 
preferential binding to either of the modified PG structures. A more recent study in L. 
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monocytogenes determined direct binding to PG by the InlB GW domains (GW1-3) and the GW 
repeats of the autolysin Ami (GW1-8) (Percy, 2016). This study used Western blot analyses of InlB 
proteins and a variant of InlB (with replaced native GWs for the eight GW repeats of the autolysin 
Ami: InlB-GWAmi), from cells and supernatant fractions of L. monocytogenes. This showed that 
GW-containing proteins are retained in the cell wall of L. monocytogenes mutant strains lacking 
D-Ala and galactose LTA modifications or the complete LTA polymer, as well as in WTA-negative 
strains. In the same study, the eight Ami GW repeats were produced as MBP-fusions and their 
binding to purified PG isolated from WT or WTA deficient L. monocytogenes was also determined 
(Percy, 2016). Although there was no direct evidence of the recognition of LTA by the GW 
domains in this study, a dual binding recognition mode was suggested by the authors. It is 
important to note that these studies used synthetic LTA polymers for their binding tests, so a 
dual-binding hypothesis should therefore be treated with caution.  Overall, the recognition of 
LTA by GWs therefore remains an open question due to limited experimental data.  
 
1.2.2.7.2 Species distribution and domain organization of the SH3_5 family  
SH3 domains from the type 5 family are found in bacteria and dsDNA viruses (Fig. 1.15). According 
to Pfam (June,2020) there are over 270 species potentially producing SH3_5 domain proteins (El-
Gebali, 2019). The distribution between bacteria and viruses is almost equivalent (53% are 
present in bacteria and 47% in bacteriophages).  
 
From 143 SH3_5 sequences identified in bacteria, over 95% are found in Firmicutes. Of these, 
91% are found in members of the Bacilli class, with Lactobacillales being the most abundant 
order. Members of the Lactobacillaceae, Streptococcaceae, and Enterococcaceae families 
harbour the highest number of identified SH3_5 sequences i.e. 38, 37, and 19, respectively. In 
the order of Bacillalles there are 22 identified SH3_5 sequences, of which 16 belong to the 
Staphylococcaceae family. All phage-encoded proteins harbouring SH3_5 domains have been 
associated to PG hydrolases exclusively targeting Firmicutes.  
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Figure 1.15. Distribution of  SH3_5 sequences across species. Sunburst chart illustrating the 
phylogenetic distribution of the SH3 type 5 family (May 2020). The SH3_5 family is present in 
bacteria (342 sequences, 143 species) and viruses (126 species and sequences). In bacteria, this 
protein family is predominantly found in the Firmicutes phylum. The sunburst image was 
obtained from the Pfam database (El-Gebali, 2019). The tree was built by considering the 
taxonomic lineage of each sequence that has a match to this family and coloured according to 
the assignment in Pfam.  
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Figure 1.16. Modular organization of proteins containing SH3_5 domains across species. 
Modular proteins were divided based on the number of SH3_5 repeats. Column (A) shows the 
total number of sequences with an identical number of SH3_5 repeats. Column (B) shows the 
distribution of  sequences following a specific modular organisation. A schematic representation 
of proteins with SH3_5 domains is shown. 
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Figure 1.16 shows the domain organization in which the SH3_5 domain is found. The most 
common architecture is made of one or more N-terminal PG hydrolases followed by a single C-
terminal SH3_5 domain. As the number of SH3_5 repeats increase, the number of identified 
sequences gradually decrease. Only two sequences with a maximum of six SH3_5 repeats have 
been identified; a multi modular protein from Lactobacillus lindner containing two PG hydrolases, 
and a protein from group B Streptococcus sp. HSISS2 (GBS) that has been implicated in the control 
of cell morphology.  
 
SH3_5 domains are commonly found in PG hydrolases that have additional types of cell wall 
binding domains. This would allow multiple interactions with different PG substrates. YSIRK is a 
Gram-positive signal peptide, mainly present in Streptococcus and Staphylococcus genera,  which 
appears to be involved in secretion of surface proteins to the cell wall, however the mechanisms 
supporting this type of protein precursor trafficking are unknown (DeDent A, 2008; Yu, 2018). 
SH3_5 domains have also been identified in proteins involved in cell adhesion, like Big_9 from 
the intimin/invasin family. Big_9 proteins have a similar topology to the eukaryotic 
immunoglobulin superfamily. In most intimin/invasin proteins, Big-9 domains appear in tandem 
followed by a C-terminal C-type lectin-like domain, however they can also occur in combination 
with cell wall targeting domains like LysM and/or SH3_5 domains (Heinz, 2016).  
 
1.2.2.7.3  Structural similarities between SH3_5 domains.   
An amino acid sequence alignment of four members of the SH3 type 5 family, generated in the 
phyre2 web portal (Kelley, 2015) is shown in Figure 1.17 A. As mentioned previously, Ale-1 and 
Lss are hydrolases targeting members of the Staphylococcus genus, and their SH3_5 domains 
typically have additional N-terminal amino acid residues when compared to the SH3_5 domains 
of other genera. Plypy is a phage-associated cell wall hydrolase from S. pyogenes M1. This 
hydrolase has an N-terminal CHAP domain (cysteine,histidine-dependent 
amidohydrolases/peptidases) linked to a C-terminal SH3_5 domain. CHAP domains are 
commonly associated with SH3_5 domains (Fig. 1.16). Many proteins with CHAP domains remain 
uncharacterized but in LysK and Twort staphylolytic phages it has been shown that the CHAP  
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Figure 1.17. Sequence and structural similarities within four SH3 type 5 domains. (A) Amino acid 
sequence alignment of four members of the SH3_5 family produced by Phyre2 web portal (Kelley, 
2015): Ale-1, S. capitis (PDB entry 1R77); Lysostaphin, S. aureus (PDB entry 6RK4); Plypy, S. 
pyogenes (PDB entry 5UDM); BacL1, E. faecalis (UniProtKB entry B1B1Z5). Conserved residues 
among all proteins are highlighted in blue. The positions of β-strands are shown below each 
sequence. β-strands  are coloured coded in agreement  with Figure 1.11. The position of the loops 
in the protein structures is indicated at the top of each sequence. (B) Structure and topology of 
SH3_5 domains. The cartoon representation with secondary structure elements is shown on the 
left side of each SH3_5 protein. The architecture of the folds is illustrated schematically on the 
right of each structure. β-strands are shown as arrows. The numbering and coloured codes of 
secondary structures are consistent with section A. Loops are labelled in the cartoon 
representations. 3D images of folds were prepared with PyMOL Molecular Graphics System and 
2D protein topology diagrams were built using Pro-origami bioinformatics (Stivala A, 2011). 
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domain displays amidase activity, cleaving the chemical bond between MurNAc and L-Ala at the 
N-terminus of the stem peptides (Becker, 2009). In the Twort phage endolysin the lytic activity 
of the CHAP domain is enhanced by the C-terminal SH3_5 domain (Becker, 2015). 
 
In S. pyogenes PG the amino acid L-lysine in position 3 is crosslinked by an L-ala-L-ala interpeptide 
bridge to a D-alanine in position 4. Recent studies using a combination of LC-MS spectrometry 
and FRET-based assays with PG-like fluorophore-quencher synthetic peptides showed that S. 
pyogenes Plypy displays a D-alanyl-L-alanine endopeptidase activity (Lood, 2014). It has been 
determined that Plypy displays a specific activity towards a limited number of bacterial species 
with D-Ala–L-Ala bonds (Lood, 2014). However, other determinants are required for the cleavage 
of Plypy since it has shown that species such as S. mutans and E. faecalis harbouring the same 
interpeptide composition as S. pyogenes proved to be insensitive to Plypy activity. This 
phenomenon was also observed in the phage lysin GBS from S. agalactiae bacteriophage, which 
displays a D-alanyl-L-alanine endopeptidase activity and was not active against S. mutans PG. It 
has been speculated that high levels of polymers like WTA could block the access of these 
hydrolases (Pritchard, 2004).  
 
In E. faecalis, the bacteriocin 41 (Bac41) produced by clinical isolates consists of six open reading 
frames (ORFs). Two of them, bacL1 and bacA, are co-expressed as surface proteins and confer 
the bactericidal activity of Bac41; BacA is presumed to be an accessory factor (Kurushima, 2013). 
BacL1 is a -D-glutamyl-L-lysine PG endopeptidase and comprises two distinct N-terminal domains 
associated with PG hydrolysis and three C-terminal SH3_5 domains (Kurushima, 2015). The first 
N-terminal domain shows homology to the bacteriophage-type PG hydrolase followed by a 
homologue of the NlpC/P60 PG hydrolase family. The description of the SH3_5 repeats from the 
BacL1 endopeptidase is addressed in greater detail in Chapter VI. Figure 1.16 shows the sequence 
and structure of the first BacL1 SH3_5 domain (closest to the N-terminal region). Binding of BacL1 
to Gram-positive bacteria harbouring an L-Ala-L-Ala crosslinked PG structure was shown in E. 
faecalis, S. pyogenes, and S. pneumoniae (Kurushima, 2015). However, the bactericidal activity of 
Bac41 is strictly specific to E. faecalis, including VanB-type vancomycin-resistant strains, and 
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requires the presence of the two extracellular components, BacL1 and BacA proteins. The SH3_5 
domains from E. faecalis BacL1 exhibit a higher structural identity to the Plypy SH3_5 domain 
from S. pyogenes compared to the SH3_5 domains from staphylolytic hydrolases.  (Fig. 1.17 B).  
The binding mechanisms of the SH3_5 domains from BacL1 and Plypy have not been investigated.  
Amongst the four SH3_5 proteins shown in Figure 1.17, the major structural elements are well 
maintained: five β-strands (β3 - β7) forming the core of the two antiparallel β-sheets, the C-
terminus of strand β2, and the β-hairpin conformation between the RT loop (Fig. 1.17 B).Studies 
investigating Lss and Ale-1 SH3_5 domains have shown that some of the most conserved residues 
within the proteins (shown in Figure 1.16 A) are either near or form part of regions identified as 
interacting with the peptide moieties of S. aureus PG (Lu JZ, 2006; Mitkowski, 2019; Tossavainen, 
2018). According to the numbering in the sequence alignment, the amino acid residues Y48 (Lss 
Y449; Ale-1 Y318), D49 (Lss D450; Ale-1 D319), and Y71 (Lss Y472; Ale-1 Y341) are located around 
the pentaglycine binding groove of the staphylococcal SH3_5 domains (Fig. 1.17 and 1.18). 
Residues Y48 and D49 are part of strand β5, which forms one of the side walls of the groove. 
Polar and charged residues are involved in direct interactions that stabilize β-sheet I, for example 
D49, which forms a salt-bridge with the conserved R residue in position 69 (Lss R470; Ale-1 R339), 
(Lu JZ, 2006). In the staphylococcal SH3_5 domains, the tyrosine amino acid residue in position 
71 is part of strand β7. This strand creates the base of the pentaglycine groove with the RT loop 
(Fig.1.16 B). In Plypy and BacL1 SH3_5 domains, the Y71 residue is part of the N-terminal region 
of strand β6 which is in close contact to their RT loops. The importance of some conserved 
residues like F17 (Lss F418; Ale-1 F286), R69 (Lss R470;Ale-1 339), and W88 (Lss W489 ; Ale-1 
W358) and their role in the recognition of PG stem peptides is the centre of discussion of 
Chapters IV and V.  
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Figure 1.18. Lysostaphin SH3_5 protein bound to a pentaglycine peptide (PDB 5LEO). Close up 
view of the pentaglycine biding groove from the lysostaphin SH3_5 domain. The RT loop and 
residues interacting with the pentaglycine ligand are indicated.  
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1.3 Project Aims and Objectives  
 
The identification of new SH3_5 domains has undergone a drastic expansion in the last decade. 
As mentioned before, these cell wall binding domains are part of a diverse range of PG hydrolases 
that play key roles in cell wall growth and regulation, and in other cases displaying bacteriolytic 
activities against other bacterial species in competition for a niche. The presence of SH3_5 
domains in diverse organisms with different PG compositions raises questions about the 
specificity of these proteins. However, as it has been mentioned in eukaryotic SH3 domains, this 
complexity exists within certain moderation (Saksela, 2012). Sequence and structure alignments 
between members of the type 5 family suggests the existence of conserved features necessary 
for the recognition of canonical ligand binding moieties. This phenomenon is not specific to SH3  
proteins, as it has been shown in the LysM carbohydrate binding modules present across all 
kingdoms (Mesnage, 2014).  
 
To contribute to the understanding of how bacteria control the enzymatic activity of PG 
hydrolases, during this project we aimed to elucidate the mechanisms underpinning ligand 
recognition by bacterial SH3_5 domains. As a model system, the C-terminal SH3_5 protein of the 
lysostaphin (Lss) bacteriocin was studied. In addition, we also aimed to explore SH3_5 binding 
recognition across species and the role of protein modularity in the enzymatic activity of proteins 
harbouring multiple SH3_5 domains.  
 
To gain insight into the binding mechanism of the Lss SH3_5 to PG, chapter III, IV and V describe 
the characterisation of the protein-substrate recognition through functional and structural 
analyses using NMR titrations, X-ray crystallography and mutational analyses. Briefly, chapter III 
covers the development of the first two objectives of this research: i) to produce the required 
recombinant Lss SH3_5 proteins and ii) to generate a panel of ligands with increasing complexity 
derived from S. aureus PG composition.  
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As little was known about the SH3_5 binding specificity and affinity to PG, and the minimal ligand 
recognised by Lss SH3_5 proteins, in chapter IV two main objectives were explored: i) to identify 
and map the residues interacting with the PG fragments generated in chapter III and ii) to 
measure affinities to determine the minimal PG motif recognised by the SH3_5 domains. 
 
The affinity of an eukaryotic SH3 domain for peptide ligands typically ranges from 1 to 100 µM 
(Lim, 1994; Mayer, 2001; Saksela, 2012). This weak affinity may be desirable under certain 
circumstances where protein complexes need to assemble and disassemble to allow processive 
catalysis. Homodimerization between SH3 proteins has been previously described in eukaryotic 
SH3 domains (Kaneko, 2008; Kristensen, 2006). On the other hand, the presence of proteins 
harbouring multiple SH3 domains highlights the complexity of the interactions governing the 
SH3_5-ligand binding. Here we combined NMR and X-ray crystallography to elucidate binding 
affinities and specificity of the Lss SH3_5 proteins.  
 
In chapter V, we sought to determine the contribution of the SH3_5 residues identified by NMR 
and X-ray crystallography to the recognition of two PG peptide motifs, the pentaglycine 
crossbridges and the peptide stems. Site-directed mutagenesis was used to explore three main 
objectives: i) to confirm the role of six chosen residues to the recognition of the pentaglycine (G5) 
and peptide stem (P4) ligands by NMR titrations; ii) to investigate the contribution of sixteen 
residues in binding to the natural substrate of the enzyme, the S. aureus PG sacculi, using a 
quantitative in vitro binding assay; and  iii) to explore the impact of the same SH3_5 mutations 
on the enzymatic activity of the mature Lss. 
 
Our work on the characterisation of the Lss SH3_5 proteins shed light into a two-site recognition 
of S. aureus PG by a single protein domain. The two binding surfaces are located on opposite 
sides of the domain, thus allowing only one SH3_5 domain to bind to the pentaglycine 
crossbridge and a second SH3_5 domain to bind to the contiguous peptide stem. This binding 
mechanism would permit the clustering of proteins on the PG. The work presented in chapter VI 
aimed to answer two main questions: i) Is the Lss binding mechanism conserved across other 
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species? and ii) does multimodular proteins i.e. proteins harbouring multiple SH3_5 domains 
recognise PG independently or do they form quaternary structures? To explore these questions, 
the aim of chapter VI was to investigate the binding mechanism of two distinct E. faecalis proteins 
containing a single and multiple SH3_5 domains. E. faecalis PG is crosslinked by two L-Ala amino 
acids instead of a pentaglycine like in the case of S. aureus. The selected proteins were: i) the 
single SH3_5 domain from the predicted EF1293 hydrolase, and ii) the three SH3_5 repeats from 
the BacL1 bacteriocin. The specific objectives described in this chapter were i) to produce: the 
single C-terminal SH3_5 domain from the putative PG endolysin EF1293 protein, and five variants 
of the three modular BacL1 SH3_5 repeats, i.e. SH31; SH32; SH33; SH31-2; SH31-3; ii) to perform 
NMR structural and functional analyses using a set of ligands corresponding to E. faecalis PG: the 
L-Ala-L-Ala, cross-links, the AQKAA, peptide stem and the AQK(L-Ala-L-Ala)AA, peptide stem with 
lateral chain. 
Finally, chapter VII discusses the implications of this research. Our published paper “Two-site 
recognition of Staphylococcus aureus peptidoglycan by lysostaphin SH3_5” is also included in the 
Appendices. 
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CHAPTER II 
Materials and Methods 
 
2.1 Chemicals and enzymes 
All chemicals and enzymes used in this study were of analytical grade and were purchased from 
Sigma-Aldrich, Fisher Scientific, MP Biomedical or Roche. Restriction enzymes, ligases, 
polymerases, DNase and appropriate buffers were purchased from New England Biolabs. 
 
2.2 Buffers and solutions  
Stock buffers were autoclaved and stored at room temperature. All 1x buffers and solutions were 
prepared with distilled water(dH2O), except for the HPLC buffers which were made with reverse 
osmosis and deionized water (RO deionized water), or equivalent. All 1x buffers were filtered 
(0.2µm) , unless otherwise stated. 
 
2.2.1 Buffers for DNA analysis  
 
2.2.1.1 TAE (50x)(Tris-acetate-EDTA) 
Tris     242 g/L 
Glacial acetic acid    5.7% (v/v) 
Na2EDTA pH 8.0    0.05 M 
1x solution adjusted with dH2O. 
 
2.2.1.2 DNA loading buffer (10×) 
Bromophenol blue   0.25% (w/v) 
Glycerol    50% (v/v) 
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2.2.2 Protein purification solutions  
 
2.2.2.1 SDS-PAGE solutions 
 
2.2.2.1.1 SDS-PAGE separating buffer (4x) 
Tris-HCl     1.5 M 
SDS      0.4% 
A final pH of 8.5 adjusted with HCl. Filtered and stored at room temperature. 
 
2.2.2.1.2 SDS-PAGE stacking buffer (4x) 
Tris-HCl     0.5 M 
SDS      0.4% 
A final pH of 6.8 adjusted with HCl. Filtered and stored at room temperature. 
 
2.2.2.1.3 SDS-PAGE loading buffer (5x) 
Tris-HCl pH 6.8   250 mM 
SDS     10% (w/v) 
Bromophenol blue   0.5 % (w/v) 
Glycerol    50% (v/v) 
DTT     0.5 M 
 
2.2.2.1.4 Coomassie Blue stain 
Coomassie Blue R-250              0.25% (w/v) 
Methanol    50% (v/v) 
Acetic acid glacial   10% (v/v) 
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2.2.2.1.5 Coomassie destaining solution 
Methanol    40% (v/v) 
Glacial acetic acid   10% (v/v) 
 
2.2.2.2 Protein purification buffers for affinity chromatography (His-tag fused proteins)  
 
2.2.2.2.1 Buffer A (Equilibration buffer)  
Tris-HCl    50 mM   
NaCl     0.5M     
Final pH dependant on the pKa of the protein. A final pH of 8.0 was used for SH3_5 proteins 
(alone or fused to mNeonGreen) and a pH of 7.0 for lysostaphin proteins. All buffers were 
filtered and stored at room temperature. 
 
2.2.2.2.2 Buffer B (Elution buffer)  
Tris-HCl    0.05M   
NaCl     0.5M  
Imidazole    0.5M         
Final pH of 8.0 for SH3_5 proteins (alone or fused to mNeonGreen) and a final pH of 7.0 for 
lysostaphin proteins. All buffers were filtered and stored at room temperature. 
 
2.2.2.3 Protein purification buffers for size-exclusion chromatography (SEC) 
 
2.2.2.3.1 His-SH3_5 proteins (alone or fused to mNeonGreen) 
NaH2PO4      0.05 M 
Final pH of 6.0. All buffers were filtered, degassed, and stored at room temperature. 
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2.2.2.3.2 Lysostaphin proteins 
NaOAc     0.02 M 
NaCl     0.015 M 
Final pH of 5.5. All buffers were filtered, degassed, and stored at room temperature. 
 
2.2.2.3.3 His-TEV-SH3_5 and untagged SH3_5 proteins (SEC, TEV-cleavage and reverse-IMAC 
buffer) 
Tris-HCl    50 mM 
NaCl     0.15 M 
Adjusted to pH 8.35 with HCl. 
 
2.2.3 HPLC Muropeptide analysis buffers 
 
2.2.3.1 Phosphate buffer system 
 
2.2.3.1.1 Buffer A (Mobile phase buffer)  
NH4H2PO4    10 mM   
NaN3     5 mM 
Final pH of 5.5. All buffers were filtered and store at room temperature.  
 
2.2.3.1.2 Buffer B (Elution buffer)  
NH4H2PO4    10 mM   
NaN3     5 mM 
Methanol    30% (v/v) 
Final pH of 5.5.  
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Final pH of 5.5. All buffers were filtered and store at room temperature.  
2.2.3.2 Water-Acetonitrile System 
 
2.2.3.2.1 Solution A (Desalting solution) 
Formic acid    0.1% (v/v) 
All buffers were prepared with reverse osmosis (RO) deionized water to avoid filtering.  
 
2.2.3.2.2 Solution B (Elution)  
Acetonitrile     99.9% (v/v) 
Formic acid    0.1% (v/v) 
All buffers were prepared with RO deionized water to avoid filtering.  
 
2.2.3.3 Buffers for enzymatic digestion  
 
2.2.3.3.1 Mutanolysin and EnpAc digestion buffer (20x) 
NaH2PO4    0.5 M 
Final pH of 5.5.  
 
2.2.3.3.1 Lysostaphin digestion- Phosphate buffered saline (PBS)   
NaCl      8 g/L 
Na2HPO4    1.4 g/L 
KCl     0.2 g/L 
KH2PO4                0.2 g/L 
Final pH of 7.4 adjusted with NaOH. 
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2.2.3.4 Sodium borate buffer for reduction of muropeptides  
Solution A:  
H3BO3     0.25 M  
Solution B: 
Na₂[B₄O₅(OH)₄]·8H₂O   0.0625 M  
Note: Solution A and B were prepared separately.  
To prepare sodium borate buffer at pH 9: 
50 ml of solution A (0.25M boric acid) + 115 ml of solution B (0.0625 M borax). The final solution 
was diluted to a total of 200 ml. 
2.3 Media  
All media were prepared in distilled water (dH2O) and sterilised by autoclaving (121°C, 20 min) 
unless otherwise stated. 
2.3.1 Brain heart infusion (BHI) 
Brain heart infusion (Oxoid)  37 g/L 
 
2.3.2 BHI agar 
Brain heart infusion (Oxoid)   37 g/L 
Oxoid agar No. 1   1.5 % (w/v). 
 
2.3.3 NMR minimal media M9 
 
1st solution:  
Per litre: (to 950ml of RO deionized water):  
Na2HPO4    6.0 g/L 
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KH2PO4        3.0 g/L 
0.5g NaCl    0.5 g/L 
 pH was adjusted to 7.4 and autoclave sterilised. 
2nd solution: 
The following were added to the above solution following autoclaving: 
Autoclaved trace elements (Note 1) 650µL 
13C-glucose  (Note 2)    2g/ 8mL                                
Thiamine (Note 3)   1.0 mL   
(15NH4)2SO4 or 15NH4Cl  (Note 4) 4.0ml (0.25g/mL) 
Autoclaved MgSO4   1.0ml (1M) 
Autoclaved CaCl2 (Note 5)  0.1ml (1M) 
Note 1: Trace elements (100 mL): 
The following were dissolved in 70 mL of RO deionized water:  
CaCl2.2H2O   550 mg 
MnSO4.H2O   140 mg 
CuSO4.5H2O   40 mg 
ZnSO4.7H2O   220 mg 
CoCl2.6H2O   45 mg 
Na2MoO4.2H2O   26 mg 
H3Bo4    40 mg 
KI    26 mg 
pH was adjusted to 8.0 and subsequently added: 
EDTA    500 mg 
pH was re-adjusted to 8.0 and lastly added:  
FeSO4.7H2O   375mg   
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The final volume was adjusted to 100 mL and autoclaved. 
 
Note 2: When 13C was not needed 12 mL of 25% glucose was added. 
Note 3: Stock solutions (1mg/mL) of thiamine were filter sterilised. Aliquots were stored at -20°C. 
Note 4: At higher concentrations the solubility decreased.  
Note 5: CaCl2 was added last. As a white precipitate formed, flasks were rapidly mixed to avoid 
precipitation.  
 
2.3.4 Overnight ExpressTM Instant TB Medium 
Overnight Express Instant TB medium  60 g/L 
Glycerol      10 mL/L 
1st The necessary amount of dH2O was autoclaved in a flask at least twice the size of the final 
volume and was left to cool down. 
2nd The Overnight Express Instant TB medium and glycerol were added. The flask was swirl gently 
until the medium was dissolved. The appropriate antibiotics were added prior to inoculation. 
 
2.4 Antibiotics  
All stock solutions were filtered sterilised (0.2 µm) and stored at -20°C. 
Table 2.1. Antibiotic stock solutions and working concentrations. 
Antibiotics 
Stock 
concentration  
(mg/mL) 
E. coli working 
concentration 
(µg/mL) 
S. aureus isogenic 
Fem mutants 
(µg/mL) 
Solvent 
Ampicillin (Amp) 100 100 - dH2O 
Erythromycin (Ery) 30 200 fem B 
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95% (v/v) ethanol 
Tetracycline (Tet) 10 - fem AB 
2 
50% (v/v) ethanol 
Chloramphenicol 35 35  98% ethanol 
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2.5 Bacterial strains and plasmids 
 
2.5.1 Bacterial strains  
Bacterial strains used in this study are described in Table 2.2. Strains were grown at 37°C in BHI 
or M9 minimal medium and supplemented with the suitable antibiotics where necessary to 
maintain the selection of resistance markers. Strains were stored as glycerol stocks (20% glycerol 
in BHI broth) at −80°C. 
 
Table 2.2. Bacterial strains used in this study. 
Strains Relevant properties or genotype Source or reference 
Staphylococcus aureus   
SH1000 8325-4 derivate with a restored rsbU allele (Horsburgh, 2002) 
NCTC8325 Wild type strain allele (Berger-Bächi, 1983) 
femB mutant BB815 8325 derivative (mec Ω2006femB::Tn551), ErmR (Henze, 1993) 
femAB null mutant 
AS145 
8325 derivative (mec, ΔfemAB:tetK), TetR (Strandén, 1997) 
Escherichia coli   
Lemo21(DE3) BL21 derivative for protein production, CmpR NEB 
NEB5α Host strain for DNA cloning NEB 
CmpR, resistant to ampicillin; ErmR, resistant to erythromycin; TetR, tetracycline resistant.  
 
2.5.2 Plasmids 
Plasmids used in this study are listed in Table 2.3. All plasmid DNAs were purified using the 
GeneJET Plasmid Mini kit (Thermo Scientific). 
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Table 2.3. Plasmids used in this study. 
Plasmid Relevant properties or genotype 
Source or 
reference 
pET15b Plasmid to produce proteins with an N-terminal His-tag a Novagen 
pET21a  Plasmid to produce proteins with a C-terminal His-tag a Novagen 
pET2818 Plasmid to produce proteins with a C-terminal His-tag a Lab stock 
pET2817-TEV  Plasmid to produce proteins with an N-terminal cleavable 
His-tag a 
Lab stock 
pET15b-His- SH3_5 pET15b derivative encoding Lss SH3_5 domain for NMR 
experiments a 
(Jagielska, 
2016) 
pET21a-Lss pET21a derivative for the expression of the full length Lss 
lysostaphin a 
(Sabała, 2014) 
pET22b(+)BacL1-
SH3 
pET22b(+) derivative encoding BacL1 SH3 repeats a (Kurushima, 
2013) 
pET-SH3_5-TEV 
 
pET-SH3_5-mNG 
pET2817-TEV derivative for the expression of the Lss-
SH3_5 domain for X-ray crystallography a 
pET2818 derivative for the expression of Lss SH3_5-
mNeonGreen fusions a 
Lab stock 
 
This study 
pET-mNG pET2818 derivative for the expression of mNeonGreen 
protein control a 
This study 
pTetH-1293  pAT18 derivative encoding TetR for tetracycline-inducible 
expression in E. faecalis 
Lab stock 
pET2818-EF1293 pET2818 derivative for the expression of EF1293 SH3_5 
protein candidates a 
This study 
a Ampicillin resistance. 
2.5.3 Growth conditions of E. coli and S. aureus  
Strains were streaked from the glycerol stocks and grown on BHI agar plates at 37°C. The 
following day, a single colony from the agar plate was used as a starter culture in BHI. Cells were 
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grown overnight with agitation (200 rpm) at 37°C, unless otherwise started. All growth media 
were supplemented with antibiotics where appropriate.  
 
2.6 Construction of recombinant plasmids for protein production 
The plasmid expressing the full-length lysostaphin protein (pET21a-Lss) and the Lss SH3_5 
domain with a non-cleavable N-terminal His-tag (pET15b-His- SH3_5) have been previously 
described (Jagielska, 2016; Sabała, 2014). The following section describes the construction of the 
pET-SH3_5-mNG, pET2818-mNG and pET2818-EF1293 plasmids.  
 
2.6.1 DNA manipulation  
 
2.6.1.1 Primer design  
Primers were synthesised by Eurofins MWG Operon. Primers were resuspended in nuclease free 
H2O (nfH2O) and stored as 100 µM master stocks or 10 µM working stocks at -20°C. Primers used 
in this study are listed in Table 2.4. 
Table 2.4. Primers used in this study. 
Oligonucleotide Sequence 5’         3’ Enzyme 
Lss_SH3 domain   
mNG_for CTTTTGTTTAACTTTAAGAAGGAGATATACCATGGTGAGCAAGG
GCGAAGAGGA 
NcoI 
mNG_rev CTAGTCAGTTAATGATGATGATGATGATGGGATCCCTTGTATAA
CTCATCCATGCCCATCACG 
BamHI 
D450N_for           CAAACAATTCATTATAATGAAGTGATGAAACAAGAC        
D450N_rev  GTTTCATCACTTCATTATAATGAATTGTTTGACCTG          
E451M_for            ACAATTCATTATGATATGGTGATGAAACAAGACGGTCATG  
E451M_rev            GTCTTGTTTCATCACCATATCATAATGAATTGTTTGAC       
F418V_for       CAGAGTCAGCTAGCGTCACACCTAATACAGATATAATAAC      
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F418V_rev         ATCTGTATTAGGTGTGACGCTAGCTGACTCTGATTTATATAGTG  
I425A_for         ACCTAATACAGATATAGCAACAAGAACGACTGGTCCATTTAG    
I425A_rev       CCAGTCGTTCTTGTTGCTATATCTGTATTAGGTGTGAAGCTAG  
R427M_for ACAGATATAATAACAATGACGACTGGTCCATTTAGAAGC  
R427M_rev ATGGACCAGTCGTCATTGTTATTATATCTGTATTAGGTG  
L473A_for         GGCCAACGTATTTACGCGCCTGTAAGAACATGGAATAAATC     
L473A_rev         CATGTTCTTACAGGCGCGTAAATACGTTGGCCACTGTTAC     
M453A_for           CATTATGATGAAGTGGCAAAACAAGACGGTCATGTTTG     
M453A_rev            ATGACCGTCTTGTTTTGCCACTTCATCATAATGAATTG      
N405A_SH3_5_
  
CATGGGATGGAAAACAGCCAAATATGGCACACTATATAAATC  
N405A_SH3_5_r TAGTGTGCCATATTTGGCTGTTTTCCATCCCATGGTATATC     
N421L_for         GCTAGCTTCACACCTCTTACAGATATAATAACAAGAACGAC     
N421L_rev         GTTATTATATCTGTAAGAGGTGTGAAGCTAGCTGACTC    
T409V_for   ACAAACAAATATGGCGTGCTATATAAATCAGAGTCAG     
T409V_rev  CTCTGATTTATATAGCACGCCATATTTGTTTGTTTTC         
T429V_for           ATAATAACAAGAACGGTTGGTCCATTTAGAAGCATG          
T429V_rev          CTTCTAAATGGACCAACCGTTCTTGTTATTATATCTG       
V452A_for         TTCATTATGATGAAGCGATGAAACAAGACGGTCATG       
V452A_rev         ACCGTCTTGTTTCATCGCTTCATCATAATGAATTGTTTG     
V461A_for        ACGGTCATGTTTGGGCAGGTTATACAGGTAACAGTG     
V461A_rev         TTACCTGTATAACCTGCCCAAACATGACCGTCTTGTTTC       
W489L_SH3_5_f ACTTTAGGTGTTCTTCTGGGAACTATAAAGGGATCCGGAG      
W489L_SH3_5_r TCCCTTTATAGTTCCCAGAAGAACACCTAAAGTATTAGTAG     
Y411S_for          AAATATGGCACACTATCAAAATCAGAGTCAGCTAGCTTC     
Y411S_rev        AGCTGACTCTGATTTTGATAGTGTGCCATATTTGTTTG     
Y427S_for           AGTGGCCAACGTATTTCCTTGCCTGTAAGAACATGGAAT    
Y472S_rev           TGTTCTTACAGGCAAGGAAATACGTTGGCCACTGTTAC     
Lss   
N405A_Lss_for   TACAGGTTGGAAAACAGCCAAATATGGCACACTATATAAATC    
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N405A_Lss_rev    AGTGTGCCATATTTGGCTGTTTTCCAACCTGTATTCGGCGTTG  
W489L_Lss_f    TACTTTAGGTGTTCTTCTGGGAACTATAAAGCTCGAGCAC      
W489L_ Lss_r GAGCTTTATAGTTCCCAGAAGAACACCTAAAGTATTAGTAG     
BacL1 SH3 domain   
pET_up (T7 promoter) TAATACGACTCACTATAGGG  
pET_dn (T7 term) GCTAGTTATTGCTCAGCGGT  
FWD S1 GGAGATTCCATGGGTTCAAAAGGAGATTCAGTGAATCCT NcoI 
FWD S2 TACCCCCATGGGATCGGGTTCAAATACGGGAAGTGCA NcoI 
FWD S3 GGTGGAGCCATGGGTTCACAGGCACACCCTAATTCT NcoI 
RVS S1 GGGCTCGAGGGTATTATTTAAAAATCCTGTTC XhoI 
RVS S2 GGGCTCGAGATCTCCACCATTATCAAAAAATCCTGT XhoI 
EF1293 SH3 domain   
FWD 1_EF1293 GGGCCATGGGAAACGATGGCGACATTGCTGAAC NcoI 
FWD 2_EF1293 TTTCCATGGGACATTTGTTAGGCTATGTGAAC NcoI 
FWD 3_EF1293 GGGCCATGGGGAAATATCAAGTAGGACAAGCAATTCGT NcoI 
RVS pTetH (sm_341) GTGGGATCCGCTAGCAAATGATCCCCATGTattctgtg BamHI 
Underlined are sites recognised by restriction enzymes. 
 
2.6.1.2 PCR amplification  
 
2.6.1.2.1 Phusion polymerase  
PCR amplification reactions were performed using the commercial  Phusion® High-Fidelity PCR 
Master Mix (2x) (New England Biolabs).  
Reaction mix: 
Phusion High Fidelity Master Mix (2x) 25 μl 
Forward primer (10 μM)   2.5 μl 
Reverse primer (10 μM)   2.5 μl 
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Template DNA     50-100 ng 
Sterile nfH2O     up to 50 μl 
 
PCR amplifications were carried out in a Bio-Rad T100  thermal cycler using the following 
program: 
Initial denaturation    98oC / 30 s 
Denaturation     98oC / 10 s 
Annealing     55-65oC / 10 s 
Extension     72oC / 15-30 s/kb, go to denaturation step, 32x  
Final extension    72oC / 2-5 min 
 
2.6.1.2.2 Agarose gel electrophoresis  
DNA samples were resolved in an agarose gel at a concentration dependent on the expected 
fragment size, generally prepared at 1% (w/v). Before polymerization, agarose gels were stained 
with 20 ng ml-1 SYBR safe (Invitrogen) prepared in DMSO. Analytical DNA samples  were mixed 
with 6x DNA loading buffer (Thermo Scientific) before loading them into the gel. DNA samples 
that were used for purification were mixed with the 6x UViewTM loading dye (BioRad). Fragments 
were separated for 30 min at 100 V. DNA was visualized using an UV transilluminator at 305 nm. 
The size of the DNA fragments was determined using a molecular-weight size marker of 1kb (New 
England Biolabs) loaded adjacent to all DNA samples.  
 
2.6.1.2.3 Gel extraction 
DNA samples were resolved on agarose gels (see above). DNA fragments were visualized using a 
UV transilluminator (305 nm) and bands were cut out using a scalpel. DNA was extracted from 
the gel using the GeneJET Gel Extraction kit (Thermo Fisher), as per the manufacturer’s 
instructions. DNA was eluted in nuclease free water (nfH2O) and quantified via A260 spectrometry. 
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2.6.1.2.4 DNA quantification  
All DNA concentrations were determined using a NanoDrop DeNovix® spectrophotometer/ 
fluorimeter. Blank measurements were taken with 1 μl solution of DNA eluent (nfH2O). The same 
volume (1 μl) of DNA sample was then used to measure the concentration at 260 nm. 
 
2.6.1.3 Restriction digestion cloning 
The plasmids encoding the SH3_5 E. faecalis (BacL1 and EF1293) proteins were constructed by 
restriction endonuclease digestion and ligation. BacL1 DNA fragments were cut with  NcoI and 
XhoI and cloned into a pET2818 similarly digested. EF1293 DNA fragments were cut with NcoI 
and BamHI and were also cloned into a similarly digested pET2818 vector. 
2.6.1.3.1 Restriction Endonuclease Digestion of DNA  
Endonuclease digestion of DNA was performed using restriction digestion enzymes (New England 
Biolabs) as per manufacturer’s instructions. Restriction enzymes and their appropriate buffers 
were added to solutions containing the purified DNA. Digestion reactions were incubated at 37oC 
for 1h. For cloning purposes, the digested fragments were purified (Sections 2.6.1.2.2 and 
2.6.1.2.3).  
 
2.6.1.3.2 Ligation of DNA  
The digested DNA fragments (see above) were ligated using T4 DNA ligase (New England Biolabs) 
as followed:  
Vector     25 ng 
Insert     3-fold molar excess of vector DNA 
T4 DNA ligase    0.5 µL (100 U)  
T4 ligase buffer (10X)   1 µL 
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nfH2O     up to 10 µL 
 
Ligation reactions were performed with a 3:1 molar ratio of insert to vector. The following 
references, as shown in Table 2.5 were used to calculate the mass of the insert required.  
 
Table 2.5. Mass of insert used in each ligation reaction. 
 
Insert 
500 bp 
Insert 
1000 bp 
Insert 
1500 bp 
Insert 
2000 bp 
Insert 
2500 bp 
pET2818 ~5300bp 7 ng 14 ng 21 ng 28 ng 35 ng 
 
Ligation reactions were incubated at 16°C overnight and heat inactivated at 65°C for 10 minutes 
before E. coli transformation.   
 
2.6.1.4 Gibson Assembly of DNA Fragments 
The plasmid encoding the Lss SH3_5–mNeonGreen fusion (pET-SH3_5-mNG) and the 
mNeonGreen control protein (pET-mNG) were constructed by Gibson assembly using a DNA 
synthetic fragment (Integrated DNA Technology) cloned into the vector pET2818 cut with NcoI 
and BamHI.  
 
PCR amplified fragments were ligated in one step by Gibson assembly (Gibson, 2009). This was 
performed using the NEBuilder HiFi DNA Assembly Cloning Kit (New England Biolabs). The 
inserted fragments had ~30 bp of overlapping sequence with the adjacent DNA fragment. After 
PCR amplification, inserts were gel extracted (Section 2.6.1.2.3) and added into a solution 
containing 25 ng of vector in a two-fold molar excess of insert. HiFi assembly master mix was 
added to a final concentration of 1x and the reactions were taken to a final volume of 10 µL using 
nfH2O. Reactions were then incubated at 50°C for 1 h before being used in E. coli transformations. 
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2.6.1.5 Site-directed mutagenesis  
Mutagenesis of plasmids pET-SH3_5-mNG and pET-Lss was performed using the GeneArt® Site-
Directed Mutagenesis System (Thermo Fisher Scientific). All primers containing the target 
mutations are described in Table 2.4. The same pair of oligonucleotides were used to introduce 
mutations in both plasmids, except for the N405A and W489L substitutions, which required 
distinct pairs of oligonucleotides to build the mNeonGreen fusions and lysostaphin mutants. In 
summary, the plasmid template was added to an  AccuPrime™ Pfx Reaction mix which includes a 
DNA methyl transferase. PCR reactions were carried out as per manufacturer’s instructions. After 
the reactions, an in vitro recombination reaction was performed at room temperature. This 
system uses McrBC endonuclease to cleave the template methylated plasmid. After 10 min the 
recombination reaction was stopped by adding 1 µL 0.5 M EDTA and the sample was incubated 
on ice for 15 min before transformation in E. coli NEB5α.  
 
2.6.1.6 E. coli transformation  
2 μl of ligation or HiFi assembly, or 1 μl of a plasmid (including the above  recombination reaction), 
was added to 25 μl of chemically competent E. coli NEB5α and incubated on ice for 30 min. Cells 
were then heat-shocked at 42°C for 30 sec and incubated on ice for a further 2 min. 950 μl of BHI 
medium was added to the mixture and incubated at 37°C for 1 h before being spread on BHI agar 
containing the appropriate antibiotic(s). 
 
2.6.1.6.1 Colony PCR screening  
For colony PCR reactions a PCRBIO Taq Red Mix (Ref PB10.13-10, Insight Biotechnology Ltd) was 
used. Using a sterile tip, a single transformed colony (see above) was transferred into a PCR tube. 
A final 25 µL reaction was performed as follow:  
 
Taq Master Mix (2x)  12.5μl 
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Forward primer (10 μM)  1.25μl 
Reverse primer (10 μM)     1.25 μl 
nfH2O                    10 μl  
 
PCR amplifications were carried out using the following program: 
 
Cell lysis   90oC  5 min 
Denaturation   94oC  10 s 
Annealing   50-60oC 20 s 
Extension   72oC  1 min/kb, go to denaturation step, 30-35x 
Final extension  72oC  5 min 
2.6.1.6.2 Plasmid DNA extraction  
Positive colonies were grown overnight (Section 2.5.3). The following day, plasmid DNA was 
extracted using the GeneJET Plasmid Miniprep kit (Thermo Scientific) as per the manufacturer’s 
instructions. DNA was eluted in 60 μl nuclease free water. Plasmids used in this project are 
outlined in Table 2.3. 
 
2.6.1.6.3 DNA Sequencing 
Plasmids were sequence by Eurofins Genomics. Sequencing results were analysed using 
SnapGene® v.5.0.8. 
 
2.7 Protein analysis  
 
2.7.1 Protein expression  
 
For the purification of all recombinant proteins, E. coli Lemo21 (DE3) were transformed (Section 
2.6.1.6) and plated with the appropriate antibiotic(s) at 37°C overnight. For Lemo21 (DE3), plates 
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were prepared with chloramphenicol at a final concentration of 35 µg/mL and ampicillin at a 
concentration of 100 µg/mL for all expression plasmids used in this work (Table 2.3).  
During day 2, a single colony was used to inoculate ~10 mL of BHI medium with the corresponding 
antibiotics in a universal tube or falcon tube (1 mL starter culture per 100 mL large scale culture). 
Cultures were grown overnight at 37°C (200 rpm).  
At day 3, large scale cultures with the necessary antibiotics were inoculated with the starter 
cultures, using a ratio of 1 mL of the starter culture per 100 mL of the large-scale culture. To 
ensure an adequate aeration, 800 mL of medium was prepared in a 3L flask , or 1.6 L in 5 L flasks. 
Cells were grown at 37°C shaking at 180-200 rpm to an optical density at 600 nm (OD600) of 0.7 
in BHI (Section 2.3.1), or M9 medium for NMR analyses (Section 2.3.3). 
 
To optimize the expression of E. faecalis EF1293 proteins described in Chapter VI, Lemo21 (DE3) 
cells were also grown in Overnight Express™ Instant TB medium (autoinduction medium) (Section 
2.3.4). All cultures in autoinduction media were initially grown for 4h at 37°C (200 rpm) and 
changed to 25°C (200 rpm) for overnight. For all the above media: BHI, M9, and Overnight 
Express™ Instant TB, the starter cultures were grown in BHI medium.  
 
To induce protein expression in cultures with BHI or M9 media, IPTG was added to a final 
concentration of 1 mM. After 4 h at 37°C or 25°C for overnight , all induced cells were harvested 
by centrifuging at 5000 rpm for 15 mins, and collected in 50 mL falcon tubes either by scrapping 
the pellet with the help of a spatula or by resuspending the cells in 10-15 mL of the affinity 
chromatography buffer A (Section 2.2.2.2.1). The cell pellets were either taken directly to 
purification at this stage or frozen at -80°C.  
 
Protease inhibitor cocktail tablets [25x] (EDTA free) were mixed into the pellet previously 
resuspended in buffer A (Section 2.2.2.2.1). Crude lysates were then obtained by sonication 
(3 × 30 s, 20% output; Branson Sonifier 450) and used for affinity purification.  
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2.7.2 Affinity chromatography  
The sonicated crude extract was centrifuged at 45,000 g for 25 min at 4°C. Soluble proteins were 
loaded onto a HiTrap IMAC column (GE Healthcare) charged with 0.1M NiSO4 for SH3_5 proteins 
(alone or fused to mNeonGreen) or 0.1M ZnCl2 for the full-length lysostaphin. His-tagged proteins 
were eluted with a 20-column-volume linear gradient of buffer B (Section 2.2.2.2.2).  
2.7.3 Size-exclusion chromatography  
Recombinant His-tagged proteins were concentrated using Amicon® Ultra Centrifugal filter tubes 
and purified by size-exclusion chromatography at room temperature on a HiLoadTM 26/60 
SuperdexTM 75 prep grade (GE Healthcare) or SuperdexTM 75 10/300 (GE Healthcare). His-SH3_5 
alone or fused to mNeonGreen were purified using SEC buffer (Section 2.2.2.3.1), full-length 
lysostaphin with SEC buffer (Section 2.2.2.3.2), and His-TEV-SH3_5 with buffer (Section 2.2.2.3.3), 
this buffer was used for the SEC purification, TEV digestion, and reverse-IMAC steps. All purified 
proteins were analyzed by SDS–PAGE. 
As mentioned, for crystallography experiments the SH3_5 domain was produced using plasmid 
pET-SH3_5-TEV described in Table 2.3. The N-terminal tag of the IMAC/SEC-purified proteins was 
removed using recombinant TEV protease (0.5 mg of TEV per mg of SH3_5 protein). Digestions 
were performed at 37 °C overnight in buffer (Section 2.2.2.3.3). Following digestion, proteins 
were loaded onto a HiTrap IMAC column equilibrated in buffer (Section 2.2.2.3.3). Cleaved SH3_5 
proteins were recovered in the flow through. Elution buffer B (Section 2.2.2.3.3) was used to 
elute the cleaved His-tag bound to the column.  
 
2.7.3.1 Protein quantification  
All protein concentrations were determined using a NanoDrop DeNovix® spectrophotometer/ 
fluorimeter. Blank measurements were taken with 1 μl of eluent buffer. The same volume of 
sample was then used to measure the concentration at 280 nm. 
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2.7.4 SDS-PAGE  
Cell lysates, soluble fractions, and each purification step were analyzed by the SDS-PAGE method 
(Laemmli, 1970). The acrylamide concentration was dependent on the size of the  proteins to be 
resolved. Standard 16% gels were prepared as follows: 
 
SDS-PAGE 16% (w/v) resolving gel: 
30% (w/v) acrylamide/bis (37.5:1)   6.75 mL 
4x separating buffer (Section 2.2.2.1.1) 3.13 mL 
dH2O      3.65 mL 
10% (w/v) APS 100 μl    125 µL 
TEMED       25 μl 
 
SDS-PAGE 16% (w/v) stacking gel: 
30% (w/v) acrylamide/bis (37.5:1)   750 μl 
4x separating buffer (Section 2.2.2.1.2) 1.5 mL 
dH2O  3.65 mL 
10% (w/v) APS 100 μl    12 µL 
TEMED       30 μl 
 
Samples were mixed with 5x SDS-PAGE loading buffer (Section 2.2.2.1.3) and incubated for 10 
min at 95°C. An appropriate volume was loaded into the gel. Electrophoresis was performed at a 
constant voltage (190 V) for 1 h or until the dye front approached the end of the gel. When  
required, gels were stained with Coomassie blue stain (Section 2.2.2.1.4) and subsequently 
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destained for analysis (Section 2.2.2.1.5). For fluorescence gel documentation, SDS-PAGE gels 
were directly scanned using a ChemiDoc XRS+ System. 
 
2.8 Purification of S. aureus PG muropeptides  
 
2.8.1 S. aureus PG isolation  
PG sacculi were isolated from exponentially growing S. aureus cells at an OD600 of 0.7 as 
previously described (Mesnage, 2008). Cells were centrifuged (6,500 rpm, 10 min) and washed 
with RO deionized water. The cell pellet was snap-frozen in liquid nitrogen (using 50 mL 
centrifuge tubes). The frozen pellets were then boiled inside a glass beaker. 8 mL of 8% v/v SDS 
was then added and left for 30 min. The tubes were then left to cool at room temperature. 4 to 
6 washes with RO deionized water was then carried out at room temperature (45,000 g for 10 
min) using 30 mL Beckman Polyallomer (25 x 89 mm) tubes. The pellets were resuspended in 2 
mL Tris-HCl (10 mM) pH 7.4 and treated with pronase (Sigma-Aldrich)  (2 mg/mL) for 3 h at 60°C. 
The volume was adjusted with RO deionized water to 15 mL, and 15 mL of 8 % v/v SDS was added. 
Samples were boiled for 30 min. Six more washes with RO deionized water was performed. To 
eliminate secondary polymers, the sample was treated with 1 mL of HF (48% v/v) and incubated 
for 48h at 4°C. After HF treatment, the pure PG was extensively washed with RO deionized water. 
Pure PG was freeze-dried and resuspended at a final concentration of 25 mg/mL. 
 
2.8.1.1 Production of muropeptides  
S. aureus PG was digested with mutanolysin (Sigma-Aldrich).  To purify PG dimers (GM–P5–G5–
GM–P4–G5), 180 mg of PG was digested with 4.5 mg of mutanolysin in a final volume of 7 mL 
using buffer (Section 2.2.3.3.1). After overnight incubation, the enzyme was heat inactivated. 
Around 60 % of the previous digestion was used to obtain disaccharide peptides. A sequential 
digestion with EnpAc (1 mg EnpAc / 50 mg PG) was performed. The pH was adjusted to 7.5 and 
after overnight incubation, the enzyme was heat inactivated (Reste de Roca, 2010).  
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2.8.1.2  β-elimination (to generate lactyl-peptide) 
Soluble muropeptides    200 µL 
Ammonia solution 32%    63.7 µL 
The reaction was mixed (vortex). After incubation for 5 h at 37°C, the following was added to 
neutralise:   
 
Acetic acid 100% (98%)    60.3 µL  
Samples were freeze-dried and resuspended in buffer A (Section  2.2.3.1.1) . 
 
2.8.2 HPLC analysis and fractionation  
 
2.8.2.1 Muropeptide reduction  
Soluble muropeptides were reduced before reverse-phase HPLC fractionation. MurNAc is 
reduced to NAc-muraminitol with sodium borohydride (NaBH4) to eliminate double peaks 
corresponding to the α- and β-anomers. The soluble muropeptides were mixed with an equal 
volume of sodium borate buffer at pH 9.0 (Section 2.2.3.4). The sample was transferred to 15 mL 
centrifuge tubes and approximately 2 mg of NaBH4 was added using a small spatula. The sample 
was incubated for 20 min at room temperature. The final pH was adjusted to 3.0 with 20 % 
phosphoric acid. The reduced muropeptides were centrifuged at 17, 000 g for 2 min. The 
supernatant with the reduced muropeptides was recovered and injected into the RP-HPLC 
system or  stored at -20 °C.  
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2.8.2.2 Muropeptide separation by RP-HPLC  
Fractionation of material corresponding to the mutanolysin digestion was carried out on a 
preparative Hypersil GOLD aQ column (C18; 20 × 250 mm; Thermo Scientific Fisher) and 
separated at a flow rate of 10 mL/min  using buffer A (Section 2.2.3.1.1) as a mobile phase. After 
a short isocratic step (two column volumes), PG fragments were eluted with a 15-column-volume 
methanol linear gradient (0–30%) in buffer B (Section 2.2.3.1.2). Individual peaks were collected, 
freeze-dried and analysed by mass spectrometry. The fractions corresponding to the major dimer 
(GM–P5–G5–GM–P4–G5) were desalted by HPLC using a water–acetonitrile gradient (Section 
2.2.3.2), freeze-dried and resuspended in RO deionized water. Separation of mutanolysin/EnpAc 
digested fragments was performed as previously described (Reste de Roca, 2010). 
 
2.9 Production of PG fragments by chemical synthesis 
The production of the tetrasaccharide (GMGM) was described previously (Mesnage, 2014). All 
peptides and branched peptides (>95% purity) were purchased from Peptide Protein Research. 
Their purity was determined  by HPLC and mass spectrometry. The characterization of all ligands 
is described in the following Chapter III. The pentaglycine peptide (G5) was purchased from Sigma 
Aldrich (cat. no. G5755). 
2.10 Crystallography  
Crystallization of the lysostaphin SH3_5 was carried out in collaboration with Dr Andrew Lovering 
and Hannah Walters at the University of Birmingham. Experiments were performed using 
standard screening in a sitting drop 96-well clover-leaf crystallography tray at 18 mg ml−1 with 
3.41 mM AγQK[GGGGG]A (P4-G5) in a 1:2 drop ratio of screening agent to protein solution. The 
trays were incubated at 18 °C. Tetragonal bipyramidal crystals formed within the first 48 h in 
100 mM Bis-Tris, pH 5.5, 25% (wt/vol) poly(ethylene) glycol 3350- and 200-mM ammonium 
sulphate. Crystals were cryo-protected using the above conditions including P4-G5 and additional 
20% (vol/vol) ethylene glycol. Two datasets were collected: a high-resolution set at the I03 
beamline, Diamond Light Source, Oxford and a second set on a Rigaku Micromax home source. 
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All data was processed with XiaII/XDS (Kabsch, 2010) at the University of Birmingham as 
described in (Gonzalez-Delgado, 2020).  
2.11 NMR experiments 
NMR experiments were conducted on Bruker Avance I 800 and DRX-600 spectrometers at 298 K. 
Two-dimensional 15NHSQC experiments were carried out using the b_hsqcetf3gpsi pulse program 
(Bruker) with a relaxation delay of 1 s, 128 complex increments (approximately 1 h 18 m per 
spectrum). Lss SH3_5 proteins were quantified by measuring the absorbance at 280 nm (Section 
2.7.3.1) and adjusted to a concentration of 60 µM in SEC buffer (Section 2.2.2.3.1). All ligands 
were quantified by one-dimensional 1H-NMR spectra with a relaxation delay of 10 s. 
Quantifications were carried out based on the intensity of methyl protons, using 
trimethylsilylpropanoic acid (TSP) as a standard. 15N HSQC experiments and CSP analysis were 
performed as previously described (Mesnage, 2014) using Bruker TOPSPIN (versions 4.0.7) and 
FELIX 2007 software (Felix NMR, Inc., San Diego, CA). Kd values were obtained through fitting to 
standard saturation curves using Microsoft Excel. Chemical shift changes were analysed as a 
weighted sum of 1H and 15N shift changes: Δδ=√(ΔδH²+(0.154x ΔδN)²) (Williamson, 2013).  
2.12 PG binding assays 
The PG binding activity of the Lss SH3_5-mNeonGreen fusion proteins was determined using in-
gel fluorescence. Protein amounts equivalent to 3 µg of the recombinant wild-type and derivative 
proteins were adjusted based on fluorescence intensity of the bands corresponding to the full-
length proteins.  Fusion proteins were incubated in the presence of increasing amounts of PG (0–
400 µg) for 20 min at room temperature in a final volume of 40 µL. PG and bound proteins were 
then pelleted at 17,000 g for 5 min. 20 µL of supernatant corresponding to unbound proteins 
were loaded onto an SDS–PAGE gel (12%) and scanned using a BioRad Chemidoc XRS+ system. 
Fluorescence intensity was quantified using ImageJ software. The percentage of binding was 
determined using the signal intensity measured in the absence of PG (control) as a reference.   
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2.13 Lysostaphin spot on-lawn assays 
S. aureus SH1000 (Horsburgh, 2002) was grown to an optical density OD600 of 1.0. Cells were 
collected, resuspended in dH2O water, autoclaved (121°C, 20 min), and incorporated onto agar 
plates at a final OD600 of 0.5. An arbitrary lysostaphin activity unit (50 ng) was defined as the 
greatest dilution used for the wild-type and derivative proteins. 5 µL corresponding to serial 
dilutions of the recombinant lysostaphin proteins were spotted onto plates coated in an 
autoclaved bacterial lawn (the substrate) and incubated overnight at 37 °C. Lytic activities were 
detected as clearing zones and compared by determining the lowest amount of enzyme 
displaying a detectable digestion of the substrate.  
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CHAPTER III 
Production and characterisation of recombinant Lss SH3_5 domains and 
peptidoglycan fragments 
 
Previous studies have suggested that S. aureus PG recognition by the SH3_5 domain is critical for 
the substrate specificity of Lss. Therefore, the molecular mechanisms underpinning this PG 
recognition were characterised and the impact of this process on Lss activity explored.  
 
3.1 Aims and Objectives  
 
To elucidate the binding mechanisms of the SH3_5 domain to PG, we first tried to identify the 
minimal PG motif recognised by the SH3_5 domain. To carry out functional and structural 
analyses using NMR titrations and X-ray crystallography, we defined two main objectives: 
• To produce a series of recombinant SH3_5 proteins 
• To generate a set of ligands with increasing complexity derived from S. aureus PG 
 
3.2 Results 
 
3.2.1 Expression and purification of the SH3_5 domain for interaction studies and X- ray 
crystallography 
Before the start of my project, a former PhD student (Barker S, personal communication) had 
built an expression vector (pET-MBP-SH3_5) to produce the Lss SH3_5 domain fused to the 
maltose binding protein (MBP). The SH3_5-MBP fusion protein has a 6x-His tag at its N-terminus 
and a TEV (Tobacco Etch Virus) cleavage site between the 2 domains (Fig 3.1 A).  
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Figure 3.1. Description of available Lss-SH3_5 constructs used for interaction studies and X-ray 
crystallography. (A) Domain organization and amino acid sequence of the recombinant fusion 
protein MBP-SH3_5 encoded by the pET-MBP-SH3_5. (B) Recombinant His-SH3_5 protein 
organization and amino acid sequence from pET15b-His-SH3_5 vector. (C) Domain organization 
and amino acid sequence of the recombinant His-TEV-SH3_5 protein encoded by pET2817-His-
TEV-SH3_5. Numbering corresponds to the transition between domains. Amino acids 
corresponding to the N-terminal 6x His-tag are coloured in red; Lss-SH3_5 domain in blue (94aa); 
Maltose-binding protein (MBP) in purple (380aa); Tobacco Etch Virus (TEV) cleavage site in green.  
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To purify this MBP-SH3_5 fusion, nickel-metal affinity (Ni-Nta) and size exclusion 
chromatography were performed, followed by an overnight TEV protease digestion. The 
products were then purified again using size exclusion chromatography to purify the cleaved 
SH3_5 domain. This recombinant SH3_5 protein was then used as a template for the NMR 
structural assignment.  
At the start of my project, one of our collaborators, Dr. Izabela Sabała, sent a new expression 
vector (pET15b-His-SH3_5) allowing the expression of an N-terminally 6xHis SH3_5 protein (Fig 
3.1 B).  Given the more straightforward purification strategy, it was decided to use this plasmid 
for all my NMR studies.  
For X-ray crystallography experiments, an expression vector available in the laboratory collection 
(pET2817-His-TEV-SH3_5) was used. This vector encodes a protein with an N-terminal cleavable 
His-tag that can be removed by TEV cleavage. (Fig 3.1 C). 
 
3.2.1.1 Unlabelled His-tagged-SH3_5 
The recombinant 11.7 kDa His-tagged SH3_5 protein (Fig. 3.1 B) was produced as described in 
the material and methods, and purified by affinity chromatography, followed by gel filtration (Fig. 
3.2 A-C). The purity of the purified protein was estimated to be over 95% with a yield of 15 mg/L.  
To test the binding activity of the recombinant His-SH3_5 protein, a pull-down assay was carried 
out using increasing amounts of S. aureus PG sacculi (0-50 µg) with 10 µg of His-SH3_5 protein. 
After incubation, samples were centrifuged and the unbound His-SH3_5 protein and 
supernatants were loaded onto an SDS-PAGE. These results showed that the recombinant SH3_5 
protein bound to PG in a dose-response manner (Fig. 3.2 D). 
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Figure 3.2. Production, purification, and binding activity of recombinant Lss-SH3_5 protein. (A) 
Production and solubility of the 11.7 kDa Lss-SH3_5 protein produced in E. coli Lemo21(DE3) cells. 
Lane 1 (MWM), molecular-weight makers; lane 2 (CE), crude extract; lane 3 (SN), soluble fraction. 
(B) SDS-PAGE analysis of Lss-SH3_5 purification steps. Lane 1 (MWM), molecular weight makers; 
lane 2 (SN), soluble fraction; lane 3 (FT), flow-through; lane 4 (W), wash; lane 5 (Ni-Nta), elution 
pool; lane 6 (GF), pooled fractions from gel filtration step. (C) Gel filtration chromatogram of the 
purified His-SH3_5 protein. Gel filtration chromatography was performed using a HiLoad 26/60 
Superdex 75 size exclusion column as described in material and methods. Fractions eluting at the 
expected volume (highlighted in blue) were pooled and the purity of the recombinant His-SH3_5 
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protein was confirmed by SDS-PAGE. Purification was followed measuring UV absorbance at 
280nm. (D) SH3_5-PG pull-down assay. The binding activity of the purified His-SH3_5 domain was 
assessed by incubating increasing amounts of S. aureus PG sacculi [0-50µg] with 10µg of protein. 
After 30-min incubation at room temperature , all samples were centrifuged and the protein 
present at the supernatant was loaded on an SDS-PAGE. The amount of His-SH3_5 protein 
present at the supernatant decreased as the PG concentration increased. 
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3.2.1.2 Singly and doubly labelled His-SH3_5 proteins 
The His-SH3_5 construct described in Fig. 3.1 B was singly labelled with 15N (Fig. 3.3 A) and doubly 
labelled with 15N and 13C (Fig. 3.3 B) to investigate Lss SH3_5-PG  interactions using NMR titration 
experiments. In both cases, proteins were purified by affinity and gel filtration chromatography.  
Protein purity was greater than 95% (SDS-PAGE) and the yields were 12 mg/L and 10 mg/L for 
the 15N- and 15N/13C-labelled proteins, respectively. 
 
3.2.1.3 Unlabelled and untagged SH3_5 proteins  
For X-ray crystallography studies, a recombinant untagged SH3_5 protein was used to avoid 
potential crystallisation issues caused by the unstructured tag. The 12.3 kDa His-tagged-TEV-
SH3_5 protein described (Fig. 3.1 C) was produced and purified by affinity chromatography 
followed by gel filtration (Fig. 3.4). The purity of the protein estimated on SDS-PAGE  was >90 % 
with a yield of 60 mg/mL. 
A digestion trial was next performed to define the best conditions for the TEV protease cleavage 
of the His-tag. The standard buffer (150 mM NaCl, 50 mM Tris-HCl, pH 8.35) was tested with and 
without 0.2 mM DTT and 25 mM EDTA. For each buffer, increasing amounts of TEV protease (0-
1 µg) were incubated with 10 µg of His-TEV-SH3_5 protein per reaction. It was found the addition 
of DTT and EDTA had no impact on the activity of the TEV protease. As shown in Figure 3.5, nearly 
100% of the N-terminal His-tag was cleaved in the presence of 1 µg of TEV per 10 µg of His-TEV-
SH3_5 substrate after 1-hour digestion at 37 °C, irrespective of the buffer condition.  
For large scale production, 1 mg of the tagged protein was incubated in the presence of 50 µg of 
TEV overnight using buffer 4 (150 mM NaCl, 50 mM Tris.HCl, pH 8.35). Following cleavage, a 
reverse affinity chromatography was carried out to recover the 10.4 kDa untagged SH3_5 protein 
in the flow through (Fig 3.6). The purity of the protein estimated on SDS-PAGE was >95 % with a 
yield of 20 mg/mL (Fig. 3.6). 
  
95 
 
 
 
Figure 3.3. Production and purification of 15N- and  15N/13C-SH3_5 labelled proteins. (A) SDS-
PAGE analysis of the purification steps to obtain the 11.7 kDa singly labelled His-SH3_5 protein 
expressed in E. coli Lemo21 (DE3) cells. Lane 1 (MWM), molecular weight makers; lane 2 (SN), 
soluble fraction; lane 3 (FT), flow through; lane 4 (W), wash; lane 5 (Ni-Nta), elution pool; lane 6 
(GF), pooled fractions resulting from the gel filtration step. (B) SDS-PAGE of the 11.7 kDa doubly 
labelled His-SH3_5 protein expressed in E. coli Lemo21 (DE3) cells. Lane 1 (MWM), molecular 
weight makers; lane 2 (GF), pooled fractions resulting from the gel filtration step. 
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Figure 3.4. Production and purification of the recombinant His-TEV-SH3_5 protein. SDS-PAGE 
analysis of the purification steps to produce the 12.3kDa His-TEV-SH3_5 protein expressed in E. 
coli Lemo21 DE3) cells. Lane 1 (MWM), molecular-weight makers; lane2 (CE), crude extract; lane 
3 (SN), soluble fraction; lane 4 (FT), flow through; lane 5 (W), wash; lane 6 (IMAC), affinity 
chromatography elution pool; lane 7 (GF), pooled fractions resulting from the gel filtration step. 
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Figure 3.5. Optimisation of the conditions for the TEV digestion of recombinant His-TEV-SH3_5. 
(A) Cleavage of the His-tag was analysed by incubating increasing amounts of recombinant TEV 
protease (0-1 µg) with 10 µg of His-TEV-SH3_5 protein using buffer 1 (150 mM NaCl, 50 mM Tris-
HCl, 25 mM EDTA, 0.2 mM DTT, pH 8.3). (B) Same experimental conditions were tested using 
buffer 2 (150 mM NaCl, 50 mM Tris.HCl, 0.2 mM DTT, pH 8.35). (C) Buffer 3 (150 mM NaCl, 50 mM 
Tris.HCl, 25 mM EDTA, pH 8.35). (D) Buffer 4 (150 mM NaCl, 50 mM Tris.HCl, pH 8.35). After 1-
hour incubation at 37 °C, all samples were loaded and analysed by SDS-PAGE. A concentration of 
1 µg TEV protease/10 µg His-TEV-SH3_5 protein cleaved approximately 100 % of the His-TEV 
fusion tag in all buffers. 
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Figure 3.6. Purification of recombinant untagged SH3_5 protein for X-ray crystallography. SDS-
PAGE of all purification steps to obtain the final 10.4 kDa untagged SH3_5 protein expressed in E. 
coli Lemo21 (DE3) cells. Lane 1 (MWM), molecular weight makers; lane2 (CE), crude extract; lane 
3 (SN), soluble fraction; lane 4 (FT), flow through; lane 5 (W), wash; lane 6 (IMAC), elution pool; 
lane 7 (GF), pooled fractions from gel filtration elution; lane 8 (Cleavage), verification of TEV 
cleavage after O/N incubation; lane 9 (r-IMAC), recovered SH3_5 protein after reverse-IMAC.  
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3.2.2 Purification of peptidoglycan  fragments  
To investigate PG-recognition by the Lss-SH3_5 domain, nine ligands with increasing complexity 
derived from S. aureus PG were generated. The most complex ligand was purified from PG sacculi 
via an N-acetyl muramidase (mutanolysin) digestion and the rest were synthetic peptides 
produced by solid-phase synthesis (Fig 3.7).  
The ligands used in this study were:  
• A linear tetrasaccharide (GlcNAc-MurNAc)2, [GM-GM]  (Fujimoto Y, 2007) 
• A pentaglycine cross-bridge [GGGGG], [G5]. 
• A G5 derivative with an extra tyrosine residue at the N-terminus [YGGGGG], [YG5] 
• A G5 derivative with an extra tyrosine residue at the C-terminus [GGGGGY], [G5Y] 
• A tetrapeptide stem with a lactyl group  [L(+)-AQKA], [P4]. 
• A lactyl (+) tetrapeptide stem bound to a pentaglycine lateral chain [AQK(GGGGG)A], [P4-G5]   
•  A tetrapeptide stem with no lactyl group linked to a pentaglycine peptide as a lateral chain 
[AQK(GGGGG)A], [P4-G5]. 
• A pentapeptide stem crosslinked to a tetrapeptide stem through a pentaglycine bridge 
[AQK[GGGGG]AA-AQKA], [P5-G5-P4-G5]. 
• A dimer made of a disaccharide pentapeptide crosslinked to a disaccharide tetrapeptide via a 
pentaglycine crosslink plus a lateral pentaglycine chain [GlcNAc-MurNAc-AQK(GGGGG)AA- 
GlcNAc-MurNAc-AQK(GGGGG)A], [GM-P5-G5-GM-P4-G5].  
One of the key ligands used in this study corresponded to a monomeric peptide stem [P4-G5]. 
Depending on the experiment carried out (NMR or X-ray), this ligand was obtained by different 
strategies. For NMR titrations, only a limited amount of ligand was required, so it was purified 
from S. aureus PG using a combination of two enzymes (mutanolysin + EnpAc). The disaccharide-
peptide [GM-P4-G5] was β-eliminated to generate the lactyl-peptide [P4-G5]. This strategy was 
only able to produce a yield of less than 1 mg of compound (Fig. 3.8). For X-ray crystallography, 
a large amount of the equivalent peptide (5-10 mg) was required. Therefore, a synthetic 
branched peptide was purchased. Due to added complexity of the synthesis and significant cost 
associated with this modification, this peptide did not contain a lactyl group.  
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Figure 3.7. S. aureus PG fragments used as SH3_5 ligands. The name and schematic 
representation of the structure of each ligand are indicated.  
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Figure 3.8. RP-HPLC analysis of available lactyl (+) P4-G5 ligand. RP-HPLC chromatogram of the 
tetrapeptide stem with a lactyl group [L(+)-AQKA], [P4] ligand used in NMR titration experiments. 
From a sequential digestion of S. aureus PG by mutanolysin followed by EnpA, a  DS-
AiQK(GGGGG)A monomer was produced and purified, to generate the Lactyl (+) P4G5 peptide 
the glycan strands from the monomer were  β-eliminated. 
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Three additional S. aureus PG fragments available in the laboratory were added to the list of 
ligands to be analysed by NMR titrations. The ligands corresponded to complex mixtures derived 
from the hydrolysis of PG sacculi by three distinct enzymes (Mesnage, 2014). Digestion by an 
amidase (S. aureus Atl autolysin) generated glycan chains and peptide stems (Fig. 3.9 A); 
digestion by Lss generated a mixture of linear PG (Fig. 3.9 B); finally, digestion by mutanolysin 
resulted in soluble disaccharide peptides with various degrees of crosslinking (Fig. 3.9 C).  
 
3.2.2.1 Optimization of the conditions to purify S. aureus PG disaccharide dimers   
The PG dimer [GM-P5-G5-GM-P4-G5] can be isolated following digestion of sacculi by the N-
acetyl muramidase (mutanolysin) (Fig. 3.10). The purification of a dimer at a mg scale requires 
the use of large amounts of mutanolysin. Given the cost of this enzyme, PG digestion conditions 
were first optimized to minimise the amount of mutanolysin used.  
A fixed amount of PG (75 µg) was digested with serial 2-fold dilutions of mutanolysin (between 
100-1.55 µg/mg) using a standard digestion volume of 100 µL/reaction. Following overnight 
incubations at 37 °C, all samples were reduced and analysed by RP-HPLC. As expected, higher 
mutanolysin concentrations led to an increasing amount of multimeric muropeptides (Fig 3.11 
A).  
To determine the optimal concentration of mutanolysin required, each muropeptide was 
quantified using UV absorbance at 210 nm. The abundance of monomers and dimers almost 
reached a plateau after 6.25 µg/mg of mutanolysin (Fig. 3.11 B), with dimers plateauing around 
25 % of total muropeptides. This was expected because low complexity muropeptides are not 
produced from the cleavage of highly cross-linked multimers. Incubations at concentrations of 
6.25 and 12.5 µg/mg displayed a similar multimeric composition with almost equal absorbance 
intensities. The three highest enzyme concentrations (25, 50, and 100 µg/mL) exhibited 
comparable muropeptide profile with a relatively high amount of crosslinked multimers. 
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Figure 3.9. RP-HPLC analysis of available S. aureus PG complex mixtures. The enzyme used and 
schematic representation of the structures produced are indicated. Adapted from (Mesnage, 
2014).  
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Figure 3.10. Muropeptide profile of S. aureus SH1000 PG obtained by RP-HPLC. Mutanolysin-
solubilized muropeptides analysed by RP-HPLC. Peaks corresponding to monomeric (Mon), 
dimeric (Di), and trimeric (Tri) muropeptides are indicated. Reduced multimers were separated 
on a 63-min methanol gradient (0 to 30 % linear gradient in buffer A), as described in the material 
and methods.  
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Figure 3.11. Analysis of S. aureus PG digestion by mutanolysin. (A) Muropeptide profile of S. 
aureus SH1000. Small scale digestions with fixed 75 µg of PG sacculi were incubated with 
increasing concentrations of mutanolysin [1.55-100 µg/mg] using a standard digestion volume of 
100 µL/reaction. Reduced soluble muropeptides were analysed by RP-HPLC using a standard 
methanol separation gradient. Peaks corresponding to the monomeric (Mon), dimeric (Di), 
trimeric (Tri), and tetrameric (Tetra) muropeptides are indicated on the top chromatogram (B). 
Analysis of the DS-multimer profile generated after each mutanolysin digestion trial. The 
integrated areas of the peaks corresponding to monomeric and multimeric muropeptides were 
measured and plotted. The muropeptide profile pattern showed an increased production of 
highly cross-linked muropeptides as the enzyme concentration augmented. Overnight 
incubations with the three highest concentrations exhibited the typical muropeptide profile 
where the DS-dimers are the most abundant species of multimers (>25 %).  
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A second mutanolysin-digestion assay was performed using a low-reaction volume (10 µL per 
reaction instead of 100 µL) to establish the predicted conditions for a large-scale digestion (180 
mg PG/7 mL). Incubations with 2-fold serial dilutions of mutanolysin were performed with fixed 
amounts of PG sacculi (250 µg). After overnight digestions all samples were adjusted to a 100 µL 
volume, reduced with sodium borohydride (NaBH4) to 200 µL, and analysed by RP-HPLC by 
injecting 100 µL (125 µg) of each sample (Fig. 3.12 A). In agreement with our previous 
observations, monomers plateaued after 6.25 µg/mg (Fig. 3.12 B). Higher enzyme concentrations 
led to a progressive but rather limited increase in the production of dimers and highly crosslinked 
muropeptides.  
Experiments presented in Fig. 3.11 and 3.12 indicated that the amount of dimer released (as 
quantified by UV absorbance) did not change markedly beyond 6.25 µg of mutanolysin/mg of PG. 
We therefore decided to use 25 µg/mg of PG as a standard condition. We assumed that this 
concentration was a reasonable compromise between using as much enzyme as possible to 
ensure optimal release of dimers, whilst keeping the cost of the experiment low.  
3.2.2.1.1 Large-scale digestion to produce the dimer [GM-P5-G5-GM-P4-G5] 
 
For our large-scale digestion, 180 mg of PG sacculi were digested with 4.5 mg of mutanolysin in 
a 7 mL volume reaction. As a quality control step, 150 µg of digested PG was analysed by RP-
HPLC. The chromatogram showed the expected S. aureus muropeptide profile (Fig 3.13 A).  
As an initial strategy to obtain additional DS-multimers, 40 % of the total digestion was used to 
purify the DS-dimer [GM-P5-G5-GM-P4-G5]. Soluble muropeptides were divided into five batches 
of ~15 mg of digested PG. Samples were then reduced and separated by RP-HPLC on a preparative 
C18 column (5μm, 250 x 20 mm). Dimers were eluted at a methanol concentration of between 
37 and 43 % (Fig. 3.13 B), and all desired fractions were collected, pooled, and freeze-dried. 
Approximately 25 mg of material were recovered and resuspended in 500 µL of water. 
To desalt and further purify the collected fraction, the gradient was adjusted to an analytical C18 
column (3 μm, 250 x 4.6 mm). Five ~5 mg injections were performed in a 45-minute linear 
acetonitrile gradient in water with 0.1 % (v/v) formic acid. Despite a large amount of sample  
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Figure 3.12. Analysis of small-scale mutanolysin-digestion assay to obtain the S. aureus PG 
dimer. (A) Muropeptide profile of S. aureus SH1000. 250 µg of PG sacculi were incubated with 
increasing concentrations of mutanolysin [1.55-100 µg/mg] in a 10 µL volume reaction. Soluble 
muropeptides were reduced and half of each digestion was analysed by RP-HPLC. Peaks 
corresponding to the monomers (Mon), dimers (Di), trimers (Tri), and tetramers (Tetra) are 
labelled. (B) Quantification of muropeptides by UV absorbance. Areas corresponding to peaks 
were measured and plotted.  
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per purification, the RP-HPLC profile revealed a well-separated peak corresponding to the dimer 
[GM-P5-G5-GM-P4-G5] (Fig. 3.13 C).  
All previous desalted fractions were pooled and freeze-dried. Approximately 0.65 mg of sample 
were recovered and resuspended in 250 µL of water. The final purification product was analysed 
by RP-HPLC by injecting ~35 µg of the sample on a 28-min acetonitrile gradient in water with 0.1 
% (v/v) formic acid using an analytical Hypersil Gold aQ C18 column (1.9 µm, 2.1 x 200 mm) (Fig. 
3.13 D). The purified dimer was analysed by RP-HPLC and LC-MS. Both experiments suggested 
that this ligand was >93% pure (Fig. 3.14).   
 
The production of the P4-G5 peptides from the remaining mutanolysin digestion was performed 
by a sequential digestion with the endopeptidase EnpAc (1 mg enzyme/ 50 mg PG). The generated 
P4-G5 was used for NMR analyses. EnpAc cleaves between the fourth D-Ala of the donor stem 
and the N-terminal residue of the sidechain, generating a monomeric disaccharide tetrapeptide 
with the full-length pentaglycine sidechain [GM-P4-G5]. The disaccharide-peptide was then β-
eliminated to generate the lactyl-peptide [P4-G5]. The purification by RP-HPLC was performed 
using the standardized method described by (Reste de Roca, 2010). Approximately 1 mg of P4G5 
was obtained.  The purity of the P4-G5 fraction (>95 %) was estimated by RP-HPLC and NMR (Fig. 
3.8).  
 
3.2.3 Quantitative 1H NMR analyses of produced S. aureus peptidoglycan fragments 
Prior to studying SH3_5-PG interactions, a quantitative NMR analysis was performed on the 
complete series of produced and synthesized S. aureus-derived PG ligands. 1H NMR is a direct 
and widely used method to determine metabolite concentrations based on absolute 
quantifications against internal reference standards. Acquiring 1D NMR spectra also allowed us 
to evaluate purity of the compounds. 1D NMR experiments were carried out with 10-second 
relaxation delays to ensure a reliable quantification by obtaining maximum magnetisation 
recovery. 
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Figure 3.13. RP-HPLC elution profiles to obtain the [GM-P5-G5-GM-P4-G5] PG dimer. (A) 
Muropeptide profile of S. aureus SH1000 PG obtained after a large-scale digestion. As a 
verification step 150 µg of mutanolysin-solubilized muropeptides were analysed by RP-HPLC. 
Peaks corresponding to monomeric (Mon), dimeric (Di), and trimeric (Tri) muropeptides are 
indicated. Reduced multimers were separated on a 63-min methanol gradient. (B) RP-HPLC 
chromatogram profile of the initial large-scale purification to obtain the dimeric fraction [GM-P5-
G5-GM-P4-G5]. Approximately 75 mg of reduced mutanolysin-solubilized muropeptides were 
split into 5 injections of ~15 mg to separate the desired dimeric fraction (highlighted in blue). The 
desired fraction eluted at a concentration between 37-43% methanol gradient on a preparative 
C18 column (5 μm, 250 x 20 mm). The collected fractions were pooled and freeze-dried. (C) 
Desalting and re-purification of the collected dimer [GM-P5-G5-GM-P4-G5]. Five injections of 
approximately 5 mg of the collected material were separated by RP-HPLC, the gradient was 
adjusted to acetonitrile in water with 0.01 % formic acid using an analytical C18 column (3 μm, 
250 x 4.6 mm). The peak corresponding to [GM-P5-G5-GM-P4-G5] is highlighted in blue. All 
fractions were pooled and freeze-dried. (D) Chromatogram profile of the final pooled fraction. 
35 µg of the sample were eluted in acetonitrile gradient using an analytical Hypersil Gold aQ C18 
column (1.9 µm, 2.1 x 200 mm).  
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Figure 3.14. Characterisation of the DS-dimer [GM-P5-G5-GM-P4-G5]. (A) Analysis of the 
purified [GM-P5-G5-GM-P4-G5] by RP-HPLC. A purity of >93% was estimated for the major DS-
dimer (peak 2, eluted at 23.2 min) on an analytical Hypersil Gold aQ C18 column (1.9 µm, 2.1 x 
200 mm) column. (B) Total Ion Chromatogram (TIC) of the DS-dimer [GM-P5-G5-GM-P4-G5] 
ligand. Peak of interest highlighted in blue. (C) The mass spectrum from all scans within the 
highlighted area of the TIC (6.953-7.252 minutes) was extracted and the background was 
removed. Background was defined as ions appearing in an area of the TIC lacking peaks. (D) 
Isotopic series of peaks highlighted in panel C used to determine ion charge.  
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To determine the concentration of the PG ligands, the peak integrals of interest were compared 
to trimethylsilyl propanoic acid (TSP), a known concentration standard. Ligands comprised of the 
saccharide units GlcNAc and MurNAc were quantified using the methyl group from their N-acetyl 
moiety as there are no neighbouring hydrogens and their signal remains as a singlet (single peak). 
For those compounds lacking saccharide units, their concentration was measured by integrating 
methyl groups corresponding to the lactyl group and their peptide moieties (D-Ala and L-Ala). 
These methyl groups appeared as two peaks of equal size, known as doublets, due to the 
presence of one hydrogen on the adjacent atom. Doublets were individually integrated and 
compared to the total methyl region with the appropriate proton correction. 
The quantification of the [GM-P5-G5-GM-P4-G5] dimer is shown in Figure 3.15 as an example. 
TSP was used at a final concentration of 0.2 mM. The area under the curve corresponding to TSP 
was determined. This area corresponds to a methyl resonance equivalent to 9 protons, that was 
then used as a reference to quantify the signal associated with the four methyl groups (12 
protons) from the dimer sugars (between 1.85-2 ppm). Considering the dilution factor of the 
purified dimer in the NMR tube, a concentration of 1.05 mM was determined for the purified 
[GM-P5-G5-GM-P4-G5] ligand. Final volumes and concentrations are summarized in Table 3.1 
and Figure 3.16.  
 
Table 3.1. Final concentration of S. aureus-derived PG ligands determined by NMR.  
Ligands Concentration (mM) Volume (mL) 
Lactyl (+) [GM-GM] 0.57 0.500 
[GM-P5-G5-GM-P4-G5] 1.05 0.250 
[P5-G5-P4-G5] 2.8 1.200 
[P4-G5] 70 0.300 
Lactyl (+) [P4-G5] 2.41 0.250 
Lactyl (+)[P4] 15 0.500 
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Figure 3.15. 
1
H NMR analysis of the purified S. aureus S1000 [GM-P5-G5-GM-P4-G5] dimer. 1D 
NMR spectrum of the purified [GM-P5-G5-GM-P4-G5] dimer was acquired after long relaxation 
delays (10 seconds), using TSP as an internal calibration standard. The value of the integrated area 
corresponding to the methyl groups from the TSP standard (yellow) was corrected for the number 
of protons. The concentration of the dimer [1.05 mM], is calculated from the integrated area of 
interest (blue), which corresponds to methyl groups from the N-acetyl moieties, when corrected 
for the number of protons (12H) and dilution factor after TSP calibration. 
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Figure 3.16. 
1
H NMR spectra of pure S. aureus derived fragments used as SH3_5 ligands. 1D 
NMR was used to quantify seven chemically defined S. aureus PG fragments using TSP as an 
internal calibration standard. The name, integrated area (blue), and schematic representation of 
every compound is indicated on each spectrum. The chemical structure of S. aureus DS-dimer 
[GM-P5-G5-GM-P4-G5] with methyl groups highlighted in blue is illustrated on the left.  
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3.2.4 Discussion  
To study PG recognition by Lss, we produced a set of SH3_5 recombinant proteins for NMR and 
X-ray crystallography analysis. NMR experiments were performed using singly and doubly 
labelled His-tagged SH3_5 proteins. The N-terminal His-tag was kept since it allowed a more 
straightforward purification process and based on the distance from the described G5 interaction 
region, it was not expected to interfere with binding. A distinct expression vector was used to 
remove the His-tag for X-ray crystallography experiments to avoid the potential interference of 
the unstructured tag during the crystallisation process.  
Highly pure compounds were required for both experimental approaches. The G5 ligand was 
purchased from SIGMA Aldrich. The rest of the synthetic peptides were purchased from Peptide 
Protein Research Ltd. Peptide purity, estimated >95%, was assessed by HPLC and mass 
spectrometry (Appendix A). The production of the GM-GM ligand is described in (Mesnage, 2014) 
Due to its complexity, the DS-dimer [GM-P5-G5-GM-P4-G5] was produced from pure S. aureus 
PG sacculi by N-acetylmuramidase (mutanolysin) digestion and purified by RP-HPLC.  
In addition to RP-HPLC and MS analyses, all our chemically defined PG fragments were assessed 
by NMR spectroscopy. NMR is a highly reliable and commonly used technique to measure the 
concentration of different compounds. NMR relaxation processes are key for the correct 
measurement and interpretation of NMR spectra. Data acquisition consists of inducing a signal 
by intense and short radio frequency (rf) pulses resulting in an excitation of all resonances. 
Application of a short rf pulse at the appropriate frequency will rotate the bulk magnetization by 
90° (into an x-y plane).  A few µs after each pulse, an extremely sensitive receiver is turned on 
and the signal recorded, this signal will then decay and return to equilibrium (z-plane).  T1 
determines how fast can you pulse, in other words, for the recovery of the excited magnetic state 
to return to equilibrium, the relaxation delay should be t = 5xT1, i.e. 5 times the longitudinal 
relaxation time (T1)  of a metabolite present in the sample (Evilia, 2007). For larger proteins, this 
occurs in a time in the order of T1 = 1 s. All our 1D NMR experiments were performed using 10 s 
relaxation delays.   
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The purity and concentration of the produced dimer was comparable with our most complex 
synthetic fragments as shown by 1D NMR and LC-MS analyses. Compounds comprised of the 
disaccharide units GlcNAc and MurNAc displayed two signals corresponding to N-acetyl moieties. 
N-acetyl groups normally resonate at 1.94 ppm. The signal corresponding to the N-acetyl group 
from the muramic acid was shifted on the spectra (~2.04 ppm), which corroborates the 
modification of the muramic acid to an anhydrous group (after reduction with sodium 
borohydride), as previously described (Atrih, 1999). Peptide analysis was conducted using the 
signal of methyls from the L-Ala, D-Ala, or D-lactyl groups as reference. A clear display of methyl 
resonances from each methyl is shown for the [Lactyl (+) P4-G5], where no overlapping of the 
signal is shown; each peak appeared as a doublet due to the hydrogen attached to the 
neighbouring carbon. To verify the accuracy of our quantification, doublets were individually 
integrated and compared to the total methyl region with the appropriate proton correction. 
Finally, our NMR quantifications highlighted slight overestimations on the concentration of our 
synthetic PG fragments. In peptide synthesis, counterions such as TFA are used for stability and 
HPLC separation; overestimation on the concentration can be explained due to the presence of 
TFA salts and residual water.  
Altogether, the results presented in this chapter showed the production of highly pure 
recombinant SH3_5 domains and PG fragments to establish the molecular basis for PG 
recognition by the Lss SH3_5 domain.  
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CHAPTER IV 
Molecular basis for substrate recognition by the Lss SH3_5 domain 
4.1 NMR titrations as a mean to characterise protein-ligand interactions. 
NMR titration experiments can be used to study biomolecular interactions. A common 
experimental approach is the study of chemical shift perturbations (CSPs) following the addition 
of increasing amounts of a binding partner. CSPs are measured in two-dimensional NMR spectra 
and quantified for every peak of the protein during each titration point, providing structural and 
kinetic information to characterise its interaction (Williamson, 2013; Zuiderweg, 2002). The 
detection of CSPs for individual residues shows a change in the chemical environment and can 
be either due to the interaction with the ligand or due to local structural rearrangements.  
During titration experiments, relative chemical shifts of both 1H and 15N nuclei from each residue 
are measured. If a spectrum assignment is available, specific residues involved in the ligand 
recognition can be identified. A standard practice is to measure the values obtained from the 15N 
HSQC spectra, then to calculate the geometrical distance travelled by each peak, weighting 15N 
shifts by a factor of 0.15 compared to 1H shifts, and select those residues for which the weighted 
shift change is larger than the standard deviation of the shift for all residues (Becker, 2018; 
Williamson, 2013). 
To determine binding affinities, the thermodynamic equilibrium that occurs when a protein (P) 
binds reversibly to a ligand (L) at a single binding site: (P+L<->PL) needs to be considered. Kinetic 
experiments are measured at incremental time points and analysed to estimate the dissociation 
constant (Kd) and the rate constants for free and bound forms, kon([P][L]) = koff ([PL]), respectively. 
Kd equals [P][L]/[PL], where [P], [L], and [PL] represent concentrations of free protein, free ligand, 
and complex. At equilibrium, kon and koff  are equal which means that Kd also equals koff/kon 
(Fersht, 1999; Maity Sanhita 2019; Williamson, 2013). 
The appearance of spectra during titration experiments is dependent on the exchange rate 
between free and bound states relative to the frequency (Hz) difference between them. 
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Exchange rates are classified as slow, fast, or intermediate. During slow exchange, koff is slower 
than the difference in Hz between the chemical shifts of free and bound protein, causing the 
signal of both states to be detected in the spectra; during incremental additions of ligand, the 
free signal starts disappearing as the bound signal appears. Opposite to slow exchange rate, 
during fast exchange rate, koff is greater (at least 10x faster) than the chemical shift difference 
between free and bound states. A single resonance is observed as its chemical shift is the weight 
average of the chemical shifts of the two individual states. During fast exchange a progressive 
change in the peak position is detected as the free signal moves to the bound spectrum. Between 
the limits of these two rates there is an intermediate exchange rate displaying a more complex 
behaviour on the spectra, since the exchange rate between both states is close to the shift 
difference (Hz) between them, peaks shift and broaden at the same time, and in some cases 
signals also disappear(Klecknera I.R., 2011; Waudby, 2016; Williamson, 2013).   
During a titration, the total ligand and protein concentrations are known. These are the sum of 
free and bound forms and can be expressed as: 
(𝟏)  [𝐿]t =  [𝐿]  + [𝑃𝐿]    
 (𝟐) [𝑃]t =  [𝑃]  + [𝑃𝐿]   
Chemical shifts (δ) are reported in ppm units, and during fast exchange the weight average of 
shifts in the free and bound states can be observed. In other words, δobs= δfƒf +δbƒb; where, ƒf and 
ƒb are fractions of free and bound states. Because ƒf +ƒb =1, the fraction of ligand bound can be 
expressed as:  
(𝟑)  ƒb =  (𝛿obs −  𝛿f)/ (𝛿b −  𝛿f)         
By knowing this, a Kd can be fitted using the following equation (Williamson, 2013): 
(𝟒)  𝜟𝜹obs = 𝜟𝜹max {([𝑷]t + [𝑳]t + 𝑲d)– [([𝑷]t + [𝑳]t + 𝑲d)2 − 𝟒[𝑷]t[𝑳]t]1/2 /𝟐[𝑷]t   
The (Δδ) are the chemical shift changes, where Δδobs is the change in the observed shift from free 
state, and Δδmax is the maximum shift change for 100 % saturation. Δδmax is commonly calculated 
as part of the fitting process since experimentally enough ligand would need to be added to 
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saturate binding i.e. a ligand concentration at least 10x the Kd which is only achievable through 
tightly bound ligands. This formula (4) can be set up in a spreadsheet by using test values of Δδmax 
and Kd to obtain the expected shift change, and then find the best fit for the dataset by using the 
least-square fit method, providing a visual demonstration of the relationship between these data 
points. As a rule of thumb, several different peaks are fitted into individual saturation curves from 
which the results are averaged to obtain a mean value of the Kd (Becker, 2018; Williamson, 2013).  
 
Different measurements are required to obtain affinities in slow and intermediate regimes. In 
the limit of slow exchange, the observed shift (Δδobs) does not move and the free signal simply 
disappears. If the exchange rate is genuinely slow, affinities are determined by plotting changes 
in the intensity of the signal as a function of the ligand concentration. Like chemical shifts, 
intensities are proportional to the concentration of free and bound protein and it is perfectly 
valid to fit a Kd using the same equation (4)(Williamson, 2013). In intermediate rates, the Δδobs 
starts to move less than the predicted chemical shift weight average; peaks will move, broaden 
and might disappear.  During intermediate limits, peaks should reappear as saturation is reached. 
If the peaks are sufficiently sharp to measure their position in an HSQC spectrum, the error of 
fitting equation (4) is small enough to be acceptable. However, intermediate rates are extremely 
complex, and signals could be affected differently introducing systematic errors in the fitted Kd. 
NMR line shape analysis also known as dynamic NMR, is a quantitative and well-established 
method that can simulate line shapes for different kon and koff rates and correctly accounts for 
the effects of intermediate exchange rates (Waudby, 2016).  
 
4.2 Aims and Objectives  
We sought to investigate the mechanisms underpinning SH3_5-PG interaction. This involved 
two objectives: 
• Mapping of the residues interacting with PG fragments 
• Determine the minimal motif by obtaining binding affinities 
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4.3 Results 
 
4.3.1 Complete resonance assignment of the doubly labelled SH3_5 domain 
Before the start of my project, an SH3_5-MBP fusion described in chapter III (Fig. 3.1 A) was 
expressed as a doubly labelled protein. After cleavage of the MBP protein, the labelled SH3_5 
protein was used for the assignment of the SH3_5 backbone amide groups using standard triple 
resonance experiments.  
Triple resonance experiments are employed to obtain a sequence-specific assignment of the HN, 
N, Cα, Cβ, and when necessary the C’ resonances of a protein (Reed, 2003; Whitehead, 1997). 
The strategy is to observe cross-peaks between sequential neighbouring amino acids through 
multidimensional NMR spectra and link them via fragments (sequential strings). The standard 
experiments are primarily based on the correlation of the HNCACB and HN(CO)CACB spectra 
(Higman, 2019; Reed, 2003). The HNCACB experiment correlates the NH group of a determined 
residue with its own Cα and Cβ chemical shifts and of the preceding residue (pCα and pCβ). In 
each sequential strip, four peaks may be visible, two of them corresponding to the same residue 
and 2 from the preceding one. Peaks from the preceding residue are usually weaker and are also 
identified using the accompanied HN(CO)CACB experiment. The HN(CO)CACB only correlates with 
the NH group of the preceding pCα and pCβ chemical shifts, which provides verification of the 
linkage of one NH group to another contiguous one, forming a long chain. In some residues, the 
chemical shifts of the Cα and Cβ adopt characteristic values specific to its amino acid type e.g. 
alanine, threonine, and serine display very different Cβ chemical shift from other amino acids 
making them easier to identify. Another clear example is  Glycine where there is no Cβ (Higman, 
2019; Reed, 2003).  
Once a long sequential string has been built, i.e. a chain of NH groups with its corresponding Cα 
and Cβ chemical shifts, it can be matched to the known sequence. To do so, a common strategy 
is to identify specific amino acid sequential patterns e.g. SxSASxT and to match them into the 
sequence. Other experiments can be performed when the quality of the spectra is low, like in the 
case of large proteins, where it is possible to study the chemical shift of the C’ instead of the Cβ 
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which might not be visible above noise. These HNCO and HNCA-based experiments can be more 
sensitive than the HNCACB and HN(CO)CACB spectra however they provide less information 
about the amino acid type (Reed, 2003; Yang, 1999).  
Most standard experiments determine all H-N correlations, mainly  from the backbone amide 
groups as described above, but also from the side chains where present e.g. tryptophan, 
asparagine, glutamine. The arginine Nε-Hε peaks are, in principle, visible, but their chemical shift 
is outside the region usually recorded (the spectrum width). Instead, their chemical shift has to 
be calculated so as to fold the peaks into the recorded spectrum (Cavanagh, 2007; Higman, 2019). 
As I started my project, a doubly labelled His-tagged SH3_5 protein was produced using a 
construct provided by collaborators. This allowed a more straightforward purification strategy 
(Fig. 3.1 B, Chapter III). The previous assignment was used as template for our new construct. To 
get a complete assignment of the protein, the tryptophan sidechain (Nε-Hε groups), as well as 
the asparagine and glutamine sidechain (Nδ-Hδ2/Nε-Hε2 groups) were also identified (Fig. 4.1).  
 
4.3.2 Analysis of Lss SH3_5-PG interactions by NMR 
 
4.3.2.1 SH3_5-pentaglycine [G5] binding 
The interaction between the singly labelled SH3_5 proteins and the synthetic G5 peptide was 
studied by 15N HSQC titrations. NMR spectra were recorded after the addition of 0.5, 1, 2.5, 4.5, 
7.5 11.5, 16.5, 22.5 and 30 equivalents of peptide (red to purple) (Fig. 4.2 A). The CSP of the 
SH3_5-G5 interaction displayed a fast exchange equilibrium; peaks that interacted with the 
peptide progressively moved maintaining the same shape throughout the titration.  
As mentioned above, to give equal weight to both 1H and 15N CSP per residue, 15N chemical shifts 
were scaled by a factor of 0.154. Once the individual Δδobs of each amino acid was obtained, their 
CSP values were divided by their average (all residues were considered). Normalised CSP were 
plotted and an arbitrary threshold of two was chosen. The largest peak shifts, Δδ/average Δδ ≥2,  
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Figure 4.1. Fully assigned 
1
H- 
15
N HSQC spectrum of the Lss SH3_5 apo domain (residues 402-
493). Assigned backbone amide resonances are shown in blue. Side-chain resonances of 
tryptophan, arginine, glutamine, and asparagine residues are in orange; the 
asparagine/glutamine Nδ-Hδ2/Nε-Hε2 groups are indicated with dotted lines.  
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were observed for the residues N405 to Y411 located in strands β1 and β2; T429 and G430 at the 
RT loop between strands β3 and β4;  H448, D450, V452, M453, D456 in strand β5 and the Src 
loop; and Y472 in strand β7 (Fig. 4.2 B). The N405 side chain also exhibited a CSP value above the 
established threshold (Table 4.1). Our NMR data is in accordance with the localisation of the G5 
binding cleft for ALE-1, a homolog of Lss, produced by Staphylococcus capitis (Lu JZ, 2006) and 
the crystal structure of Lss-SH3_5-pentaglycine complex (PDB 5LEO), which was used to map the 
residues identified by the CSP analysis in all our NMR titrations (Fig. 4.2 B). 
To obtain the G5 binding affinity, the value of individual 1H and 15N chemical shifts were 
measured from all residues after the incremental addition of the ligand. The Δδobs  were plotted 
and those residues that could be fitted into saturation curves were selected (Fig 4.3). In a 
spreadsheet, test values of Kd and Δδmax were assigned using the previously described equation 
(Δδobs= Δδmax {([𝑃]t + [𝐿]t + 𝐾d) – [([𝑃]t +  [𝐿]t + 𝐾d)2 − 4[𝑃]t[𝐿]t]1/2 }/2[𝑃]t ), then 
individual saturation curves were fitted by the least-square method (Fig. 4.4 A). The calculated 
Kd values were then averaged to a mean Kd in the range of millimolar (889± 163 µM), which 
indicates a weak binding affinity (Fig. 4.4 B). This observation is in line with other G5-SH3_5 
domain interactions described by (Benešík M., 2018; Gu, 2014; Tossavainen, 2018).  
To validate our method, binding affinities were estimated  by fitting many saturation curves 
simultaneously. In theory, this is a better practice though less common. Instead of calculating 
Kd values separately, the same Kd but different Δδmax were used, and by using the same equation 
as before, a single fitting was calculated as the sum of squares for all resonances (22 resonances 
were fitted at the same time).  The shift changes were re-scaled so that the maximum shifts of 
the N were roughly in the same range as the H, otherwise the N shift changes would have been 
much larger than the H shift changes, and effectively only the N differences in the fit would be 
considered. A weak binding affinity was estimated in agreement with the values calculated by 
averaging individual fits (Kd= 852 ± 120 µM) (Fig. 4.4 C). Although this is a better fitting procedure, 
it has the disadvantage that the error value of fitting all the affinities in a single equation is harder 
to calculate. The method of choice for fitting global parameters and the corresponding errors is 
the Monte Carlo error estimation (Arai, 2012).  
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Figure 4.2. Mapping of SH3_5 residues interacting with the G5 peptide by NMR titrations. (A) 
Overlaid 1H15N HSQC spectra of the SH3_5-G5 titration acquired in the absence (dark red contour) 
and presence (light red to purple contour) of 0.5 to 30 equivalents of peptide. Peaks from the 
backbone NH assignment are labelled in black and sidechains in blue. The enlarged view 
illustrates a region of the spectra with peaks interacting with the G5 peptide in fast exchange. 
The largest peak shifts are indicated in red. (B) Histogram of the observed CSP values calculated 
as Δδ=√(ΔδH²+(0.154x ΔδN)²), as a function of the amino acid sequence. The y-axis represents 
the ratio between individual CSPs and the average CSP (taking all residues into account). An 
arbitrary threshold of 2 was chosen. Residues associated with CSPs above the threshold are in 
red. The SH3_5 protein (PDB 5LEO) was used to map the residues identified to interact with G5 
(N405,Y407-Y411, T429, G430, H448, D450, V452, M453, D456, and Y472).  
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Table 4.1. CSPs associated with amino acid side chains.  
G5 P4 
Side chain Normalized Δδa 
(ppm) 
Δδ/averageΔδb 
(0.016)c 
 
Side chain Normalized Δδa 
(ppm) 
Δδ/averageΔδb 
(0.079) c 
 
Ws402 0.006 0.383 Ws402 0.039 0.489 
N405s 0.122 7.643 N405s 0.028 0.350 
Ws460 0.005 0.288 Rs427 0.168 2.122 
Ws478 0.004 0.258 Rs433 0.048 0.610 
Ws489 0.001 0.068 Ws460 0.143 1.796 
   Rs470 0.038 0.484 
   Rs476 0.015 0.194 
   Ws478 0.014 0.175 
   Ws489 0.157 1.982 
P4-G5 P5-G5-P4-G5 
Side chain Normalized Δδa 
(ppm) 
Δδ/averageΔδb 
(0.069) c 
Side chain Normalized Δδa 
(ppm) 
Δδ/averageΔδb 
(0.119) c 
 
Ws402 0.010 0.143 Ws402 0.059 0.499 
N405s 0.180 2.497 N405s 0.078 0.653 
Rs427 * * Rs427 0.244 2.059 
Rs433 0.024 0.348 Rs433 0.132 1.108 
Ws460 0.129 1.879 Ws460 0.189 1.597 
Rs470 0.231 3.367 Rs470 0.083 0.703 
Rs476 0.012 0.175 Rs476 0.032 0.272 
Ws478 0.004 0.058 Ws478 0.172 1.452 
Ws489 0.097 1.417 Ws489 0.095 0.802 
GM-P5-G5-GM-P4-G5  
Side chain Normalized Δδa 
(ppm) 
Δδ/averageΔδb 
(0.057) c 
 
   
Ws402 0.015 0.256    
N405s 0.191 3.343    
Rs427 0.071 1.247    
Rs433 0.013 0.235    
Ws460 0.066 1.165    
Rs470 0.019 0.334    
Rs476 0.029 0.513    
Ws478 0.053 0.925    
Ws489 0.039 0.689    
Side chain signals above the threshold are highlighted in pink. 
a Normalized 1H and 15N chemical shifts in ppm. 
b Value for the 1H 15N chemical shift divided by the mean.  
c Average chemical shift value from all residues when titrated with the corresponding ligand. 
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*Intermediate conformational exchange was reported for the backbone and side chain of 
this residue, showing line broadening and disappearance of signal when adding the highest ligand 
concentrations. 
130 
 
 
 
Figure 4.3. 1H and 15N chemical shifts from all SH3_5 residues upon titration of G5 peptide. (A) 
Individual 1H chemical shift charts from all SH3_5 residues after nine titration points with the G5 
peptide. The y-axis represents the relative chemical shift of the 1H nuclei from each residue (0.10 
to 0.10 ppm) and the x-axis the ligand concentration (0-1 mM). (B) Individual 15N chemical shift 
charts from SH3_5 residues after nine titration points with the G5 peptide. The y-axis corresponds 
to the relative chemical shift of the 15N nuclei from each residue (-0.30 to 0.80 ppm) and the x-
axis represents the ligand concentration (0-1 mM). The plotted titrations  were used to select  1H 
and 15N chemical shifts that could be fitted into saturation curves to measure binding affinities 
(Kd). 
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Figure 4.4. Calculated saturation curves for determining  SH3_5-G5 binding affinities. (A) 
Binding affinity estimation by averaging individual Kd values. Four nuclei with the largest chemical 
shifts from the G5 titration were assigned with Kd and Δδmax test values to fit their CSP data to 
equation: (Δδobs= Δδmax {([P]t + [L]t +Kd) – [([P]t + [L]t +Kd)2 -4[P]t[L]t]1/2 }/2[P]t ). Using the least-
square fit method, calculated saturation curves were obtained and individual Kd values were 
determined: N405 (H) in red, G430 (H) in blue, N405 (N) in black, and M453 (N) in yellow. An 
average Kd of 889± 163 µM was estimated. (B) Binding affinity estimation by fitting different CSP 
data simultaneously. A common Kd with different Δδmax is used to fit individual CSP data into the 
same equation as before but fitting all data simultaneously. A single fitting is used as the sum of 
squares for all resonances (22 resonances). The N chemical shifts were re-scaled to give 
comparable shift changes to the H nuclei. A global binding affinity of Kd= 852 µM was calculated.  
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4.3.2.1.1 Pentaglycine orientation on the SH3_5 binding cleft  
To further investigate the SH3_5-G5 interaction in solution, the orientation of the G5 peptide in 
the cleft was analysed by NMR. The reason for this study was that although the crystal structure 
shows only a single orientation, it looks possible to fit a pentaglycine into the binding cleft in both 
orientations, and there are well-established examples of protein binding sites being able to bind 
peptides in both orientations (Fernandez-Ballester, 2004; Saksela, 2012). To test this hypothesis, 
the binding of SH3_5 was analysed by titrating two synthetic pentaglycine peptides with an extra 
tyrosine residue either at the N-terminus (YGGGGG; YG5) or the C-terminus [GGGGGY; G5Y]. 15N 
HSQC titrations were carried out under the same conditions as previously described for G5. 
4.3.2.1.1.1 Binding to YGGGGG (YG5) 
SH3_5-YG5 NMR titrations were recorded after the addition of 1, 2.5, 4.5, 7.5 11.5, 16.5, 22.5 and 
30 equivalents of peptide. The CSP of the SH3_5-YG5 interaction displayed a fast exchange rate 
as observed for the G5 titration (Fig. 4.5 A). The largest peak shifts above the stablished threshold 
(Δδ/averageΔδ ≥2) were residues K403, N405, Y407, T409, Y411, T429, G430, H448, V452, M453, 
D456, and Y472. Only one residue (K403) was not identified in the G5 titration and appeared to 
be specifically interacting with the tyrosine located at the N-terminus of the peptide. This amino 
acid is in the β1 strand at the top of the binding cleft, where the N-terminal end of the G5 peptide 
is found in the crystal structure of SH3_5-pentaglycine complex (PDB 5LEO) (Fig. 4.5 B).  
YG5 binding affinities were calculated by fitting  individual values as described previously. The 
average Kd from fitting individual nuclei was 345 ± 60 µM.  
4.3.2.1.1.2 Binding to GGGGGY [G5Y] 
The G5Y NMR titrations were performed as described for the YG5 peptide. In agreement with G5 
and YG5, SH3_5 binding to G5Y exhibited a fast exchange rate (Fig. 4.6 A). Residues with the 
largest peak shifts were N405, Y407, T409, L410, Y411, T429, G430, R433, S434, H448, V452, 
M453, and D456. Two residues, R433 and S434, located in the RT loop between β strands 3 and 
4 at the  
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Figure 4.5. Mapping of SH3_5 residues interacting with the YG5 peptide by NMR titrations. (A) 
Superposition of the 1H15N HSQC spectra from the SH3_5-YG5 titration acquired in the absence 
(red contour) and presence (yellow to blue contour) of 0.5 to 30 equivalents of peptide. Peaks 
from the backbone NH assignment are labelled in black and sidechains in purple. The enlarged 
view illustrates a region of the spectra with peaks interacting with the YG5 peptide in fast 
exchange. The largest peak shifts are indicated in red. (B) Histogram of the observed CSP values 
calculated as Δδ=√(ΔδH²+(0.154x ΔδN)²), as a function of the amino acid sequence. The y-axis 
represents the ratio between individual CSPs and the average CSP (taking all residues into 
account). An arbitrary threshold of 2 was chosen. Residues above the threshold associated with 
G5 CSPs are in red (N405, Y407, T409, Y411, T429, G430, H448, V452, M453, D456, and Y472). 
Residue K403 (in blue), appeared to be specifically interacting with the tyrosine at the N-terminus 
of the peptide.  The SH3_5 protein (PDB 5LEO) was used to map the residues identified to interact 
with the YG5 peptide.  
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Figure 4.6. Mapping of SH3_5 residues interacting with the G5Y peptide by NMR titrations. (A) 
Overlay of 1H15N HSQC spectra of the SH3_5-G5Y titration acquired in the absence (red contour) 
and presence (yellow to blue contour) of 0.5 to 30 equivalents of peptide. Peaks from the 
backbone NH assignment are labelled in black and sidechains in purple. The enlarged view shows 
a region of the spectra with peaks interacting with the G5Y peptide in fast exchange. The largest 
peak shifts are indicated in red. (B) Histogram of the observed CSP values calculated as 
Δδ=√(ΔδH²+(0.154x ΔδN)²), as a function of the amino acid sequence. The y-axis represents the 
ratio between individual CSPs and the average CSP (taking all residues into account). An arbitrary 
threshold of 2 was chosen. Residues above the threshold associated with G5 CSPs are in red 
(N405, Y407- Y411, T429, G430, H448, V452, M453, and D456). Residues R433 and S434 (in blue), 
appeared to be specifically interacting with the tyrosine at the C-terminus of the peptide.  The 
SH3_5 protein (PDB 5LEO) was used to map the residues identified to interact with the G5Y 
peptide.  
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bottom of the G5 binding groove were identified to interact with the C-terminal tyrosine (Fig. 4.6 
B). Similar binding affinities were observed for both YG5 and G5Y peptides. The averaged Kd of 
the SH3_5-G5Y interaction was 494± 48 µM.  
Titration experiments with YG5 and G5Y peptides therefore indicated the expected preferential 
binding orientation of the pentaglycine motif in the cleft, with no evidence that the peptide binds 
in the opposite orientation.  
 
4.3.2.2 SH3_5-tetrasaccharide [GM-GM] interaction 
NMR titration experiments were performed under the same conditions as the previous ligands. 
No CSPs (peak movements or intensity changes) were identified on the spectra after the addition 
of 0.5, 1, and 2 equivalents of tetrasaccharide. All peaks were in line with our blank spectrum (no 
ligand added) revealing no interaction between the SH3_5 domain and the saccharide moieties 
(Fig. 4.7).  
 
4.3.2.3 SH3_5-Lactyl(+) AγQKA [P4] binding 
The weak affinity of the SH3_5 domain for the G5 peptide suggested that other residues may 
contribute to the recognition of PG. The interactions of the SH3_5 protein with synthetic P4 
peptides  were investigated. Due to the high level of cross-linkage in S. aureus PG, the  P4 peptides 
resemble the most abundant peptide stems. NMR spectra were acquired after the addition of 
0.33, 0.66, 1, 2, 4, 8, 16, and 32 equivalents of peptide. Interestingly, SH3_5 proteins bound to 
the P4 ligand and their binding displayed a fast exchange equilibrium in a similar manner to G5 
(Fig. 4.8 A). Residues interacting with P4 were located on the opposite side of the protein surface 
(~180o rotation), with the largest chemical shifts observed for N421 located between strands β2 
and β3; I425 and T426, in strand β3; S438 in strand β4; K442 and A443 between strands β4 and 
β5; V461, G462, and G465 in strand β6; and R470 and L473 in strand β7 (Fig. 4.8 B). The sidechain 
of residue R427 also displayed a CSP above the established threshold and is in the same region 
as the identified P4 interactions (Table 4.1).  
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Figure 4.7. SH3_5-tetrasaccharide [GM-GM] NMR titration. Overlay of 1H15N HSQC spectra of 
the SH3_5-GM-GM titration acquired in the absence (red contour) and presence (yellow to blue 
contour) of 0.5 to 2 equivalents of peptide. Peaks from the backbone NH assignment are labelled 
in black and sidechains in purple. The enlarged view shows in better detail the superposition of 
peaks due to the absence of interaction between the SH3_5 domain and the GM-GM ligand.  
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Figure 4.8. Mapping of SH3_5 residues interacting with the P4 peptide by NMR titrations. (A) 
Overlaid 1H15N HSQC spectra of the SH3_5-P4 titration acquired in the absence (red contour) and 
presence (yellow to blue contour) of 0.33 to 32 equivalents of peptide. Peaks from the backbone 
NH assignment are labelled in black and sidechains in purple. The enlarged view illustrates a 
region of the spectra with peaks interacting with the P4 peptide in fast exchange. The largest 
peak shifts are indicated in green. (B) Histogram of the observed CSP values of all residues 
calculated as Δδ=√(ΔδH²+(0.154x ΔδN)²). The y-axis represents the ratio between individual CSPs 
and the average CSP (taking all residues into account). An arbitrary threshold of 2 was chosen. 
Residues associated with CSPs above the threshold are in green. The SH3_5 protein (PDB 5LEO) 
was used to map the residues identified to interact with P4 (N421, I425, T426, S438, K442, A443, 
T446, V461, G462, G465, R470, and L473). The (*) in residue R427 indicates that the sidechain 
crossed the threshold.  
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Residues V461 and L473 displayed the most pronounced chemical shift changes yet are buried in 
the structure suggesting no direct contact with the ligand. NMR chemical shift changes are very 
sensitive and can be measured very accurately. This implies that almost any genuine interaction 
will produce a CSP, however binding could also affect adjacent residues. It is possible to 
hypothesize that given the small size of the P4 peptide, it  possess a dynamic structure that would 
allow it to fit and facilitate contact with a region in close proximity to these residues, and  it is 
also likely that the protein changes its conformation upon binding to P4. This conformational 
change, however, must be subtle since there are no obvious rearrangements in the bound crystal 
structure as discussed later.   
The average Kd displayed a low affinity in the millimolar range (963 ± 198 µM). Like the G5 
peptide, SH3_5 domains showed a weak binding to the P4 ligand. These results showed that the 
SH3_5 domain recognises both PG peptide moieties but on opposite faces of the protein.  
 
4.3.2.4 SH3_5-Lactyl(+)-AγQK[GGGGG]A binding 
To expand our studies on SH3_5 binding mechanisms and to confirm specific interactions to both 
peptide moieties, binding to a monomeric P4-G5 ligand was analysed. Titrations were acquired 
after the addition of 0.33, 0.66, 1, 1.5, 3, 5, and 9 equivalents of peptide (Fig. 4.9 A). During the 
first titration points a larger number of peaks shifted throughout the spectra in comparison to 
the simpler ligands. After the addition of 1 equivalent of peptide, seven peaks that were originally 
shifting broadened and disappeared (N405, I425, V461, G462, Y472, L473, and the side chain of 
R427) indicating stronger interactions; N405 was the only signal to re-appear for the last two 
titration points (Fig. 4.9 B; Table 4.1). In total, sixteen residues were identified to interact with 
the ligand, fourteen of them corresponding to residues previously determined  in the G5 and P4 
titrations (N405, N421, I425, G430, S438, A443, T446, M453, V461, G462, R470, Y472, L473, and 
R427 sidechain) (Fig. 4.9 B). The two remaining residues, F432 and Y449, are also localised in the 
binding regions (Fig. 4.9 B). These observations are characteristic of an intermediate exchange 
equilibrium, and as expected SH3_5 exhibited a tighter binding to the monomer P4-G5 with a Kd 
of 98 ± 42 µM, almost ten times higher than the individual G5 and P4 peptides.  
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Figure 4.9. Mapping of SH3_5 residues interacting with the P4-G5 peptide by NMR titrations. 
(A) Overlaid 1H15N HSQC spectra of the SH3_5-[P4-G5] titration acquired in the absence (red 
contour) and presence (yellow to blue contour) of 0.33 to 9 equivalents of peptide. Peaks from 
the backbone NH assignment are labelled in black and sidechains in purple. The enlarged view 
illustrates a region of the spectra with peaks interacting with the P4-G5 peptide exhibiting 
intermediate exchange rate characterised by shifting, broadening, and in some peaks 
disappearance of signals. The largest CSP are indicated in green for those residues previously 
identified to interact with the P4 peptide and in red for G5. (B) Histogram of the observed CSP 
values of all residues calculated as Δδ=√(ΔδH²+(0.154x ΔδN)²). The y-axis represents the ratio 
between individual CSPs and the average CSP (taking all residues into account). An arbitrary 
threshold of 2 was chosen. Residues associated with CSPs above the threshold associated with 
the G5 chain are in red, and those with CSPs above the threshold associated with P4 are in green. 
The SH3_5 protein (PDB 5LEO) was used to map the residues identified in the P4-G5 titration 
(N405, N421, I425, G430, F432, S438, A443, T446, Y449, M453, V461, G462, G465, R470, Y472, 
and L473). Seven residues (*) were shifting and disappeared. The (+) in residue R470 indicates 
that its sidechain peak also crossed the threshold.  
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4.3.2.5 SH3_5-AγQK[GGGGG]AA-AγQKA binding 
We next analysed SH3_5 interactions with branched PG fragments. SH3 proteins were titrated 
with a synthetic dimer containing two peptide stems connected by a pentaglycine crossbridge 
[P5-G5-P4].  NMR spectra was acquired after the addition of 0.3, 1, 2, 4, 8, and 16 equivalents of 
peptide. During the first titration points, peaks that interacted with the ligand were seen to shift, 
however higher concentrations of ligand led to the aggregation of the protein. In general, the 
formation of aggregates significantly decreases the intensity of the NMR signals; usually all the 
signals of the labelled protein are affected and very often they do not recover (this is therefore 
different from the intermediate exchange described in the previous section, where only a subset 
of signals broadened and disappeared.) Unlike the monomer P4-G5, signals decreased but did 
not disappear and it was possible to follow changes in residues interacting with the protein  (Fig. 
4.10 A).  
Most CSPs were observed in residues already identified using simpler ligands (N421, I425, V452, 
M453, V461, Y472, L473, and the sidechain of R427). One surface residue (W489) and three 
residues buried in the structure (A416, F418, T419) had not been previously identified. It was 
established that they were more likely to interact with the peptide stem based on their proximity 
to residues found in the P4 binding region (Fig. 4.10 B).  The CSPs from P5-G5-P4 interactions 
exhibited fewer and less pronounced chemical changes (Fig. 4.10 B). As previously seen for 
peptides harbouring a P4 moiety, the side chain of residue R427 also displayed a CSP above the 
established threshold (Table 4.1). 
SH3_5-P5-G5-P4 binding affinities were approximately 10 times higher than for the individual 
peptides P4 and G5, as determined for the P4-G5 peptide. An average Kd of 100 ± 34 µM was 
calculated. It is worth noting that compared to P4-G5, the fitted affinity is roughly the same, but 
the chemical changes were smaller and protein aggregation was observed. These features are 
discussed later. 
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Figure 4.10. Mapping of SH3_5 residues interacting with the P5-G5-P4 peptide by NMR 
titrations. (A) Overlaid 1H15N HSQC spectra of the SH3_5-[P5-G5-P4] titration acquired in the 
absence (red contour) and presence (yellow to green contour) of 0.3 to 16 equivalents of peptide. 
Peaks from the backbone NH assignment are labelled in black and sidechains in purple. The 
enlarged view illustrates a region of the spectra where peaks that interacted with the ligand 
shifted during the first titrations, but at higher concentrations of ligand, protein aggregation 
caused significant loss of signal intensity. The largest CSP are indicated in green for those residues 
previously identified to interact with the P4 peptide and in red for G5. (B) Histogram of the 
observed CSP values of all residues calculated as Δδ=√(ΔδH²+(0.154x ΔδN)²). The y-axis 
represents the ratio between individual CSPs and their average CSP. An arbitrary threshold of 2 
was chosen. Most residues associated with CSPs above the threshold had already been identified 
with simpler ligands, residues associated with the G5 chain are in red (V452, M453, and Y472), 
those associated with P4 are in green (N421, I425, V461, and L473). Four residues (A416, F418, 
T419, and W489) had not been previously identified (orange), however they were more likely to 
interact with the peptide stem based on their proximity to the P4 binding region. The SH3_5 
protein (PDB 5LEO) was used to map the residues identified in the P5-G5-P4 titration. 
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4.3.2.6 SH3_5- DS-AγQK[GGGGG]A-DS-AγQK[GGGGG]AA binding 
Our most complex defined ligand, the dimer GM-P5-G5-GM-P4-G5, was titrated by adding 0.25, 
0.5, 1, 2, 3.5, and 5 equivalents of peptide (Fig. 4.11 A). All CSP corresponded to peaks previously 
identified (N405, N405 sidechain,Y411, A416, F418, V452, M453, V461, L473, and W489) (Fig. 
4.11 B; Table 4.1). Interestingly, interactions with residues A416, F418, and W489 were only 
determined for our two most complex ligands.  
Binding affinities were not determined since the protein precipitated after the addition of the 
fourth titration point, resulting in line broadening and general loss of signal intensity. The unusual 
changes in the line shape during titrations with the most complex ligands indicated that more 
complex interactions were happening, such as a possible structural rearrangement of the 
protein/ligand complex, or protein oligomerisation due to binding. As discussed later, we believe 
that the correct interpretation is protein oligomerisation arising from interactions at multiple 
sites on the protein.  
 
4.3.2.7 SH3_5 binding to a complex mixture of uncrosslinked (linear) PG fragments 
To study the binding of the SH3_5 domain to complex PG fragments, we solubilised PG sacculi 
using Lss. The resulting fragments correspond to uncrosslinked material (linear glycan strands 
substituted by heptapeptide stems). Titrations were performed by adding 8, 16, 24, and 32 µL of 
the digestion mixture. Peaks interacting with the protein hardly moved, instead they broadened, 
and their signal intensity decreased; some peaks disappeared during the last titrations, 
presumably due to a tight binding (Fig. 4.12 A). Protein precipitation was evident during the last 
titration points. 
CSP analyses in the limits of the slow exchange regime can be determined by plotting changes in 
the intensity of the signal. First, to adjust the rate of signal decrement for all residues the intensity 
of the signals that disappeared during the last two titrations was set to zero. The residues that 
disappeared at first were Y411, I425, R427, and W489, followed by N405, V452, and S438. To 
correct for the presence of protein precipitation all intensities were plotted, and 18 unaffected 
peaks were selected (peaks not interacting). These intensities were collected and averaged to get  
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Figure 4.11. Mapping of SH3_5 residues interacting with the GM-P5-G5-MG-P4-G5 dimer by 
NMR titrations. (A) 1H15N HSQC spectra overlaid of the SH3_5-[GM-P5-G5-GM-P4-G5] titration 
acquired in the absence (red contour) and presence (yellow to blue contour) of 0.25 to 5 
equivalents of peptide. Peaks from the backbone NH assignment are indicated in black and 
sidechains in purple. The enlarged view shows a group of peaks that were originally shifting but 
after the addition of 1 equivalent of peptide the protein precipitated causing line broadening and 
loss of signal intensity. The largest CSP are indicated in red for those residues previously identified 
to interact with the G5 peptide and in green for P4. (B) Histogram of the observed CSP values of 
all residues calculated as Δδ=√(ΔδH²+(0.154x ΔδN)²). The y-axis represents the ratio between 
individual CSPs and their average CSP. An arbitrary threshold of 2 was chosen. Residues 
associated with the G5 chain are in red (N405, Y411, V452, and M45), those associated with P4 
are in green (A416, F418, V461, L473, and W489. The SH3_5 protein (PDB 5LEO) was used to map 
the residues identified in this titration. 
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the mean of 'unaffected' intensities, with these values the relative average and the standard 
deviation of each titration point was calculated. Then, all values were divided by each of their 
corresponding means to obtain a normalised table to plot our data. Due to the slow exchange 
equilibrium and the presence of precipitation it was not possible to fit a Kd, but the obtained 
values were fitted to a straight line and gradients were considered as a measure of signal decay.  
The biggest changes were seen for residues N421, V461, I425, R427, W489,V452, N405, S438, 
and M453 (Fig. 4.12 B).  
The strongest interactions were consistent with our identification of a defined group of residues 
in the G5 and P4 binding sites (Fig. 4.12 B). The sidechains of residues I425, R427, and W489 are 
exposed forming a crevice in the surface where SH3_5 potentially fits the peptide stems. 
 
4.3.2.8  SH3_5 binding to PG disaccharide peptides with various degrees of cross-linking  
Another complex mixture of PG fragments was prepared by mutanolysin digestion of S. aureus 
PG sacculi (Fig. 4.13 A). The resulting soluble PG fragments correspond to disaccharide peptides 
with various degrees of cross-linking. After the addition of 10 and 30 µL of sample, signals of 
residues interacting with the digestion mixture rapidly decreased and disappeared. Like in the 
titration with Lss products, CSP analysis exhibited a slow exchange rate reflecting a tighter 
binding (Fig. 4.13 B). No further titrations were carried out due to the precipitation of the protein.  
CSP analysis was performed by measuring signal intensities throughout the titrations. The signal 
intensity of residues that disappeared in the last titrations was adjusted to zero and the signal 
decay from all residues was normalised to correct for the presence of protein precipitation. As 
explained for the previous titration, values were fitted to a straight line to obtain gradients as a 
measure of signal decrement. The rate of signal decay was similar to the previous titration. The 
strongest interactions were seen in residues K406, N405, K412, M453, V452, Y411, and V461; 
followed by F432, R427, I425, T491, N421, L473, T429, Y472, G430, and A416. All residues had 
been previously identified (Fig. 4.13 B).   
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Figure 4.12. Mapping of SH3_5 residues interacting with S. aureus linear PG fragments by NMR 
titrations. (A) Overlaid 1H15N HSQC spectra of the SH3_5 interaction with S. aureus linear PG 
fragments derived from Lss digestion. Titrations were acquired in the absence (red contour) and 
presence (yellow to blue contour) of 8 to 32 µL of the digestion mixture. Peaks from the backbone 
NH assignment are labelled in black and sidechains in purple. The enlarged view shows a region 
of the spectra with peaks that disappeared during the last titrations (absence of the last peak 
contours). The largest CSP are indicated in green for those residues previously identified to 
interact with the P4 peptide and in red for G5. (B) Histogram of signal intensities as a function of 
protein-ligand interaction. The intensities of residues that disappeared during the last two 
titrations were set to 0. Values of the rate of signal decay were adjusted to correct for the 
presence of protein precipitation. Individual intensities were divided by the average intensity of 
unaffected residues calculated for each titration point. Normalised values were fitted to a 
straight line and the gradient was considered as a measure of signal decay (y-axis). An arbitrary 
threshold of -2 was chosen. Most residues associated with CSPs that decreased beyond the 
threshold had already been identified. Residues N421, V461, I425, R427, W489, V452, N405, 
S438, and M453 displayed the biggest chemical changes. The SH3_5 protein (PDB 5LEO) was used 
to map the residues identified in this titration. 
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Figure 4.13. Mapping of SH3_5 residues interacting with S. aureus disaccharide peptides by 
NMR titrations. (A) Overlaid 1H15N HSQC spectra of the SH3_5 interaction with S. aureus 
disaccharide  fragments derived from mutanolysin digestion. Titrations were acquired in the 
absence (red contour) and presence (green to blue contour) of 10 and 30µL of the digestion 
mixture. Peaks from the backbone NH assignment are labelled in black and sidechains in purple. 
The enlarged view shows a region of the spectra with peaks that disappeared during the titration 
(absence of the last peak contours). The largest CSP are indicated in green for those residues 
previously identified to interact with the P4 peptide and in red for G5. (B) Histogram of signal 
intensities as a function of protein-ligand interaction. The signals that disappeared during the 
ligand addition were set to 0. Values of the rate of signal decay were adjusted to correct for the 
presence of protein precipitation. Individual intensities were divided by the average intensity of 
unaffected residues calculated for each titration point. Normalised values were fitted to a 
straight line and the gradient was considered as a measure of signal decay (y-axis). An arbitrary 
threshold of -2 was chosen. All residues associated with CSPs that decreased beyond the 
threshold had already been identified. Residues K406, N405, K412, M453, V452, Y411, and V461 
displayed the biggest chemical changes; followed by F432, R427, I425, T491, N421, L473, T429, 
Y472, G430, and A416. The SH3_5 protein (PDB 5LEO) was used to map the residues identified in 
this titration. 
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4.3.2.9 SH3_5 binding to a mixture of glycan chains and peptide stems  
Finally, the last NMR titration was performed using soluble PG fragments resulting from the 
digestion of S. aureus sacculi by an amidase. The digestion products correspond to a mixture of 
linear glycan strands and peptide stems. 10, 18, 26, and 34 µL of this mixture were used for 
titration experiments (Fig. 4.14 A). CSPs were characteristic of slow exchange equilibrium (Fig. 
4.14 B). Fewer residues exhibited loss of signal beyond our stablished threshold (N405, Y411, 
I425, G430, V452, M453, and V461), but precipitation and signal intensities were roughly at the 
same rate as previously seen in titrations containing a mixture of PG fragments (Fig. 4.14).  
Altogether, our NMR analyses revealed a distinct subset of residues interacting with both PG 
peptide moieties, with the pentaglycine cleft and the proposed peptide stem pocket located on 
opposite sides of the surface. (Fig. 4.15 A-H).  
4.3.3 High resolution crystal structure of the SH3_5 domain in complex with the  [P4-G5] 
fragment 
Our results clearly showed that the G5 and P4 PG moieties interact in two distinct binding sites 
of the SH3_5 domain. Around the same time, another research group obtained similar results in 
a study using NMR titrations with a P4 peptide (Tossavainen, 2018). From these results two 
proposed models tried to explain the SH3_5 binding mechanism to a monomeric P4-G5 fragment 
(Mitkowski, 2019; Tossavainen, 2018).  
In all the NMR titrations reported above, most of the CSP are associated with residues situated 
in the G5 cleft or the stem peptide binding site.  No residues located between the two sites 
undergo CSP. We therefore hypothesized that an adjoining crosslinked peptide cannot bind to 
both sites at the same time, and the interaction must be more complex. Changes in signal 
intensity also imply that there are dynamic processes occurring on binding.  To fully characterise 
binding to both substrates, the co-crystallisation of the SH3_5 domain in complex with our P4-
G5 ligand was attempted. 
For the X-ray crystallography studies, a recombinant untagged SH3_5 protein was produced and 
concentrated to 20mg/mL (Fig. 3.6, chapter III). Our collaborators at the University of  
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Figure 4.14. Mapping of SH3_5 residues interacting with S. aureus linear glycan chains and 
peptide stems by NMR titrations. (A) Overlaid 1H15N HSQC spectra of the SH3_5 interaction with 
S. aureus linear glycan chains and peptide stems derived from amidase digestion. Titrations were 
acquired in the absence (red contour) and presence (yellow to blue contour) of 10 and 34 µL of 
the digestion mixture. Peaks from the backbone NH assignment are labelled in black and 
sidechains in purple. The enlarged view shows a region of the spectra with peaks that 
disappeared during the titration (absence of the last peak contours). The largest CSP are indicated 
in green for those residues previously identified to interact with the P4 peptide and in red for G5. 
(B) Histogram of signal intensities as a function of protein-ligand interaction. The signals that 
disappeared during the ligand addition were set to 0. Values of the rate of signal decay were 
adjusted to correct for the presence of protein precipitation. Individual intensities were divided 
by the average intensity of unaffected residues calculated during every titration point. 
Normalised values were fitted to a straight line and the gradient was considered as a measure of 
signal decay (y-axis). An arbitrary threshold of -2 was chosen. Residues associated with CSPs that 
decreased beyond the threshold were N405, Y411, I425, G430, V452, M453, and V461. The SH3_5 
protein (PDB 5LEO) was used to map the residues identified in this titration. 
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Figure 4.15. Mapping of the SH3_5 protein surface interacting with distinct S. aureus PG 
fragments. (A-H) Interaction maps of the two opposite sides of the Lss SH3_5 protein (PDB 5LEO) 
with the identified binding sites for the pentaglycine [G5] and tetrapeptide [P4] ligands. (A), G5 
peptide; (B), P4; (C), P4-G5; (D), P5–G5–P4; (E), GM–P5–G5–GM–P4–G5; (F), Lss-digested PG 
fragments; (G), Mutanolysin-digested PG fragments; (H), Amidase-digested PG fragments. Black 
lines show the location of key residues interacting with G5 (highlighted in red) and those for P4  
(green); dotted lines indicate the location of residues buried in the structure.  
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Birmingham,  Dr Andrew L. Lovering and Hannah Walters-Morgan carried out the crystallographic 
experiments and analyses.  
To determine the conditions for SH3_5 crystallisation, standard screen conditions with and 
without ligand were run in parallel. The JCSG+ screen (Molecular dimensions) was performed  
using a 2 µL drop volume and a 1:1 ratio of screening agent to protein solution in 200 µL wells. 
Crystals were formed in 0.2 M zinc  acetate dihydrate, 0.1 M imidazole pH 8.0 and 20% (w/v) PEG 
3000. Four crystals were taken from this condition and three of them were soaked with 20% (v/v) 
ethylene glycol for 2, 3, or 4 minutes for cryo-protection. One crystal was frozen without any 
cryo-protection. The cryo-protected crystals diffracted poorly, the non-cryo crystal diffracted to 
about 2.5 Å, allowing the structure to be solved. Interestingly, the SH3_5 protein formed a 
heptamer with the presence of Zn+ at the interface of monomers (Fig. 4.16). These crystals were 
optimised with a home screen using similar drops as previously described. Needles formed in 0.1 
M imidazole pH 7.75, 30% PEG 3000 and 0.2 M zinc acetate dihydrate. The first approach to 
generate protein-ligand complex crystals was soaking the P4 and P5-G5-P4 peptides, however, 
after testing different conditions the diffraction showed  that the crystals had no ligand. 
For co-crystallisation experiments, SH3_5 proteins were crystallised in the presence of a synthetic 
peptide ([AQK(GGGGG)A], [P4-G5]) a key ligand in our NMR studies. For these experiments, a 
highly concentrated compound was required. 14 mg of peptide were resuspended in water at a 
final concentration of 70 mM.  Crystallization was initiated via JCSG+ screening in sitting drop 96-
well clover-leaf crystallography trays at 18 mg/mL SH3_5 (1.7 mM) with 3.41 mM [P4-G5] in a 1:2 
drop ratio of screening agent to protein solution. Trays were incubated at 18°C. Tetragonal 
bipyramidal crystals formed within the first 48 h in 100 mM Bis-Tris, pH 5.5, 25% (w/v) 
poly(ethylene) glycol 3350 and 200 mM ammonium sulphate. Crystals were cryo-protected using 
the above conditions (including P4-G5 to maintain the ligand–protein complex) and additional 
20% (v/v) ethylene glycol (Fig. 4.17).  
Two datasets were collected, a high-resolution set at the I03 beamline, Diamond Light Source, 
Oxford and a second set on a Rigaku Micromax home source (PDB 6RJE). Both datasets were used  
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Figure 4.16. 2.5Å crystal structure of the Lss-SH3_5 domain forming Zn2+-bound heptamers. 
Each SH3_5 monomer is coloured separately; Zn2+ was present at the interface of the monomers. 
Crystals were formed in JSCG+ crystallisation screening with 0.2 M zinc acetate dihydrate, 0.1 M 
imidazole pH 8.0 and 20% PEG 3000. Non-cryoprotected crystals diffracted at 2.5 Å.  Crystals 
were optimised with a home screen; all drops were 2 µL: 2 µL protein: well. Needles formed in 
0.1 M imidazole pH 7.75, 30% PEG 3000 and 0.2 M zinc-acetate. 
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Figure 4.17. Crystallisation of Lss-SH3_5 proteins in complex with the P4-G5 ligand. Optimised 
crystallisation of the SH3_5-[P4-G5] complex from initial hit used for diffraction. Crystallography 
trays at 18mg/mL with 3.41 mM P4-G5 in a 1:2 drop ratio of screening agent to protein solution. 
(A) 25% PEG 3350, 0.1 M Bis tris pH 5.75, 0.2 M Ammonium sulphate (JCSG+). From this tray two 
datasets, a Rigaku Micromax home source and a high resolution set at the 103 beamline, 
Diamond Light Source, Oxford were collected; (B) 35 % PEG 3350, 0.1 M Bis tris pH 6.0, 0.2 M 
Ammonium sulphate  (JCSG+) ; (C) 25% PEG 3350, 0.1 M Bis tris pH 5.75, 0.2 M Lithium sulphate 
(JCSG+); (D) 35 % PEG 3350, 0.1 M Bis tris pH 5.0, 0.2 M Lithium sulphate (JCSG+). All crystals 
were cryo-protected in 20% ethylene glycol (v/v)  for 3 minutes.  
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to solve the final structure. A high-resolution diffraction pattern at 1.4 Å (PDB 6RK4) was obtained 
(Table 4.2). All data was processed with XiaII/ XDS40. The B factors for the high-resolution set 
were higher than expected, but match that of the Wilson B, and the dataset has a normal 
intensity distribution. An initial model was solved using the existing apo structure (PDB 5LEO, 1.6 
Å) as a molecular replacement model in PHASER (McCoy, 2007), and the corresponding structure 
was auto built using PHENIX (Zwart, 2008), with the ligand added via visual inspection of the 
difference map. The structure was updated and refined using COOT (Emsley, 2004), PHENIX 
(Zwart, 2008) and PDB-redo (Joosten, 2011), resulting in a final structure with an R/Rfree of 
19.9%/23.0% . 
 
The 1.4 Å Lss SH3_5 crystal structure in complex with the P4-G5 fragment revealed an unexpected 
dual binding mechanism. The pentaglycine chain is identically bound to the SH3_5 protein as the 
PDB 5LEO structure, but contrary to recently published models (Mitkowski, 2019; Tossavainen, 
2018), the bridge-linked stem peptide (K to G5) is directed towards a second protein domain that 
fits the tetrapeptide stem [P4] in a pocket  located at the opposite side to the G5 binding cleft 
(Fig. 4.18 A). As shown in Figure 4.18 B, the SH3_5 domains do not interact with one another but 
are brought in close proximity through interactions with the shared ligand acting as a bridge.  
 
The P4 binding site displays a more open space for L-Ala1, γQ2, and K3 interactions; the L-Ala 1 
location would place the linear saccharide chains at the edge of both domains (Fig. 4.18 C-D). 
These three peptide units adopt a linear β-like conformation with their peptide bonds hydrogen-
bonding to residues from both SH3_5 domains. Figure 4.18 D shows the bond between γQ2 NH 
to the carbonyl of K406, the K3 NH to the carbonyl of D423’, and K3 CO to the NH of I425’ (prime 
indicates opposing SH3_5). The carbon atoms of the K3 sidechain make favourable contacts with 
the hydrophobic sidechains of Y407, T422’, I424’ and W489’.  
Finally, the D-Ala 4 unit sits in a defined hydrophobic pocket made of I424’, I425’, R433’, H458’, 
W460’, P474’, and W489’ which encloses the methyl sidechain of the ligand; with the COO - 
forming a salt bridge to the R427’ sidechain. The conformational arrangement adopted by the P4 
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chain generates stronger contacts to the third and fourth units of the stem peptide.  The G5 chain 
adopts an extended conformation and sits into the pentaglycine cleft in a more rigid lock-and key 
type of binding. As  previously reported, the walls of the cleft are formed of the sidechains of 
residues N405, T429, G430, F432, E451, M453, and Y472, between strands β1, β2, and the RT 
loop. 
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Table 4.2 Data collection and refinement statistics of the SH3_5: P4-G5 co-crystal (PDB 6RK4) 
 
Home source set Synchrotron se 
Data collection 
  
Space group P4
1
2
1
2  P4
1
2
1
2 
Cell dimensions 
  
a, b, c (Å) 47.2, 47.2, 123.1 47.1, 47.1, 122.4  
α, β, γ (°) 90, 90, 90 90, 90, 90 
Resolution (Å) 2.5(2.6-2.5)* 1.43 (1.47-1.43)  
Rmerge 12.8(21.5) 5.9 (341.3)  
I / σI 14.3(6.0) 21.6(1.1) 
Completeness (%) 99.6(98.7) 98.9(98.4)  
Redundancy 11.9(8.9) 24.3(24.7)  
Refinement 
  
Resolution 
  
(Å) 2.5 1.43 
No. reflections 5270 26342  
Rwork / Rfree 25.4/29.0 19.9/23.0  
No. atoms 
  
Protein 741 741 
Ligand/ion 49 52 
Water 
B-factors 
3 24 
Protein 27.7 43.4 
Ligand/ion 29.7 44.2 
Water 17.9 44.3  
R.m.s. deviations 
  
Bond lengths (Å) 0.003 0.008 
Bond angles (°) 1.18 1.49 
A single crystal was used for both data collections. 
 *Values in parentheses are for highest-resolution shell 
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Figure 4.18. Crystal structure of Lss-SH3_5 in complex with the P4-G5 ligand. The SH3_5 domain  
and a symmetry-related partner are coloured white and blue, respectively; ligands are coloured 
by atom type, with P4 C atoms green and G5 C atoms pink. (A), cartoon protein fold with termini 
labelled; proteins shown in two representations (ribbon/stick and surface formats). (B), Co-
crystal structure showing the SH3_5:ligand shape complementarity. (C), Rotated view of a single 
SH3_5 domain showing the interaction with the P4 ligand; peptide units labelled 1-4: L-A1-γQ2-
K3-A4. (D), experimental 2fo-fc electron density map contoured at 1 for different regions of the 
bound ligand, with selected interacting residues in stick form. The L-Ala 1 end panel is from the 
2.5 Å dataset, others are from the 1.4 Å form. Residues from the symmetry-related SH3_5 domain 
are denoted by use of a prime (‘), and hydrogen bonds represented as a dashed line. 
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4.4 Discussion  
NMR and X-ray crystallography are two of the major techniques to analyse protein structure and 
function. The combined use of these methods allowed the identification of two distinct binding 
sites for S. aureus PG. The co-crystal structure determined in this study corroborated our NMR 
observations revealing an unexpectedly complex binding mechanism. The pentaglycine binding 
was found to rely on the very tight positioning of the glycine residues within a narrow cleft 
previously described (Lu JZ, 2006; Mitkowski, 2019), and at the opposite face, a more open site 
for the peptide stem binding. Previously the Lss-SH3_5 domain had been thought to confer the 
substrate specificity of the enzyme by its G5 recognition, but our NMR results showed that the 
SH3_5 domain adopted a dynamic binding mechanism by interacting with two distinct PG 
substrates.  
 
Individually, G5 and P4 display weak binding affinities with some large CSPs clearly defining the 
location of each site, whilst more complex ligands comprised of both G5 and P4 moieties 
displayed higher affinities but lower CSPs. Although the affinities to more complex ligands are 
approximately 10x higher, this suggests a cooperative but suboptimal binding due to the distance 
between both binding pockets preventing a simultaneous binding of both peptide moieties from 
the same molecule.  The CSPs from the increasingly complex ligands highlighted a dynamic 
binding mechanism rather than an overall weaker binding, as could be interpreted from the small 
CSPs observed.  
 
The analysis and interpretation of the CSPs, and of the affinities determined by fitting CSPs to a 
saturation curve exhibited the intricacy of individual molecules interacting together to form 
active complexes. NMR exploits the inherent property of some nuclei that exist in specific nuclear 
spin states when exposed to an external magnetic field. The electronic environment of each 
nucleus slightly modifies its exact resonance frequency through a process called chemical 
shielding. The local chemical environment surrounding a given nucleus determines the extent of 
shielding of that nucleus, causing different nuclei to resonate at slightly different frequencies. A 
perturbation of an 15N or 1H nuclear shielding is typically caused by a change in the magnetic field 
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at the nucleus; for example, a change in hydrogen bonding or a change in the position of 
neighbouring functional groups. Since hydrogen bonds are highly directional, a dynamic 
interaction with increased mobility of complex ligands could result in smaller CSPs. As mentioned 
before, this does not necessarily imply weaker binding as observed in the P4-G5 and P5-G5-P4 
peptides, since the loss of enthalpy caused by spending less average-time hydrogen bonding can 
be compensated by the gain of entropy.  Furthermore, titrations with complex mixed PG 
fragments were in the slow exchange limits which implies tighter interactions along with loss of 
signal due to protein aggregation.  
 
SH3_5 domains are structurally related to the eukaryotic SH3 domains. SH3 domains are involved 
in a wide variety of biological processes such as increasing local concentration of proteins, 
altering their subcellular location, and mediating the assembly of large multiprotein complexes 
(Mayer, 2001). The solved crystal structure of the SH3_5 in complex with the P4-G5 peptide is 
consistent with the formation of large protein aggregates observed during titration with complex 
PG fragments. Recognition of PG peptide stems by independent SH3_5 domains leads to the 
formation of “clusters” that would effectively increase the enzyme concentration at the cell 
surface.  
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CHAPTER V 
Mutational analyses on the binding activity of lysostaphin SH3_5 domains 
 
Previous studies have proposed that the SH3_5 domain of Lss is responsible for the high 
specificity of the enzyme to staphylococcal PG by guiding it to pentaglycine interpeptide bridges, 
the target substrate of the catalytic domain. The NMR titrations and X-crystallography results 
described in Chapter IV led to the identification of two independent binding sites located on 
opposite sides of the SH3_5 domain. Moreover, the interpretations of the CSP perturbations of 
the most complex defined PG fragments exhibited a larger number of residues interacting with 
the P4 ligand compared to the G5 peptide.  
 
5.1 Aims and objectives 
 
Site-directed mutagenesis was used to explore the individual contribution of SH3_5 residues to 
the binding activity of the Lss-SH3_5 domain. The specific objectives were: 
• To confirm the role of chosen SH3_5 residues to the recognition of pentaglycine and stem 
peptides using NMR titrations.  
 
• To study the contribution of several residues to the binding of SH3_5-mNeonGreen fusions 
to PG sacculi. 
 
• To investigate the impact of SH3_5 mutations on the activity of the full-length mature Lss 
enzyme. 
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5.2 Results 
 
 5.2.1 Expression and purification of SH3_5 and full-length Lss mutants 
 
5.2.1.1 Singly labelled His-SH3_5 derivatives   
 
The contributions of six residues identified by NMR and X-ray crystallography to the binding of 
G5 and P4 peptides were analysed by 15N HSQC titrations. The pET15b-His-SH3_5 vector, used to 
produce the singly labelled WT SH3_5 domain, was mutagenized to generate three recombinant 
proteins harbouring single-site substitutions in residues associated with the G5 peptide (N405A, 
M453A, and Y472S), and three SH3_5 mutants harbouring substitutions in residues interacting 
with P4 peptide (I425A, R427M, and W489L) (Figure 5.1).  
The aromatic ring current effects, observed in amino acids with aromatic side chains, can 
considerably influence chemical shifts in molecules. Ring current effects are largely dominant and 
most of the direct effects on protein chemical shifts from ligand titrations are due to either ring 
current effects or, for those amino acids without an aromatic ring, from hydrogen bonding to 
amide protons. The largest HN shifts generally arise from hydrogen bonding interactions. In fact, 
chemical shift effects arising from hydrogen through-space interactions are just as important as 
through-bond interactions. Thus, the reasoning behind the selected amino acid substitutions for 
all the amino acid residues investigated in this research, was to disrupt distances to alter ring 
current effects and hydrogen-bonding, through non-conservative amino acid substitutions of the 
side chains  with different physicochemical properties.  
The six  His-SH3_5 constructs were expressed as singly 15N-labelled His-SH3_5 mutant domains. 
The 11.7 kDa proteins were purified by affinity and gel filtration chromatography. A typical 
purification corresponding to the mutant R427M is shown as an example in Figure 5.2 A. The 
purity of the produced proteins was greater than 90% (SDS-PAGE) (Fig. 5.2 B). The obtained yield 
of the 15N His-SH3_5 proteins was ~10mg/L. 
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Figure 5.1. Description of six SH3_5 single-site substitution mutant domains analysed by NMR. 
(A) Schematic representation of the domain organization and amino acid sequence of the 
recombinant His-SH3_5 protein encoded by the pET15b-His-SH3_5 vector used for site-directed 
mutagenesis. Amino acids corresponding to the N-terminal 6x His-tag are coloured in pink; Lss-
SH3_5 domain in grey; mutagenized amino acids interacting with the G5 ligand are underlined 
and coloured in red, those interacting with the P4 peptide are coloured in green. The residues 
that were introduced by site-directed mutagenesis in constructing the SH3_5 derivatives are 
shown below the WT SH3_5 sequence (B) Region of the bound ligands from the Lss SH3_5 co-
crystal structure displaying the six residues selected for mutation in stick form and coloured 
according to their G5 (red) or P4 (green) peptide recognition. The G5 and P4 ligand mesh surfaces 
are coloured by atom type.  
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Figure 5.2. SDS-PAGE analysis of singly labelled SH3_5 derivatives used for NMR studies. (A)  
SDS-PAGE analysis of the purification steps to obtain the 11.7 kDa singly labelled R427M His-
SH3_5 mutant protein expressed in E. coli Lemo21 (DE3) cells. Lane 1 (MWM), molecular weight 
makers; lane 2,  pellet ; lane 3 (CE), crude extract;  lane 4 (SN), soluble fraction; lane 5 (FT), flow 
through; lane 6 (W), wash; lane 7 (IMAC), elution pool; lane 8 (GF), pooled fractions resulting 
from the gel filtration step. (B) SDS-PAGE of the six 11.7 kDa singly labelled His-SH3_5 derivative 
proteins expressed in E. coli Lemo21 (DE3) cells. Lane 1 (MWM), molecular weight makers; lane 
2-7, pooled fractions resulting from the gel filtration step to obtain the I425A, R427M, M453A, 
Y472S, W489L, and N405A His-SH3_5 mutant proteins. 
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5.2.1.2 SH3_5-mNeonGreen fusion proteins 
 
5.2.1.2.1 Construction of pET2818-SH3_5-NG expressing a SH3_5-mNeonGreen fusion 
 
A quantitative in vitro binding assay was designed to investigate the impact of SH3_5 mutations 
on binding to PG sacculi, which represents the natural substrate of the Lss enzyme. The SH3_5 
domain was fused to the fluorescent protein mNeonGreen. The mNeonGreen fluorescent 
protein, described by (Shaner, 2013), is a monomeric protein brighter than any other monomeric 
fluorescent protein (green and yellow). It has become a better alternative to GFP and eGFP by 
being systematically brighter by 5 to 3 times, respectively. This has also been shown when tested 
for in vivo imaging in C. elegans tissues (Hostettler, 2017). 
The plasmid encoding the WT SH3_5-mNeonGreen fusion was constructed by Gibson assembly 
using a 784 bp DNA synthetic fragment flanked with  BamHI and XhoI sites (Fig. 5.3 A) . It encoded 
the last C-terminal residues of the SH3_5 domain, a 14-residue linker, followed by the 
mNeonGreen fluorescent protein and a C-terminal  6x-His tag. The synthetic DNA fragment was 
digested with BamHI and XhoI and cloned into a similarly digested pET2818-SH3_5-GFP (pET-SG). 
The pET-SG plasmid was constructed during my first year of PhD using a similar strategy. 
Recombinant plasmids were screened by PCR and putative positive clones were sequenced. The 
final 6.7 kb pET-SH3_5-mNG plasmid containing the 784 bp insert was digested with BamHI and 
XhoI and the expected 771 bp mNeonGreen fragment was obtained (Fig. 5.3 B). Since the 
previous pET-SH3_5-GFP plasmid had a similar digestion pattern, a second plasmid restriction 
analysis with KpnI and BspHI  was also performed to confirm the replacement of the desired 
fragment (Fig. 5.3 C). 
The 39.1 kDa WT SH3_5-mNeonGreen fusion was produced and purified by affinity 
chromatography followed by gel filtration (Fig. 5.4). The purity of the protein estimated on SDS-
PAGE  was >90%, with a yield of 12mg/mL. 
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Figure 5.3. Construction of pET-SH3_5-mNG fusion. (A) Schematic representation of the cloning 
strategy. A 784 bp DNA synthetic fragment encoding the last C-terminal 10 bp of the SH3_5 
domain, a 36 bp linker, and the 708 bp of the mNeonGreen fluorescent protein, flanked with  
BamHI and XhoI sites, was cloned by Gibson assembly into the similarly digested 6.7 kb pET-SG 
plasmid. (B) Comparison of the restriction profile from pET-SG and pET-SH3_5-mNG after 
digestion with BamHI and XhoI. (MW), molecular weight marker; lane 2 (pET-SG), doubly digested 
plasmid with BamHI/XhoI, showing the 777 bp liberated fragment encoding the GFP-linker-SH3_5 
fusion and the 5948 bp plasmid; lane 3 (pET-SH3_5m-NEG), doubly digested plasmid with 
BamHI/XhoI, showing the 771 bp liberated fragment encoding the mNeonGreen-linker-SH3_5 
fusion and the 5948 bp plasmid. C) Restriction profile confirmation of the mNeonGreen 
replacement. (MW), molecular weight marker; lane 2 (pET-SG), doubly digested plasmid with 
KpnI/BspHI, showing the expected DNA bands sizes of 3926 bp, 1686 bp, and  1008 bp; lane 3 
(pET-SH3_5-mNG), doubly digested plasmid with KpnI/BspHI, showing the predicted excised DNA 
bands of 3926 bp, 1082 bp, 1008 bp, and 598 bp. The expected sizes of the liberated DNA 
fragments  are indicated with blue arrows on the right hand of the gel.  
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Figure 5.4. Production and purification of the SH3_5mNeonGreen fusion. (A) Domain 
organization and amino acid sequence of the recombinant SH3_5-mNeonGreen fusion protein 
encoded by the pET-SH3_5-mNG. Numbering corresponds to the amino acid positions. Amino 
acids corresponding to the Lss-SH3_5 domain are coloured in blue (94aa); linker in orange (14 
aa); mNeonGreen protein in green (236aa); C-terminal 6x His-tag in pink. (B)  SDS-PAGE analysis 
of the purification steps to obtain the 39.1 kDa SH3_5-mNeonGreen fusion expressed in E. coli 
Lemo21 (DE3) cells. Lane 1 (MWM), molecular weight makers; lane 2,  pellet ; lane 3 (CE), crude 
extract;  lane 4 (SN), soluble fraction; lane 5 (FT), flow through; lane 6 (W), wash; lane 7 (IMAC), 
elution pool; lane 8 (GF), pooled fractions resulting from the gel filtration step. 
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5.2.1.2.2 Construction of pET2818-mNG expressing the mNeonGreen protein  
 
To produce the mNeonGreen control, the pET2818-mNG plasmid was constructed by Gibson 
assembly (Fig. 5.5). A 774 bp DNA fragment encoding the mNeonGreen protein was PCR amplified 
from the pET2818-SH3_5-NG plasmid using the oligonucleotides mNG-FWD and mNG-RVS, 
introducing NcoI and BamHI flanking restriction sites and a sequence encoding 6 histidine 
residues (material and methods). The PCR product was cloned into a similarly digested pET2818. 
The 6.4 kb pET2818-mNG plasmid containing the mNeonGreen insert was digested with BamHI 
and NcoI and the expected 710 bp mNeonGreen fragment was obtained. The final pET2818-mNG 
plasmid was also sent for sequencing to verify the absence of mutations in the insert. 
The 27.6 kDa mNeonGreen protein was produced and purified by affinity chromatography 
followed by gel filtration (Fig. 5.6). The purity of the protein estimated on SDS-PAGE  was >90%, 
with a yield of 20mg/mL. 
5.2.1.2.3 Single-site mutagenesis of sixteen SH3_5-NG fusion proteins 
The pET2818-SH3_5-NG vector was mutagenized  to produced 16 SH3_5-mNeongreen fusions 
harbouring single-site substitutions in residues identified to interact with pentaglycine 
crossbridges and the peptide stems. Figure 5.7 shows a representation of two SH3_5 domains 
displaying the location of the mutagenized residues interacting with G5 peptide (N405A, T409V, 
Y411S, T429V, D450N, E451M, V452A, M453A, and Y472S), and the P4 peptide (F418V, N421L, 
I425A, R427M, V461A, L473A, and W489L). The oligonucleotides used to introduce the single-site 
substitutions are described in the Materials and Methods section (Table 2.4). Two putative clones 
per mutant were sent for sequencing to verify for the presence of the single-site substitution.  
The sixteen 39.1 kDa SH3_5-mNeongreen fusions were produced and purified by affinity and gel 
filtration chromatography. Figure 5.8 shows the final purification step of the 18 fusion proteins 
produced for the quantitative binding analyses (mNG, WT and 16 mutants). Despite the addition 
of protease inhibitors during the purification process, monomeric mNG protein was detected in 
all fusion protein purifications, indicating a cleavage of the full-length protein. The amount of  
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Figure 5.5. Construction of pET-2818-mNG. (A) Schematic representation of the cloning strategy. 
A 774 bp DNA  fragment encoding the mNeonGreen fluorescent protein, flanked with  BamHI and 
NcoI sites was PCR amplified from the pET2818-SH3_5-mNG plasmid. The amplified fragment 
was  cloned by Gibson assembly into the 5.7 kb pET-2818 plasmid which was similarly digested. 
(B) PCR amplified  mNeonGreen fragment. (MW), molecular weight marker; lane 2, 774 bp 
mNeonGreen DNA sequence. (C) Restriction digestion of pET2818 with BamHI and NcoI. (MW), 
molecular weight marker; line 2 (Nat), undigested 5710 bp pET2818 plasmid; lane 3 (BamHI) 5710 
bp singly digested pET-2818 plasmid with BamHII restriction enzyme; lane 4 (NcoI), 5710 bp singly 
digested pET-2818 plasmid with NcoI restriction enzyme; lane 5 (BamHI/NcoI), doubly digested 
plasmid with BamHI/NcoI restriction enzymes.  (D) Restriction profile confirmation of pET2818-
mNG. (MW), molecular weight marker; lane 2 (pET-2818-mNG), doubly digested plasmid with 
BamHI/NcoI, showing the expected excised DNA bands of 5699 bp plasmid and 710 bp 
mNeonGreen fragment.  
 
  
181 
 
 
Figure 5.6. Production and purification of mNeonGreen fluorescent protein. (A) Domain 
organization and amino acid sequence of the recombinant mNeonGreen protein encoded by the 
pET2818-mNG. Numbering corresponds to the transition between domains. Amino acids 
corresponding to the mNeonGreen protein are coloured in green (236aa); N-terminal 6x His-tag 
in pink. (B)  SDS-PAGE analysis of the purification steps to purify the 27.6 kDa mNeonGreen 
protein expressed in E. coli Lemo21 (DE3) cells. Lane 1 (MWM), molecular weight makers; lane 2,  
pellet ; lane 3 (CE), crude extract;  lane 4 (SN), soluble fraction; lane 5 (FT), flow through; lane 6 
(W), wash; lane 7 (IMAC), elution pool; lane 8 (GF), pooled fractions resulting from the gel 
filtration step. 
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Figure 5.7. Location of  the sixteen mutagenized residues at the SH3_5:P4-G5 interaction 
interface. (A) Domain organization and amino acid sequence of the recombinant SH3_5-
mNeonGreen fusion protein encoded by the pET-SH3_5-mNG used for site-directed mutagenesis. 
Numbering corresponds to the amino acid positions. Amino acids corresponding to the Lss-SH3_5 
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domain are coloured in blue (94aa); linker in orange (14 aa); mNeonGreen protein in green 
(236aa); C-terminal 6x His-tag in pink. SH3_5 mutagenized amino acids are underlined; the 
residues that were introduced by site-directed mutagenesis in constructing the SH3_5-mNG 
derivatives are shown below the WT SH3_5 sequence. (B) Two symmetry-related SH3_5 domains 
coloured in blue and white with the P4-G5 ligand bound cooperatively. The P4-G5 ligand is 
coloured by atom type, with the P4 C atoms in green and G5 C atoms in in pink.  For clarity, all 
mutated residues are shown in stick form and displayed only once on the SH3_5 domain that 
places them closest to the ligand. 
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Figure 5.8. SDS-PAGE analysis of the SH3_5-mNG derivative fusion proteins used for in vitro 
biding assays. (A) Pooled fractions resulting from the gel filtration step to obtain the 27.4 kDa 
mNeonGreen control and 39.1 kDa SH3_5-mNG proteins harbouring mutations in the residues 
involved in the interaction with G5 ligands. (B) Pooled fractions resulting from the gel filtration 
step to obtain the 39.1 kDa SH3_5-mNG mutants harbouring mutations in the residues involved 
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in the interaction with P4 ligands. The amount of protein per binding assay was adjusted using 
the fluorescent signal intensity of the full-length protein. 
protein per binding assay was adjusted using the fluorescent signal intensity of the full-length 
protein. 
5.2.1.3 Lss proteins containing point mutations in the SH3_5 domain 
 
To investigate the impact of SH3_5 mutations on the activity of the Lss enzyme, an expression 
vector available in the laboratory collection (pET21a-Lss; Fig. 5.9 A) was used to produce 13 Lss 
derivatives harbouring the previously described single-site substitutions in their C-terminal 
SH3_5 domains. The same pair of oligonucleotides used to introduce mutations in the SH3_5 
fusion domains were used for the full-length enzyme, except for N405A and W489L, which 
required a distinct pair of oligonucleotides to build the Lss derivatives (Materials and Methods, 
Table 2.4).  
Three Lss mutants were not analysed since they did not bind to the HiTrap IMAC column charged 
with Zn2+ ions (F418V, R427M, and M453A). The 28.1 kDa full-length Lss enzymes were produced 
and purified by affinity chromatography followed by gel filtration. Figure 5.9 B shows the 
purification steps for the WT-Lss protein.  The purity of the proteins estimated on SDS-PAGE  was 
>95%, with a yield of 8mg/mL (Fig. 5.9 C). 
 
5.2.2 Contribution of six identified SH3_5 residues to the recognition of  pentaglycine and the 
peptide stem. 
 
To confirm the contribution of SH3_5 residues to the recognition of G5 and P4 peptides identified 
by NMR and X-ray crystallography, 6 His-SH3_5 constructs described in Figures 5.1 and 5.2 were 
expressed as a singly 15N labelled recombinant proteins and analysed by NMR titrations. The 15N 
HSQC spectra of all mutant domains revealed that these were properly folded. 
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5.2.2.1 Binding of the N405A-SH3_5 mutant to the G5 peptide 
 
The interaction between the singly labelled N405A SH3_5 mutant and the synthetic G5 peptide 
was studied by 15N HSQC titrations. NMR spectra were recorded before and after the addition of 
the maximum concentration of ligand used for the previous WT SH3_5 analysis (30 equivalents 
of peptide, black to red on Fig. 5.10 A). The CSP of the N405A SH3_5-G5 interaction displayed a 
fast exchange rate with an evident reduction of the chemical shift changes on the residues 
interacting with G5 compared to the WT SH3_5-G5 titration. The largest effects were seen in 
residues G430, F432, M435, M453, D456, and Y472 (Fig. 5.10 B).  
To determine the reduction on the binding affinity, the percentage of residual binding was 
established as a measurement of the ratio of chemical shift changes of mutant to WT for every 
residue and then averaged over all amino acids. The N405A SH3_5 domain retained 16.1% of 
residual binding and had the most pronounced effect from the group of domains with mutations 
in residues involved in the interaction with the G5 peptide  
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Figure 5.9. Production and purification of full-length Lss proteins used to assess the impact of 
SH3_5 mutations on the enzyme activity. (A) Domain organization and amino acid sequence of 
the mature full-length Lss protein encoded by the pET-21a-Lss plasmid. Numbers correspond to 
amino acid positions . Amino acids corresponding to the N-terminal catalytic domain are coloured 
in red (136aa); linker in yellow (15 aa); SH3_5 protein in blue (92aa); C-terminal 6x His-tag in pink. 
SH3_5 mutagenized amino acids are underlined; the residues that were introduced by site-
directed mutagenesis in constructing the Lss derivatives are shown below the WT sequence. (B)  
SDS-PAGE analysis of the purification steps to obtain the 28.1 kDa WT Lss protein expressed in E. 
coli Lemo21 (DE3) cells. Lane 1 (MWM), molecular weight makers; lane 2 (CE), crude extract;  lane 
3 (SN), soluble fraction; lane 4 (FT), flow through; lane 5 (W), wash; lane 6 (IMAC), elution pool; 
lane 7 (GF), pooled fractions resulting from the gel filtration step. (C) SDS-PAGE of the thirteen 
28.1 kDa Lss derivative proteins expressed in E. coli Lemo21 (DE3) cells. Lane 1 (MWM), molecular 
weight makers; lane 2 (WT), pooled fractions resulting from the gel filtration step to obtain the 
full-length WT Lss protein; lane 3-15, pooled fractions resulting from the gel filtration step to 
obtain the thirteen Lss derivatives with mutagenized residues involved in the interaction with the 
G5 and P4 peptide.  
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Figure 5.10. Residual binding of the N405A mutant to the G5 peptide. (A) Overlaid 1H15N HSQC 
spectra of the N405A SH3_5-G5 titration acquired in the absence (black) and presence (red) of 
the maximum concentration of G5 ligand used in the WT SH3_5 analysis (30 equivalents of 
peptide). The distribution of the peaks revealed a similar spectrum to that of the WT. Peaks from 
the backbone NH assignment are labelled in black and side chains in purple. The enlarged view 
illustrates a region of the spectra with peaks that interacted with the G5 peptide in fast exchange 
in the WT protein (labelled in red). Dotted circle indicates the original location of the mutagenized 
residue. (B) Comparison of chemical shift perturbations (CSP) in WT and N405A SH3_5 mutant 
domains associated with the binding to G5 ligand. Histograms show individual CSP values from 
the 15N-HSQC titrations of N405A (in red) compared to the CSP values from the WT protein (in 
black) following addition of 30 equivalents of G5. The percentage of residual binding activity 
deduced from the average CSP values was 16.1% with the largest effects observed in residues 
G430, F432, M435, M453, D456, and Y472. 
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5.2.2.2 Binding of the M453A-SH3_5 mutant to the G5 peptide 
15N HSQC titrations of the M453A SH3_5-G5 interaction were recorded before and after the 
addition of 30 equivalents of peptide (black to red on Fig. 5.11 A). Like mutant N405A, the CSP of 
the M453A SH3_5-G5 binding displayed a fast exchange rate; however, the peaks that displayed 
the most pronounced chemical shift changes in the WT had a similar CSP rate in the M453A 
mutant domain. The main differences were seen in residues K403, N421, and M435. (Fig. 5.11 B). 
The M453A-SH3_5 mutant exhibited  the least effect from the group of domains with mutations 
in residues involved in the interaction with the G5 peptide with a 55.5% of residual binding. 
 
5.2.2.3 Binding of the Y472S-SH3_5 mutant to the G5 peptide 
15N HSQC spectra of the Y472S SH3_5 mutant revealed amide signals similarly positioned as those 
of the WT protein. Only a few residues were affected (R427-G430), suggesting that the protein 
was properly folded and did not have major conformational differences. The Y472S SH3_5-G5 
interaction was analysed as previously described by adding a single titration point with the 
maximum concentration of ligand used in the WT Lss-SH3_5 titration (black and red on Fig. 
5.12A). The Y472S mutant protein bound to the ligand in a fast exchange equilibrium with 
noticeable differences in the chemical shift changes of residues identified to interact with the 
ligand, the main differences compared to the WT were observed for residues K412, F432, D450, 
and M453. The Y472S mutant domain retained 24.6% of residual binding (Fig. 5.12 B).  
 
5.2.2.4 Binding of the I425A-SH3_5 mutant to the P4 peptide 
The interaction between the I425A SH3_5 derivative and the P4 peptide was analysed by NMR 
following the same strategy as the previous mutant domains. NMR spectra were recorded before 
and after the addition of the maximum concentration of P4 ligand used for the previous WT 
SH3_5 analysis (32 equivalents of peptide, black to green on Fig. 5.13 A). The same amount of 
ligand was used for all mutant domains harbouring mutations in residues interacting with the P4 
peptide. 
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Figure 5.11. Residual binding of the M453A mutant to the G5 peptide. (A) Overlaid 1H15N HSQC 
spectra of the M453A SH3_5 mutant titrated with the G5 peptide. Spectra were acquired in the 
absence (black) and presence (red) of the maximum concentration of G5 ligand used in the WT 
SH3_5 analysis (30 equivalents of peptide). The distribution of the peaks revealed that the protein 
was properly folded. Peaks from the backbone NH assignment are labelled in black and side 
chains in purple. The enlarged view illustrates a region of the spectra with peaks that interacted 
with the G5 peptide in fast exchange in the WT protein (in red). Dotted circle indicates the original 
location of the mutagenized residue. (B) Comparison of chemical shift perturbations (CSP) in WT 
and M453A SH3_5 mutant domain associated with the binding to G5 ligand. Histogram shows 
individual CSP values from the 15N-HSQC titrations of M453A in red compared to the CSP values 
from the WT protein (in black) following addition of 30 equivalents of G5. The percentage of 
residual binding activity deduced from the average CSP values was 55.5% with the largest effects 
observed in residues K403, N421, and M435. 
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Figure 5.12. Residual binding of the Y472S mutant to the G5 peptide. (A) Overlaid 1H15N HSQC 
spectra of the Y472S SH3_5 -G5 titration acquired in the absence  (black) and presence (red) of 
the maximum concentration of G5 ligand used in the WT SH3_5 analysis (30 equivalents of 
peptide). The distribution of the peaks revealed that peaks were similarly distributed as those of 
WT indicating that the protein was properly folded. Peaks from the backbone NH assignment are 
labelled in black and side chains in purple. Dotted circle indicates the original location of the 
mutagenized residue. The enlarged view illustrates a region of the spectra with peaks that 
interacted with the G5 peptide in fast exchange in the WT protein (labelled in red). Residues 
highlighted in grey were not assigned to the Y472S mutant spectrum since they did not resonate 
at the expected position (ppm) as compared to the WT protein. (B) Comparison of chemical shift 
perturbations (CSP) in WT and Y472S SH3_5 mutant domain associated with the binding to G5 
ligand. Histograms show individual CSP values from the 15N-HSQC titrations of Y472S in red 
compared to the CSP values from the WT protein (in black) following addition of 30 equivalents 
of G5. The percentage of residual binding activity deduced from the average CSP values was 
24.6% with the largest effects observed in residues K412, F432, D450, and M453. 
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The I425A SH3_5 mutant bound to the P4 ligand in a fast exchange equilibrium. During the CSP 
analysis, a reduction of the chemical shift changes in residues previously identified to interact 
with the P4 ligand was determined,  particularly for residues R470 and L473. However, the I425A 
SH3_5 mutant displayed the least effect on binding to the P4 ligand, with 29.4% of residual 
binding (Fig. 5.13 B).  
 
 5.2.2.5 Binding of the R427M-SH3_5 mutant to the P4 peptide 
15N HSQC titrations were recorded before and after the addition of 32 equivalents of peptide. A 
marked impact on binding to the P4 peptide was observed during the spectra acquisition. All 
peaks maintained the same shape throughout the titration and no apparent chemical shift 
changes were observed after the addition of the maximum concentration of ligand, as seen in 
the almost complete superposition of the bound spectrum (SH3_5+ligand) over the blank 
spectrum (protein with no ligand) (Fig. 5.14 A). 
As expected from the co-crystal structure, the CSP analysis of the R427M SH3_5 mutant revealed 
the largest impact in binding to the P4 peptide with 1.6% residual binding compared to the WT 
protein (Fig. 5.14 B).   
 
5.2.2.6 Binding of the W489L-SH3_5 mutant to the P4 peptide 
The  last NMR titration was performed assessing the W489L SH3_5 mutant. After the addition of 
32 equivalents of P4 peptide, the CSP of the W489L SH3_5-P4 interaction displayed a fast 
exchange rate with a noticeable decrease in the chemical shift changes from residues identified 
to interact with the P4 peptide. As observed for all previous titrations, all peaks maintained the 
same shape after the addition of the maximum ligand concentration (Fig. 5.15 A). Like the R427M 
mutant domain, the W489L mutation had a major impact on binding to the P4 ligand, and the 
mutant protein only retained 6.6% residual binding compared to the WT protein (Fig. 5.15 B).  
Collectively, the NMR titration experiments confirmed the contribution of 6 SH3_5 residues 
identified by NMR and X-ray crystallography to the recognition of the S. aureus PG peptide  
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Figure 5.13. Residual binding of the I425A mutant to the P4 peptide. (A) Overlaid 1H15N HSQC 
spectra of the I425A SH3_5 -P4 titration acquired in the absence (black) and presence (green) of 
the maximum concentration of P4 ligand used in the WT SH3_5 analysis (32 equivalents of 
peptide). The distribution of the peaks revealed that the protein was properly folded. Peaks from 
the backbone NH assignment are labelled in black and side chains in purple. The dotted circle 
indicates the original location of the mutagenized residue. The enlarged view illustrates a region 
of the spectra with peaks that interacted with the P4 peptide in fast exchange in the WT protein 
(labelled in green). (B) Comparison of chemical shift perturbations (CSP) in WT and I425A SH3_5 
mutant domain associated with the binding to P4 ligand. Histograms show individual CSP values 
from the 15N-HSQC titrations of I425A (in green) compared to the CSP values from the WT protein 
(in black) following addition of 32 equivalents of P4. The percentage of residual binding activity 
deduced from the average CSP values was 29.4% with the largest effects observed in residues 
R470 and L473. 
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Figure 5.14. Residual binding of the R427M mutant to the P4 peptide. (A) Overlaid 1H15N HSQC 
spectra of the R427M SH3_5 mutant titrated with the P4 peptide. Spectra were acquired in the 
absence (black)  and presence (green) of the maximum concentration of P4 ligand used in the WT 
SH3_5 analysis (32 equivalents of peptide). The distribution of the peaks revealed a similar 
spectrum distribution to that of the WT. Peaks from the backbone NH assignment are labelled in 
black and side chains in purple. Dotted circle indicates the original location of the mutagenized 
residue. The enlarged view illustrates a region of the spectra with peaks that interacted with the 
P4 peptide in fast exchange in the WT protein (labelled in green). (B) Comparison of chemical 
shift perturbations (CSP) in WT and R427M SH3_5 mutant domain associated with the binding to 
P4 ligand. Histograms show individual CSP values from the 15N-HSQC titrations of R427M (in 
green) compared to the CSP values from the WT protein (in black) following addition of 32 
equivalents of P4. From all the SH3_5 mutants analysed by NMR, R427M exhibited the largest 
effect in binding with an average residual binding of 1.6% compared to the WT SH3_5 protein.   
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Figure 5.15. Residual binding of the W489L mutant to the P4 peptide. (A) Overlaid 1H15N HSQC 
spectra of the W489L SH3_5 -P4 titration acquired in the absence (black)  and presence (green) 
of the maximum concentration of P4 ligand used in the WT SH3_5 analysis (32 equivalents of 
peptide). The distribution of the peaks revealed that the protein was properly folded. Peaks from 
the backbone NH assignment are labelled in black and side chains in purple. Dotted circle 
indicates the original location of the mutagenized residue. The enlarged view illustrates a region 
of the spectra with peaks that interacted with the P4 peptide in fast exchange in the WT protein 
(labelled in green). (B) Comparison of chemical shift perturbations (CSP) in WT and W489L SH3_5 
mutant domain associated with the binding to P4 ligand. Histograms show individual CSP values 
from the 15N-HSQC titrations of W489L in green compared to the CSP values from the WT protein 
(in black) following addition of 32 equivalents of P4. The percentage of residual binding activity 
deduced from the average CSP values was 6.6%, the second lowest activity after the R427M 
mutant. 
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moieties. All mutant domains exhibited a decrease in binding activity to the peptide ligands 
tested. Domains harbouring mutations with residues identified to interact with the G5 peptide 
maintained a relatively high residual binding. The N405A derivative displayed the largest impact 
on binding (16.1% residual binding), whilst the M453A mutant retained 55.5% of binding to G5 
compared to the WT. Mutations in residues associated with the P4 peptide displayed major 
effects in binding. The I425A had the least impact maintaining 29.4% of residual binding, whereas 
R427M and W489L substitutions caused a major impact in the recognition of the P4 peptide (1.6 
and 6.6% residual binding, respectively).  
Since the affinity reduction was not associated with any major structural rearrangements, the 
limited impact in binding for most of the mutations is in agreement with the X-ray crystal 
structure and the WT NMR analyses, in which it is shown that the recognition of both peptide 
moieties relies on a complex network of interactions, particularly for the mutations in residues 
involved  in interactions with G5, where specific interaction with the pentaglycine stem seems to 
be reliant on the very tight positioning of the glycine residues within the narrow binding cleft. 
 
5.2.3 Binding of SH3_5 derivatives to purified PG sacculi 
A quantitative in vitro binding assay using S. aureus PG sacculi was designed to further investigate 
the contribution of residues involved in the recognition of both PG peptide moieties. The binding 
of the WT SH3_5-mNG fusion was first assessed by incubating the protein with three distinct PG 
sacculi, the WT S. aureus SH1000 (Horsburgh, 2002), femB and femAB mutants (containing five, 
three and one glycine residue in their crossbridges, respectively). Binding was followed in the 
presence of increasing amounts of PG using in-gel fluorescence. Protein amounts equivalent to 3 
µg of the WT SH3_5-mNG fusion were adjusted based on the fluorescence intensity of the bands 
corresponding to the full-length protein (Fig. 5.16 A). Binding curves were used to determine the 
amount of PG required for 50% binding (PG50; Fig. 5.16 B). This value was used as a proxy to 
compare binding affinities to various PGs and to compare the relative binding activities of 
mutants (Fig. 5.17).  
  
204 
 
 
Figure 5.16. Binding activity of the SH3_5-mNeonGreen fusion protein to WT S. aureus PG and 
fem mutants. (A) Analysis of the PG-binding activity of the WT SH3_5-mNeonGreen fusions 
(SH3_5-mNG) to three distinct PG sacculi, the WT S. aureus SH1000 and two mutants with altered 
PG crossbridges, femB mutant (GGG) and femAB (G), respectively. Binding was followed in the 
presence of increasing amounts of PG (0-400 µg). Protein amounts equivalent to 3 µg of the WT 
SH3_5-mNG fusion were adjusted based on the fluorescence intensity of the bands 
corresponding to the full-length protein. Fluorescence of the supernatant was measured using 
in-gel fluorescence. The graph shows dose binding responses of the SH3_5-mNG fusions to all 
purified PG. As a positive control, no binding activity of the mNeonGreen (mNG) protein alone 
was determined in the presence of (0-400 µg PG); as a negative control, the maximum amount 
of PG sacculi (400 µg) was incubated without the presence of protein to verify for 
autofluorescence, and finally the SH3_5-mNG fusion was also incubated without the presence of 
PG (B) The amount of PG required for 50% binding (PG50) was determined from the dose-
response binding curves shown in (A) and the corresponding fold change as compared to the 
amount of PG required for 50% binding of the SH3_5-mNG to the WT PG.  
205 
 
As expected, the WT SH3_5-mNG fusion bound in a dose-response manner to the S. aureus PG 
sacculi (GGGGG) (Fig. 5.16 A). The SH3_5-mNG protein also bound to the femB mutant (GGG) in 
a dose-response manner but its binding was reduced by a 1.71-fold change. A larger impact was 
observed for the femAB mutant with a binding reduction of 2.20-fold binding reduction. The 
mNeonGreen protein alone did not bind to any of the purified PG sacculi. The residual binding 
observed in both fem mutant PGs supports the existence of a second binding recognition site for 
the peptide stem. This observation was also described by (Lu JZ, 2006), where they determined 
that the SH3_5 domain from Ale 1, a close homologue of Lss, exhibited residual binding to both 
femB and femAB mutants. 
 
Sixteen SH3_5-mNeonGreen fusions with mutations in residues previously identified were 
purified (Fig. 5.8), and their binding to WT S. aureus S1000 PG  sacculi was measured (Fig. 5.17). 
Two independent series of protein purifications were carried out, the first included the group of 
SH3_5 derivatives harbouring residues identified to interact with the G5 peptide,  and the second 
set was comprised of mutant domains associated with the P4 peptide. Each purification batch 
included a WT SH3n-mNG fusion. The binding activity was assessed using the same strategy as 
the previously described WT SH3_5-NG fusion.  All proteins were adjusted on the basis of 
fluorescence intensity of the bands corresponding to the full-length proteins.  
Most of the mutants displayed reduction in binding to PG, and the amount of PG required for 
50% binding was similar to that of the WT protein to the femB PG. Like the SH3_5 derivatives 
studied by NMR, the major impact in binding was observed with the R427M and W489L mutants 
exhibiting a 2.47 and 2.18-fold reduction, respectively. In the set of proteins harbouring 
substitutions in residues interacting with the G5 peptide, the Y411S SH3_5-mNG fusion displayed 
the largest effect with a reduction of 1.83-fold-change.  
No single substitution abolished binding to the PG sacculi confirming the involvement of multiple 
amino acid residues in the recognition of both peptide moieties as determined by NMR and X-
ray crystallography. To further corroborate the dual recognition by the Lss-SH3_5 domain, the 
binding of the R427M SH3_5-mNG mutant to the fem AB PG was assessed (Fig. 5.17 C). 
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Figure 5.17. Binding activity of the SH3_5-mNeonGreen derivative proteins to purified S. aureus 
PG. Analysis of the PG-binding activity of sixteen SH3_5-mNeonGreen derivatives (SH3_5-mNG) 
to S. aureus WT (SH1000) PG. For each SH3_5-mNG fusion, protein amounts equivalent to 3 µg 
were adjusted based on the fluorescence intensity of the bands corresponding to the full-length 
protein. Binding was followed in the presence of increasing amounts of S. aureus PG (0-400µg). 
Fluorescence of the supernatant was measured using in-gel fluorescence. (A) PG-binding 
activities of WT SH3_5–mNG and derivatives with substitution of residues involved in the 
interaction with the G5 ligand. (B) PG-binding activities of WT SH3_5–mNeonGreen and 
derivatives with substitution of residues involved in the interaction with the P4 ligand. The graphs 
show dose binding responses of all SH3_5-mNG fusions to S. aureus PG. No binding activity to PG 
was determined for the mNeonGreen (mNG) protein control. The table next to each graph 
indicates the amount of PG required for 50% binding (PG50) and the corresponding fold change 
as compared to the amount of PG required for 50% binding of the WT protein as a reference. (C)  
Comparison of the binding activity of R427M SH3_5-mNeonGreen fusion to purified WT S. aureus 
PG and femAB mutant. PG-binding activity of WT SH3_5-mNG and the R427M SH3_5-mNG 
derivative to the femAB mutant in comparison with their binding to WT S. aureus SH1000 PG. The 
graph shows dose binding responses of the WT SH3_5-mNG fusion to both purified PG sacculi. 
The R427M SH3_5-mNG fusion displayed a similar binding dose response to WT S. aureus PG as 
the WT SH3_5-mNG protein to the femAB mutant. The major impact in binding was observed 
between the R427M SH3_5-mNG derivative and the femAB mutant. No binding activity was 
determined for the mNeonGreen (mNG) protein control to any of the PG sacculi. 
 
  
208 
 
As expected, binding was not completely abolished but a major impact was observed. As a 
reference, the binding curves of the (i) WT SH3_5-mNG to fem AB PG) and the (ii) R427M SH3_5-
mNG to WT S. aureus PG were also included. These results showed that, when only one 
recognition side was impaired either by the mutant SH3_5 protein or fem AB PG, comparable 
binding curves were observed with the previously described PG50 reduction of 2.20 and 2.47-fold, 
respectively.  
 
5.2.4 Impact of SH3_5 single-site mutations on Lss activity  
To study the impact of SH3_5 mutations on the activity of the full-length Lss enzyme, 13 Lss 
derivatives were produced (Fig. 5.9 C). Two-fold serial dilutions of each recombinant protein 
were spotted on LB agar plates containing  S. aureus autoclaved cells (Fig. 5.18). An arbitrary Lss 
activity unit was defined as the greatest dilution of each sample. The enzymatic activity was 
detected as clear lytic zones on the agar plate as a result of the solubilization of the cell walls. 
The lytic zones were compared by determining the lowest amount of enzyme with a detectable 
digestion of the substrate. Three independent series of protein purifications were carried out, 
each including a WT Lss protein. In all purifications the WT Lss proteins exhibited comparable 
activity.  
The spot assay results showed no major differences between the activity of the Lss derivatives 
compared to the WT proteins. Two Lss mutants showed the largest effect when compared to the 
WT: the Y472S and W489L mutants both exhibited a nine-fold decrease in activity. These 
observations are in line with the limited impact on binding to PG by the SH3_5-NG derivatives. 
Unfortunately, the R427M Lss mutant did not bind to the nickel column and had to be excluded 
from the study.  
The results from the mutational analyses described in this chapter showed that the recognition 
of the pentaglycine peptide and the peptide stem are equally important, it could even be 
suggested that recognition of the peptide stem is the most critical,  as will be discussed later.  
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Figure 5.18. Enzymatic activity of Lss recombinant proteins harbouring mutations in the SH3_5 
domain. Three independent series of purifications were carried out (left, middle and right 
panels), each including a WT Lss protein as a control. Five µL corresponding to two-serial dilutions 
of recombinant Lss proteins were spotted on agar plates containing autoclaved S. aureus cells 
(final OD600 of 1) as a substrate. Lytic activities were detected as clearing zones and compared by 
determining the lowest amount of enzyme giving a detectable digestion of the substrate.  
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5.3 Discussion  
NMR mutational analyses confirmed the role of six residues identified to interact with the G5 and 
P4 peptides by NMR and X-ray crystallography. Interestingly, substitutions in residues involved 
in the recognition of the peptide stems displayed the biggest effect in binding, especially R427M 
and W489L which almost prevented binding to the ligand in solution.  
However, when a larger set of SH3_5 derivatives were tested using S. aureus PG sacculi as a 
substrate, only a moderate impact in binding was determined. Nonetheless, the SH3-mNG 
derivatives R427M and W489L also exhibited the most pronounced effect. These residues have 
been identified in the homologous SH3_5 domain from the Ale-1 hydrolase produced by S. capitis 
EPK1. Mutagenized Ale-1 SH3_5 domain harbouring single-site substitutions in residues R296A 
and W358A, corresponding to R427 and W489 in the Lss SH3_5 protein, displayed 3 to 2-fold 
reduction in binding to S. aureus PG, respectively, as compared to the WT protein (Lu JZ, 2006).  
Sequence alignments between the Lss SH3_5 domain (SH3_5_5) and other proteins have shown 
that residues I425, R427 and W489 are also conserved amongst various cell wall binding domains, 
including phage endolysins targeting PG that differ in their interpeptide bridge composition 
(Benešík M., 2018). These results indicate that the P4 D-Ala–carboxylate pocket is likely a 
conserved feature of wider bacterial SH3 family members (Fig. 5.19), with relevance for the 
SH3_3 family. The SH3_3 domains of Clostridium phage lysin phiSM101 have a carboxylate ligand 
bound at this position, suggesting an important role for the residues equivalent to Lss R427 
(Tamai, 2014). 
The Lss-SH3_5 recognition of both peptide moieties appears to provide a biological advantage to 
the SH3_5 protein as determined for the moderate binding impact in the protein derivatives and 
PG mutants (fem mutants). Binding of the WT SH3_5-mNG fusion to the fem B (GGG) mutant had 
a similar effect to those observed for the SH3_5 mutations to WT S. aureus PG. The WT SH3_5-
mNG fusion exhibited limited binding to the fem AB mutant (G) with a 2.20-fold change compared 
to the WT PG. This limited binding has also been described by (Gargis S.R., 2010), and the result 
resembled the decrease in binding observed with the R427M SH3_5-mNG fusion to WT PG, 
implying that impaired binding to the pentaglycine or stem peptide moieties could be moderately 
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compensated by the recognition of the second site. Moreover, when the binding of the R427M 
SH3_5-mNG derivative to the fem AB mutant was tested, a major decrease in binding was 
determined (Fig. 5.17 C). These observations, along with the limited effect in the lytic activity of 
the full-length Lss derivatives, support the NMR results reported for the WT SH3_5 protein 
(Chapter IV) and the determined crystal structure of the SH3_5 domain in complex with the P4-
G5 peptide. It appears that the Lss-resistance to modified cross bridges in staphylococcal PG is 
likely to be associated with a deficient enzymatic activity  of the catalytic domain.  
Single-site substitutions in residues involved in the recognition of the peptide stem [P4] displayed 
a higher impact in binding. These observations are in agreement with the results obtained from 
the NMR titrations of the WT SH3_5 domain using complex PG fragments (more cell wall-like 
ligands), in which lesser CSP were determined for residues interacting with the G5 ligand 
compared to the P4 peptide. These results appeared to be a mechanism adopted by the Lss 
enzyme to favour binding of its SH3_5 domain to the peptide stems as long as some recognition 
of the pentaglycine remains. By not binding too tightly to either of its ligands, especially the 
pentaglycine cross bridges, it would allow access for the catalytic domain to cleave its substrate, 
whilst always keeping at least one site bound to avoid being detached from the PG surface so the 
SH3_5 domain could continue binding to more non-contiguous PG peptide moieties.  
Therefore, the recognition of non-contiguous PG fragments determined in this study reveals the 
mechanisms adopted by the cell targeting domain to effectively bind the PG lattice and thus 
enhance the activity of the catalytic domain.  
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Figure 5.19. Comparison of ligand-binding pocket to other SH3_5 structures and SH3 
superfamily members. (A) Lss SH3_5 domain in complex with the P4-G5 ligand. (B) 
Superimposition of the structure shown in A onto the ALE-1 structure (PDB 1R77, two symmetry-
related monomers orange and yellow). The P4-G5 ligand occupies the same space as an affinity 
purification tag (helical turn, N-terminus labelled). (C) Superimposition of the structure shown in 
A onto the phi7917 structure (PDB 5D76, tan). Ligand P3(K)-P4(A) are sterically equivalent to tag 
residues K269 and V268, respectively. The phi7917 ligand (L-Ala-D-Gln) is positioned with its 
peptide bond over the P3-P4 peptide. (D) Sequence alignment of Lss SH3_5 (SH3_5 subfamily) 
with ALE-1 (SH3_5) and the two tandem domains of Clostridium phage phiSM101 (PDB 4krt, 
SH3_3 subfamily), G5 and P4-ligating residues annotated with magenta and green block below 
text, respectively. (E) Weblogo (Crooks et al., 2004) plot of sequence consensus of SH3_4 
subfamily, identifying features with likely equivalence to SH3_3 and SH3_5 alignment: NxR 
(position 6-8, match Lss I425-R427), W (36, match to W460), GxxGW (43-47, match to G468-Y472) 
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and LWG (53-55, match to L488-G490). No structures are currently available for SH3_4 proteins, 
but structural comparison between Lss/ALE-1 and 4krt confirms conservation of the P-stem D-
Ala(4)-carboxylate pocket. 
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CHAPTER VI 
Production of E. faecalis SH3_5 proteins to explore  PG binding mechanisms  
across species 
 
Our work on lysostaphin has shed light on a very unusual PG recognition mechanism and several 
questions remain to be answered: is the dual recognition of the peptide stem and the crossbridge 
shared across bacteria? Do multimodular SH3_5 domains recognise PG independently or do they 
form quaternary structures? In this chapter, we tried to address these two questions using two 
proteins produced by E. faecalis. One of these proteins is a PG hydrolase with a single SH3_5 
repeat (EF1293) and the other protein is a bacteriocin that contains an SH3_5 domain made of 
three repeats.  
 
E. faecalis is a Gram-positive commensal bacterium present in the gastro-intestinal tract of 
humans. This opportunistic pathogen can cause life-threatening nosocomial infections associated 
with antimicrobial resistance, such as the vancomycin-resistant enterococci (VRE) strains 
(Gilmore, 2013; Paulsen, 2003; Polidori, 2011; Wisplinghoff, 2004).   
 
Plasmid-encoded bacteriocins are often present in infection-derived E. faecalis strains (del 
Campo, 2001; Jack, 1995; Ness, 2014).  These antimicrobial proteins are thought to provide a 
competitive advantage to the producer bacteria in an ecological niche where a wide variety of 
species are present. Bacteriocin-producing bacteria also possess immunity factors to protect 
them from their lytic effect (Kurushima, 2013, 2015; Ness, 2014). A study based on 636 VRE 
isolates showed that 44% of them were bacteriocin-producing strains (Inoue, 2006).  One of these 
bacteriocins called “bacteriocin 41” or Bac41 is frequently found amongst clinical isolates (in up 
to 50% of the isolates analysed) (Ke, 2010)  
 
The bactericidal activity of Bac41 is conferred by two extracellular proteins BacL1 and BacA.  
Although both proteins are shown to be necessary for cell lysis, BacL1 possess the enzymatic 
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machinery to bind and hydrolyse E. faecalis PG, whilst  BacA has been proposed to act as an 
accessory factor. The BacL1 C-terminal region is made of three nearly identical SH3_5 repeats of 
approximately 90 amino acids. A previous study determined that fluorescent labelled BacL1 can 
be localized in species harbouring an L-Ala-L-Ala crosslinked structure, such as E. faecalis, S. 
pyogenes, and S. pneumoniae (Kurushima, 2015). Although BacL1 recognises these 3 different 
species, it can only lyse E. faecalis cells. The mechanism underpinning the specific lysis of E. 
faecalis by this bacteriocin is unknown. 
 
Almost a quarter of the genome of E. faecalis V583 clinical  isolates consists of mobile and/or 
exogenously acquired DNA, including integrated phage regions (Paulsen, 2003). The 
chromosome of V583 harbours seven prophage-like elements (pp1 to pp7), one of which (pp2) is 
found in all E. faecalis isolates and is part of the core genome (Matos, 2013; Paulsen, 2003; 
Solheim, 2011). Within this pp2 region, a well-conserved gene encoding for a putative PG 
hydrolase named EF1293 (accession number Q835S9) is present. The putative PG hydrolase is 
made of an N-terminal amidase domain and a single C-terminal SH3_5 repeat. Interestingly, this 
is the only amidase described in E. faecalis. To our knowledge no further studies have been 
performed to characterise  the binding of the EF1293 SH3_5 domain.  
 
6.1 Aims and objectives 
 
The aim of the work described in this chapter was to explore (i) the binding mechanism of the 
SH3_5 domain from the hydrolase EF1293, recognising a PG with a compositions distinct from S. 
aureus (E. faecalis PG contains 2 L-Ala-L-Ala residues instead of 5 glycine residues), and (ii) to 
investigate the binding mechanism of a multimodular domain containing three SH3_5   domain 
repeats (BacL1).  
 
The specific objectives were:  
• To produce E. faecalis  SH3_5 recombinant proteins with different domain architectures: 
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(i) Five variants of the three modular BacL1 SH3_5 repeats, i.e. SH31; SH32; SH33; SH31-2; 
SH31-3. 
(ii) The single C-terminal SH3_5 domain from the putative PG endolysin EF1293 protein. 
 
• To perform NMR structural and functional analyses using a set of ligands corresponding 
to E. faecalis  PG: the L-Ala-L-Ala, cross-links, the AQKAA, peptide stem and the AQK(L-
Ala-L-Ala)AA, peptide stem with lateral chain. 
 
6.2 Results  
 
6.2.1 Expression and purification of five unlabelled BacL1 SH3_5-His proteins 
 
Five variants of the BacL1  SH3_5 domain were constructed using the plasmid pET22-BacL-SH3 
previously described as a template (Kurushima, 2013) (Fig. 6.1 A). This plasmid encodes the BacL1 
SH3_5 domain made of three repeats connected by their linker regions. The region encoding the 
entire domain is flanked by NcoI and XhoI sites followed by a C-terminal histidine-tag (Fig. 6.1 A). 
An alignment of the three BacL1 SH3_5 repeats with their linker regions is shown in Figure 6.2.  
 
Five DNA fragments flanked with NcoI and XhoI sites were PCR amplified from the pET22-BacL-
SH3 plasmid (Fig. 6.1 B-C): 
(i) a 929 bp fragment encoding the complete BacL1 SH3_5 domain  (SH31-3);  
(ii) a 567 bp fragment encoding the first two SH3_5 repeats (SH31-2);  
(iii) a 380 bp fragment encoding the most distal SH3_5 repeat (SH33) 
(iv) a 292 bp fragment encoding the second SH3_5 repeat  (SH32) ; 
(v) a 288 bp fragment encoding the first SH3_5 repeat  (SH31) .  
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Figure 6.1. PCR amplification of E. faecalis BacL1 SH3 modules from pET22b-BacL1 SH3.  
(A) Schematic representation of the pET22b-BacL1  SH3 plasmid encoding the three E. faecalis 
BacL1  SH3_5 repeats (Kurushima, 2015) used as a PCR template. The SH31 (183 bp), SH32 (180bp) 
and SH33 (186bp) DNA fragments are coloured in red, blue and yellow, respectively; linkers in 
grey (from 3’ to 5’) are 30, 93, 102, and 57 bp, respectively. (B) SH3_5 fragments amplified for 
protein expression. All fragments were PCR amplified from pET22b-BacL1  SH3 and flanked with 
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NcoI and XhoI sites: From top to bottom: (i) a 929 bp fragment encoding the complete BacL1 
SH3_5 domain  (SH31-3), (ii) a 567 bp fragment encoding the first two SH3_5 repeats (SH31-2),  (iiI) 
a 380 bp fragment encoding the most distal SH3_5 repeat (SH33), (iv) a 292 bp fragment encoding 
the second SH3_5 repeat  (SH32) ; (v) a 288 bp fragment encoding the first SH3_5 repeat (SH31). 
(C) Agarose gel electrophoresis of SH3_5 PCR products encoding SH31-3 (lane 1),  SH31-2 (lane 2), 
SH33  (lane 3), SH32 (lane 4), SH31 (lane 5); lane 6, molecular weight marker (MWM).   
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Figure 6.2. Amino acid sequence alignment of the three BacL1 C-terminal SH3_5 repeats. The 
residues corresponding to the three SH3_5 proteins (SH31 to SH33) are boxed in red (60 residues); 
linker sequences flanking the N- and C-terminal regions of each protein repeat are indicated by 
purple brackets. Identical residues are highlighted in black and residues in light grey indicate 
conservative substitutions. 
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All PCR products were cloned into pET2818 using XhoI and NotI restriction sites to produce 
proteins with a C-terminal His-tag encoded by the plasmid. The cloning strategy for each 
construct is described in Figures 6.3 to 6.7. The final plasmids: pET2818-S1, pET2818-S2, pET2818-
S3, pET2818-S1S2, and pET2818-S1S3 were confirmed by colony PCR screens and sent to 
sequencing to check for the absence of mutations in the inserts.  
 
Small-scale expression trials were performed to determine the expression level and solubility of 
the five recombinant SH3 constructs (Fig. 6.8 A-C). Proteins were produced in E. coli Lemo21(DE3) 
cells and IPTG induced at 25°C for overnight. Cells and supernatant samples were harvested and 
analysed by SDS-PAGE. All recombinant SH3_5 proteins were highly expressed and soluble under 
standard expression conditions (Fig. 6.8 C). The expected molecular weights of the produced 
proteins are: SH31-3, 30.2 kDa;  SH31-2, 20.4 kDa; SH31, 10.7 kDa;  SH32, 10.7 kDa; SH33, 10.9 kDa 
(Fig 6.8 B-C).    
 
A subsequent large-scale expression (1L) was performed for each protein . Proteins were purified 
by affinity chromatography followed by gel filtration (Fig. 6.8 D). The overall purity was estimated 
on SDS-PAGE  (>90%) with a yield of 20mg/mL. 
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Figure 6.3. Construction of pET2818-S1. (A) Schematic representation of the cloning strategy. A 
288 bp PCR fragment encoding the first BacL1  SH3_5 repeat (SH31) was cloned into pET2818 using 
NcoI and XhoI sites. (B) Restriction digest of the SH31 PCR fragment using NcoI and XhoI. Lane 1 
(MW), molecular weight marker; lane 2, 277bp SH31 fragment digested with NcoI and XhoI. (C) 
Restriction digest of pET2818 with NcoI and XhoI. Lane 1, (MW), molecular weight marker; lane 
2 (Nat), undigested 5710 bp pET2818 plasmid; lane 3 (NcoI), 5710 bp pET-2818 digested with 
NcoI; lane 4 (XhoI), 5710 bp pET-2818 digested with XhoI; lane 5 (NcoI/XhoI), pET-2818 doubly 
digested with NcoI and XhoI. (D) Identification of pET2818-S1 by colony PCR using 
oligonucleotides pET_up and pET_dn. Lane 1, (MW), molecular weight marker; lane 2, 452 bp 
PCR fragment corresponding to SH31. 
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Figure 6.4. Construction of pET2818-S2. (A) Schematic representation of the cloning strategy. A 
292 bp PCR fragment encoding the second BacL1 SH3_5 repeat (SH32) was cloned into pET2818 
using NcoI and XhoI sites. (B) Restriction digest of the SH32 PCR fragment using NcoI and XhoI. 
Lane 1 (MW), molecular weight marker; lane 2, 272bp SH31 fragment digested with NcoI and XhoI; 
lane 3, 278bp SH32 fragment digested with NcoI and XhoI. (C) Restriction digest of pET2818 with 
NcoI and XhoI. Lane 1, (MW), molecular weight marker; lane 2 (Nat), undigested 5710 bp pET2818 
plasmid; lane 3 (NcoI), 5710 bp pET-2818 digested with NcoI; lane 4 (XhoI), 5710 bp pET-2818 
digested with XhoI; lane 5 (NcoI/XhoI), pET-2818 doubly digested with NcoI and XhoI. (D) 
Identification of pET2818-S2 by colony PCR using oligonucleotides PET_up and pET_dn. Lane 1, 
(MW), molecular weight marker; lane 2 to 4 (PET2818-S2), 458 bp PCR fragment corresponding 
to SH32. 
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Figure 6.5. Construction of pET2818-S3. (A) Schematic representation of the cloning strategy. A 
380 bp PCR fragment encoding the third BacL1 SH3_5 repeat (SH33) was cloned into pET2818 
using NcoI and XhoI sites. (B) Restriction digest of the SH33 PCR fragment using NcoI and XhoI. 
Lane 1 (MW), molecular weight marker; lane 2, 272bp SH31 fragment digested with NcoI and XhoI; 
lane 3, 278bp SH32 fragment digested with NcoI and XhoI; lane 4, 278bp SH33 fragment digested 
with NcoI and XhoI. (C) Restriction digest of pET2818 with NcoI and XhoI. Lane 1, (MW), molecular 
weight marker; lane 2, (NcoI/XhoI), pET-2818 doubly digested with NcoI and XhoI. (D) 
Identification of pET2818-S3 by colony PCR using oligonucleotides PET_up and pET_dn. Lane 1, 
(MW), molecular weight marker; lane 2 (PET2818-S3), 458 bp PCR fragment corresponding to 
SH33. 
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Figure 6.6. Construction of pET2818-S1S2. (A) Schematic representation of the cloning strategy. 
A 567 bp PCR fragment encoding the first and second BacL1 SH3_5 repeats (SH31-2) was cloned 
into pET2818 using NcoI and XhoI sites. (B) Restriction digest of the SH31-2 PCR fragment using 
NcoI and XhoI. Lane 1 (MW), molecular weight marker; lane 2, 551bp SH31-2 fragment digested 
with NcoI and XhoI. (C) Restriction digest of pET2818 with NcoI and XhoI. Lane 1, (MW), molecular 
weight marker; lane 2, (NcoI/XhoI), pET-2818 doubly digested with NcoI and XhoI. (D) 
Identification of pET2818-S1S2 by colony PCR using oligonucleotides pET_up and pET_dn. Lane 
1, (MW), molecular weight marker; lane 2 (pET2818-S3), 731 bp PCR fragment corresponding to 
SH31-2. 
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Figure 6.7. Construction of pET2818-S1S3. (A) Schematic representation of the cloning strategy. 
A 929 bp PCR fragment encoding the three BacL1 SH3_5 repeats (SH31-3) was cloned into pET2818 
using NcoI and XhoI sites. (B) Restriction digest of the SH31-3 PCR fragment using NcoI and XhoI. 
Lane 1 (MW), molecular weight marker; lane 2, 827 bp SH31-3 fragment digested with NcoI and 
XhoI. (C) Restriction digest of pET2818 with NcoI and XhoI. Lane 1, (MW), molecular weight 
marker; lane 2, (NcoI/XhoI), pET-2818 doubly digested with NcoI and XhoI. (D) Identification of 
pET2818-S1S3 by colony PCR using oligonucleotides pET_up and pET_dn. Lane 1, (MW), 
molecular weight marker; lane 2 (pET2818-S3), 1007 bp PCR fragment corresponding to SH31-3. 
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Figure 6.8. Production and purification of BacL1 SH3-5 domains. (A) Domain organization of E. 
faecalis BacL1 recombinant SH3_5 domains produced in this study. Amino acid numbers refer to 
the transition between SH3_5 domains. The expected molecular weight of each protein is shown 
on the right. (B) Sequence alignment of the three SH3_5 modules present in the C-terminal 
domain of the bacteriocin protein BacL1. Identical residues are highlighted in black and residues 
in light grey indicate conservative substitutions.  (C) SDS-PAGE analysis of the expression level and 
solubility of five BacL1 SH3_5 recombinant proteins described in A; proteins were produced in E. 
coli Lemo21(DE3) cells. Lane 1 (MWM), molecular-weight makers; lane 2 and 3, SH31; lane 4 and 
5, SH32; lane 6 and 7, SH33; lane 8 and 9, SH31-2; lane 10 and 11, SH31-3; (CE), crude extract; (SN), 
soluble fraction. (D) SDS-PAGE analysis of the purification steps to obtain the five BacL1 SH3_5 
recombinant proteins. Lane 1 (MWM), molecular weight makers; lane 2 to 6, SH31-3; lane 7 
(MWM), molecular weight makers; lane 8 to 12, SH31-2; lane 13 (MWM), molecular weight 
makers; lane 14 to 18, SH31; lane 19 to 23, SH32; lane 24 (MWM), molecular weight makers; lane 
25 to 29, SH33; (SN), soluble fraction; (FT), flow-through; (W), wash; (IMAC), elution pool; lane 6 
(GF), pooled fractions from gel filtration step. 
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6.2.2 Expression of EF1293 SH3_5 domain 
The EF1293 protein consists of an N-terminal amidase domain and C-terminal SH3_5 domain. It 
is unclear where the precise N-terminus (start) of the SH3_5 protein is located within the C-
terminal region of the PG hydrolase since the predicted SH3-like fold is preceded by a β-rich 
region. Protein homology predictions indicate a strong sequence similarity between the Lss and 
the EF1293 SH3_5 domains corresponding to the last seven β-strands of these proteins. This 
sequence similarity starts about 20 amino acids into the Lss SH3_5 domain (Fig. 6.9). This was 
somewhat expected since the N-terminal extension of the staphylococcal SH3_5 domain is 
involved in binding to the pentaglycine cross-bridges (Lu, 2006; Sabala,2019). In the E. faecalis 
BacL1 SH31 protein (first repeat), this region of homology started more proximally, about 10 
amino acids into the BacL1 protein (Fig. 6.9). All factors considered, it seemed likely that the more 
distal seven β-strands of the EF1293 protein formed the SH3_5 structure (Fig. 6.10 A), although 
the possibility that the C-terminal domain is adorned with extra secondary structures from the 
preceding β-rich region cannot be excluded.  
 
Three alternative N-terminal sequences were selected as candidates to express and produce the 
EF1293 SH3_5. A plasmid encoding the full length EF1293 protein (pTetH-1293 plasmid, available 
in the laboratory collection, (Fig. 6.10 B) was used as a PCR template to build expression vectors. 
The selected sequences were: (i) A 296 bp fragment encoding the last eight β-strands of the 
EF1293 protein (EF12931; residues N274-S365); (ii) a 314 bp fragment encoding the last nine β-
strands of the EF1293 protein (EF12932; residues H268-S365); and (iii) a 474 bp fragment 
encoding the complete β-rich sequence (EF12933; residues K214-S365, (Fig. 6.10 C). The three 
fragments were digested with NcoI and BamHI and cloned into a similarly digested pET2818 
vector. All plasmids encode proteins with a C-terminal 6x-his-tag (Fig. 6.11). The recombinant 
expression plasmids (pET2818-EF12931, pET2818-EF12932, and pET2818-EF12933) were 
identified by colony PCR and sent for sequencing to ensure the absence of mutations in the 
inserts (Fig. 6.12). 
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Figure 6.9. Amino acid sequence alignment between the C-terminal region of the E. faecalis 
EF1293 protein, the E. faecalis N-terminal BacL1 SH31 repeat, and the S. aureus Lss SH3_5 
domain. The region of homology between the EF1293 C-terminal region; BacL1 SH31; and Lss 
SH3_5 is highlighted in pink. Conserved residues among all proteins are highlighted in black and 
conservative substitutions are in light grey.  
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Figure 6.10. Selection of E. faecalis EF1293 SH3_5 domain candidates. (A) Secondary structure 
prediction of the EF1293 endolysin from E. faecalis. The sequence analysis was generated using 
the Phyre2 web portal for protein modelling, prediction and analysis. Secondary structures are 
indicated by arrows (β-strands) and ribbons (α-helix). Coloured boxes correspond to the three N-
terminal candidates of the EF1293 SH3_5 domain: EF12321 red; EF12932, blue, and EF12933, 
yellow (B) Schematic representation of pTetH-1293 plasmid encoding the EF1293 endolysin used 
for the amplification of three SH3_5 domains with alternative N-terminal sequences. (C) PCR 
product encoding EF12931; lane 1, (MW), molecular weight marker; lane 2, 296 bp EF12931 DNA 
fragment flanked with NcoI and BamHI sites. (D) PCR product encoding EF12932; lane 1, (MW), 
molecular weight marker; lane 2, 314 bp EF12932 DNA fragment flanked with NcoI and BamHI 
sites (E) PCR product encoding EF12933; lane 1, (MW), molecular weight marker; lane 2,474 bp 
EF12933 DNA fragment flanked with NcoI and BamHI sites.  
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Figure 6.11. Construction of pET2818-EF1293 expression plasmids. (A) Schematic representation 
of the cloning strategy. Three distinct DNA fragments encoding the EF1293 SH3_5 domain flanked 
with NcoI and BamHI sites were cloned into pET2818. (B) Restriction digest of the PCR fragments 
EF12931 and EF129322. Lane 1, 248bp EF12931 fragment digested with NcoI and BamHI; lane2 
(MW), molecular weight marker; lane 3, 302 bp EF12932 fragment  digested with NcoI and BamHI. 
(C) Restriction digest of the PCR fragment EF12933. Lane 1 (MW), molecular weight marker; lane 
2, 462 bp EF12933 fragment  digested with NcoI and BamHI. (D) Restriction digest of pET2818. 
Lane 1, (MW), molecular weight marker; lane 2, 5710 bp pET-2818 plasmid digested with NcoI 
and BamHI.  
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Figure 6.12. PCR confirmation of pET2818-EF1293 expression plasmids. (A) Confirmation of 
pET2818-EF12931 by colony PCR. Lane 1, (MW), molecular weight marker; lane 2, 417 bp PCR 
product amplified with oligos FWD1_EF1293 and pET_dn . (B) Confirmation of pET2818-EF12932 
by colony PCR. Lane 1, (MW), molecular weight marker; lane 2, 432 bp PCR product amplified 
using oligos FWD2_EF1293 and pET_dn. (C) Confirmation of pET2818-EF12933 by colony PCR. 
Lane 1, (MW), molecular weight marker; lane 2, 677 bp PCR product using pET-up and pET_dn 
oligos. 
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Small-scale expression trials were performed to determine the expression level and solubility of 
the EF1293 constructs (Fig. 6.13). Due to the lockdown caused by Covid-19 all experiments were 
stopped and only the production of EF12931 and EF12932 proteins was assessed. Both 
recombinant proteins were produced in E. coli Lemo21(DE3) using two different media: BHI 
medium and Overnight Express™ Instant TB medium. Cultures grown in BHI broth were IPTG-
induced (1 mM) at OD600=0.6 and grown alongside the cultures in AIM at 25°C for 16 h. Cells and 
supernatant samples were harvested and analysed by SDS-PAGE (Fig. 6.13 A-C). None of the 
SH3_5 recombinant proteins were soluble under standard expression conditions in either of the 
conditions tested (Fig. 6.13). Proteins at the expected molecular weight (11.3 and 12 kDa for 
EF12931 and EF12932, respectively), were only observed in the crude extract of each culture (Fig 
6.13).    
 
As previously mentioned, owing to the circumstances it was not possible to further analyse the 
expression of the EF12933 recombinant protein.   
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Figure 6.13. SDS-PAGE analysis of the expression level and solubility of the EF12931 and EF12932 
recombinant proteins. (A) Small-scale expression of EF1293 (11.3 kDa) produced in E. coli 
Lemo21(DE3) cells grown in BHI medium at 25°C for 16 h after IPTG induction. Lane 1 (MWM), 
molecular-weight makers; lane 2 (CE), crude extract; lane 3 (SN), soluble fraction. (B) Small-scale 
expression of EF12931 (11.3 kDa) produced in E. coli Lemo21(DE3) cells grown in Overnight 
Express™ Instant TB medium at 25°C for 16 h. Lane 1 (MWM), molecular-weight markers; lane 2 
242 
 
(CE), crude extract; lane 3 (SN), soluble fraction. (C) Small-scale expression of EF12932 (12 kDa). 
Lane 1 (MWM), molecular-weight markers; lane 2 to 4, EF12932 produced in E. coli Lemo21(DE3) 
cells grown in BHI medium at 25°C for 16 h after IPTG induction; lane 5 to 7, EF12932 produced in 
Lemo21(DE3) cells grown in Overnight Express™ Instant TB medium at 25°C for 16 h;  (CE), crude 
extract; lane 4 (SN), soluble fraction.  
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6.3 Perspectives  
To explore E. faecalis PG recognition by the BacL1 SH3_5 domain and investigate the role of 
domain modularity, a combination of NMR, isothermal titration calorimetry (ITC), circular 
dichroism (CD) spectroscopy, and crystallography experiments will be required. A first step will 
be to express doubly labelled proteins. Several experiments will have to be performed. These 
include standard heteronuclear triple resonance experiments (HNCACB and HN(CO)CACB) to 
assign the spectra corresponding to the different proteins analysed. Protein-ligand titrations (15N 
HSQC) will also be required to map the residues involved in substrate recognition  
 
NMR titrations with labelled SH3_5 domains and four key peptide ligands already available in our 
laboratory could have been sufficient to determine the PG motif(s) recognised by the BacL1 
SH3_5 domain. The ligands planned to be used in this study were:  
• An L-Ala dipeptide cross-bridge [L-Ala-L-Ala], [L-A2]. 
• A D-Ala dipeptide cross-bridge [D-Ala-D-Ala], [D-A2]. 
• A pentapeptide stem [-AQKAA], [P5]. 
• A pentapeptide stem bound to a dipeptide L-Ala lateral chain [AQK(L-Ala-L-Ala)AA], [P5-L-A2]   
 
The time-length and number of NMR titrations depends on the protein-ligand biomolecular 
interactions: a standard 15N HSQC titration takes approximately 2.5 hours per titration point and 
typically requires eight titrations. A combination of ITC and CD spectroscopy would allow the 
individual contribution of SH3_5 repeats to PG binding to be explored and enable the study of 
protein conformational behaviour in solution alongside the NMR analyses. This could have been 
done by performing a comparative analysis between the SH31, SH3_51-2, and SH31-3 proteins, 
both in the presence and in the absence of a PG ligand identified by NMR and/or ITC. Despite the 
high sensitivity of ITC, this method might not be suitable if, like in the case of the Lss SH3_5 
domain, the BacL1 SH3_5 repeats exhibit relatively low binding affinities to their ligands. This is 
because weak binding interactions lead to small enthalpy changes (released heat), resulting in 
ITC outputs having relatively low signal to noise.  
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Altogether, the outlined experiments would have taken approximately four to six months and 
fitted within the established time frame of my PhD. With most of the experimental methods 
already standardized, it seemed plausible to have provided enough information about the 
contribution of individual modules to the binding of E. faecalis PG as well as the minimal PG 
ligand. This could be recognized by either individual modules that do not interact with each other 
and contribute to additive binding as seen for E. faecalis AtlA LysM modules and M. tuberculosis 
PknB PASTA domains (Mesnage, 2014; Mir, 2011) or a quaternary structure necessary to 
generate a functional protein as determined for S. pneumoniae PBP2x PASTA domains (Yeats, 
2002).  
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CHAPTER VII 
General discussion 
 
Protein domains are classified into fold families which are thought to share functional and 
structural features often resulting from a common origin (Hartwell, 1999; Wang, 2009).  The 
independent evolution of protein domains is a major drive for the diversification of protein 
functions (Hartwell, 1999; Vogel, 2004) and how protein domain organization contributes to the 
creation, recruitment, and diversification of biological functions that underpin life is a 
fundamental question (Caetano-Anollés, 2009; Murzin, 1995; Vogel, 2004; Wang, 2009).  One of 
the most studied domains to answer this question are SH3s. SH3 domains are found in proteins 
distributed across different kingdoms and are part of multimodular proteins exhibiting a wide 
range of functions. 
 
7.1 The SH3 domain as a model to investigate functional and structural diversification during 
evolution 
 
Eukaryotic SH3 domains represent a model system for the study of protein-ligand interactions. 
They are found in proteins playing critical roles in a wide variety of biological processes such as 
cell proliferation, migration, and cytoskeletal modifications (e.g. tyrosine kinases, myosin, and 
cortactin) (Mayer, 1998). SH3 domains are also found in a large number of prokaryotic proteins 
and represent one of the most common domains. Since SH3 proteins are structurally conserved 
across kingdoms (Lu JZ, 2006; Ponting, 1999; Saksela, 2012; Whisstock, 1999), their evolutionary 
timelines provide important information about their structure/function relationships (te 
Velthuis, 2007; Wang, 2009).  
 
Over the last decade, proteomic evolutionary timelines have been generated based on 3D 
structures since fold family domains generally share only moderate sequence similarity (Caetano-
Anollés, 2003; Wang, 2009; Yang, 2005). Atomic structures and domain organization are far more 
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conserved than amino acid sequences and have remained well-preserved for long periods of time 
(Fukami-Kobayashi K, 2007). 3D architectures carry evolutionary information that has revealed 
three main eras in proteomics evolution: (i) architectural diversification, (ii) super kingdom 
speciation, (iii) organismal diversification (Caetano-Anollés, 2009; Wang, 2009).  
 
SH3 proteins are considered highly promiscuous because they are found in >132 domain 
combinations in eukaryotes (Wang, 2009). Evolutionary timelines place SH3 proteins in early 
architectural diversifications and show their involvement in several combinatory events during 
super kingdom speciation ( Wang,2008; te Velthuis, 2007). It is likely that their ability to establish 
multiple inter and intramolecular interactions has allowed them to evolve moderate selectivity 
towards a large variety of ligands, as determined for the numerous eukaryotic and bacterial SH3-
like families (Desvaux, 2018; Gonzalez-Delgado, 2020; Saksela, 2012). Interestingly, a massive 
domain combinatorial event coincides with the establishment of organismal lineages. This event 
marked the period where multifunctional architectures were replaced by highly specialized 
counterparts, a process that is clearly seen for SH3s (Caetano-Anollés, 2009; Kim, 2006; Wang, 
2009). 
 
7.2 Does SH3_5 domain organization reflect the diversity of binding mechanisms? 
According to Pfam (as of June, 2020), 364 sequences with an SH3_5 domain are organised into 
65 protein domain organizations (El-Gebali, 2019). Both the domain organisation of SH3_5 
proteins and the organisation of the SH3_5 domains themselves are very diverse, suggesting that 
during evolution, proteins have used the SH3_5 domain as a building block to diversify protein 
functions. 
 
7.2.1 Modularity of proteins containing SH3_5 domains  
Most SH3_5 domains are associated with one or two other domains (54% and 36% of the 
proteins, respectively). Only five proteins are made of four domains including an SH3_5 domain 
(Fig. 1.16, Chapter I). This domain organisation amongst SH3_5 proteins is in agreement with the 
results published in a study searching for the number of domains present in 4636 protein 
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combinations. These proteins were analysed at a family fold level and it was  shown that 64% of 
them were comprised of two domains, 18% had three domains, and the rest were similarly 
distributed either by single domains or more than three domains (Wang, 2009). 
 
The domain organization of SH3_5 proteins matches evolutionary models suggesting the 
selective advantages of preserving short, multimodular proteins (Brocchieri, 2005; Kurland, 
2007). Relatively short proteins (with fewer domains and hence a limited modularity) seem less 
costly to preserve than exceedingly long protein sequences that could enhance the likelihood of 
events such as fission or intragenomic shuffling. Although bacteria have acquired domains from 
other kingdoms by horizontal gene transfer, it is through the duplication, insertion, and deletion 
of genes that proteins mostly acquire or lose domains to generate new combinations. These 
processes are referred to as domain shuffling (Gomperts, 2009; Wang M, 2009).  
 
7.2.2 Modularity of the SH3_5 domain  
SH3_5 domains can contain one to six repeats, but a clear preference for a single SH3_5 repeat 
is observed. From the 364 total protein sequences, 85% of them harbour a single SH3_5 repeat. 
Only 5% of the protein sequences have two SH3_5 repeats, 3.5% have three repeats, 3% have 4 
repeats, 3% have 5 repeats, and only 2 sequences (0.5%) have 6 repeats.  
  
The fact that most proteins contain a single SH3_5 repeat indicates that the binding mechanism 
mediated by these domains must be highly efficient. The protein evolution of Lss has preserved 
this situation to allow for a more dynamic binding to PG (as detailed below). On the other hand, 
the existence of multiple repeats in SH3_5 domains may reflect distinct cell wall binding 
mechanisms in a similar way to what has been described for the LysM domain. It is possible that 
multiple repeats provide a stronger binding activity as in the case of the LysM domain from E. 
faecalis AtlA (Mesnage, 2014). The AtlA LysM domain is made of 6 LysM repeats all able to bind 
to PG independently. They have been proposed to be organised as “beads on a string”, 
contributing to substrate recognition in a cooperative manner. Another possibility is that in some 
proteins, SH3_5 domains form a quaternary structure (e.g. a dimeric, trimeric or tetrameric 
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SH3_5 structure) that binds optimally to PG. It has been shown that Cladosporium fulvum LysM 
domain effector, Ecp6 , can dimerize and generate an ultrahigh affinity binding site (Kd=280 pM) 
recognising chitin (Sanchez-Vallet, 2013). In some eukaryotic LysM proteins, disulphide bonds 
between LysM repeats form a trimeric structure that have been proposed to maintain the 
structural integrity of the LysM domain (Liu, 2012).   
 
Interestingly, a relatively large number of proteins are exclusively made of SH3_5 repeats (30 
proteins contain a single SH3_5 repeat and 3 proteins were found to contain 2, 3 and 5 repeats). 
This result seems surprising, but a similar phenomenon has been described with proteins 
exclusively made of LysM repeats (Willmann, 2011). These LysM proteins are produced by fungi 
and bind soluble chitin. They have been shown to bind fungal cell wall fragments generated by 
host chitinases in response to a phytopathogen infection. These LysM binding proteins have been 
proposed to “hide” the fungal cell wall fragments from the host immune system. It is therefore 
possible that bacteria have evolved a similar mechanism with SH3_5 domains that could bind PG 
fragments and hide them from the host immune system to limit the inflammatory response. 
 
7.3 Lss SH3_5 binding affinities  
Lss is a powerful lytic enzyme highly specific to staphylococci with a pentaglycine crossbridge 
(Baba, 1996; Lu JZ, 2006; Thumm, 1997). The presence of a single SH3_5 domain in this protein 
might seem counterintuitive since one might predict it to have a weak binding affinity for PG 
(Gonzalez-Delgado, 2020; Tossavainen, 2018). Low binding affinities  have been previously 
described in the SH3 eukaryotic counterparts (Mayer, 2001; Tossavainen, 2018). At the start of 
this work, two possibilities were envisaged: (i) a high binding affinity and a high specificity or (ii) 
like in eukaryotic SH3 proteins, a weak affinity and a moderate specificity. Based on the very 
powerful activity of Lss and its high specificity for PG containing pentaglycine crossbridges, we 
expected that the SH3_5 targeting domain would have a very high affinity and specificity for the 
PG pentaglycine crossbridges. 
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Interestingly, the CSP analyses revealed rather low binding affinities for soluble monomeric PG 
fragments (millimolar range) and as the complexity of the ligands increased, a 10x improvement 
in binding affinities was determined. We were also able to observe that an increased level of 
ligand complexity led to the formation of protein aggregates. Together, these results were 
indicative of the ability of  a single domain to mediate highly efficient binding interactions with 
cross-linked PG fragments.  
 
7.4 Lss SH3_5 binding specificity  
As previously mentioned, Lss displays a restrictive lytic activity against Staphylococcus spp. strains 
with a PG crosslinked by pentaglycine crossbridges. Besides the strength of the Lss SH3_5-PG 
binding affinities, another unanswered question that we investigated was the role of the SH3_5 
domain in the enzyme specificity. Since the discovery of the Lss PG substrate, it had been largely 
assumed that Lss exclusively recognised pentaglycine crosslinks. The results obtained in this 
study were unexpected since they showed that the SH3_5 domain has evolved moderate 
selectivity to its substrate. This domain was shown to bind to a PG feature common to most 
Gram-positive bacteria, the tetrapeptide stem (AiQKA, P4) in addition to a specific feature of the 
staphylococcal PG (the pentaglycine crossbridge, G5). Moreover, the results obtained here also 
show that SH3_5 can efficiently bind to PG lacking an intact pentaglycine crossbridge like those 
found in the S. aureus mutants fem B and fem AB, containing three and one glycine residues in 
their PG crossbridges, respectively.  
 
7.5 Lss SH3_5 binding mechanism  
The NMR analyses of the SH3_5-PG titrations revealed that the Lss SH3_5 domain recognises 
both PG peptide moieties via distinct sets of residues located at opposite sides of the protein 
surface. The results were initially hard to reconcile with (i) the assumption that this domain was 
primarily binding to pentaglycine crosslinks via a binding groove made of the N-terminal 
extension (Lu JZ, 2006; Sabała, 2014) and (ii) the fact the contiguous peptide stem is too short to 
reach the identified P4 binding cleft located at the opposite side of the protein. Another puzzling 
observation we could not immediately explain was the fact that the G5 and P4 binding sites 
250 
 
represented two completely independent and discrete binding sites, with no other CSPs being 
observed between them. Another group published similar results but could not explain how the 
two PG motifs recognised (P4 and G5) could bind the SH3_5 domain simultaneously (Tossavainen, 
2018). At this point, we sought to determine the structure of the SH3_5 domain in complex with 
a PG fragment comprised of both PG moieties (P4-G5).   
 
The 1.4 Å co-crystal structure of the SH3_5-[P4-G5] complex shed light onto the dual SH3_5 
binding mechanism whereby the G5 ligand from a monomeric fragment was recognized by one 
SH3_5 domain and the contiguous P4 peptide was bound to another SH3 protein. Altogether, the 
NMR and crystallography results provided an explanation of the efficient mechanisms adopted 
by this potent enzyme. They allow us to explain an interesting phenomenon occurring in the CSPs 
from the PG-like fragments and to propose a model for the molecular mechanisms underpinning 
the Lss-PG binding, both of which are outlined below.  
 
The greater SH3_5 affinities to complex PG ligands carrying both P4-G5 moieties exhibited 
smaller CSPs. We hypothesized that the off-rates are fast and that the binding partners can be 
rapidly exchanged upon re-localization (Gonzalez-Delgado, 2020). This dual ligand recognition of 
the SH3_5 domain is at the cost of suboptimal geometry i.e. having two binding pockets at 
opposite sides of the protein prevents simultaneous binding by the same molecule (monomeric 
fragment). This reduced time-average hydrogen bonding can be compensated for by acquiring a 
more dynamic binding (more entropy). Furthermore, single-site mutations displayed modest 
impact on PG binding and on the enzymatic activity, suggesting that the weaker enthalpy caused 
by this suboptimal geometry is compensated for by greater entropy (increased ligand mobility) 
governed by a large network of interactions. 
 
The mature PG lattice is therefore more entropically favourable to satisfy the SH3_5 binding 
requirements and highlights the physiological relevance of the results determined in this study. 
In other words, such plasticity is advantageous since it allows the SH3_5 proteins to ‘walk’ across 
the PG without detaching from the surface by always having one site bound. A similar strategy 
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has been described in some celluloses that  potentiate their activity by having two different 
cellulose-binding domains (Bolam, 1998; Gill, 1999; Nagy, 2007; Raghothama, 2001). Moreover, 
two distinct peptide-binding sites have been identified in the eukaryotic SH3 protein from the 
Ser/Thr mixed-lineage kinase 3 (MLK3) (Kokoszka, 2018). The binding pockets are located at 
opposite faces of the SH3 protein and were shown to interact with different viral peptides. The 
MLK3 SH3 domain binds the proline rich NS5A peptide from the Hepatitis C virus inhibiting the 
apoptosis of the infected cells (Macdonald, 2004; Tan, 1999).The non-canonical binding pocket 
is located between the Src loop and the edge of the β3 strand, whilst the canonical proline-rich 
peptide from the hepatitis C virus binds in the groove made from three loops: RT, n -Src, and 310 
helix loop (Kokoszka, 2018).  
 
The binding mechanism proposed here is consistent with the aggregation observed during the 
titration of complex PG fragments. These titrations were within the slow exchange limits 
indicating a tighter binding. Taken together, these results suggest that protein clusters are 
formed and lead to an increase in the concentration of the enzyme at the PG surface, thereby 
enhancing the activity of the catalytic domains. In agreement with this hypothesis, a study using 
atomic force microscopy in S. aureus cells exposed to Lss revealed the creation of nanoscale 
perforations that preceded lysis (Francius, 2008). Interestingly, a similar mechanism has been 
recently described for the single LysM domain from the fungal wheat pathogen Zymoseptoria 
tritici. The crystal structure of this LysM domain revealed their ability to form a supramolecular 
structure through the induction of homodimers that are ‘bridged’ by their ligand (chitin).  This 
property confers protection of Z. tritici from the host by secreting LysM effectors that scavenge 
the chitin oligomers that trigger the plant immune system (Sánchez-Vallet, 2020).  
 
7.6 Is the catalytic domain the major determinant of the Lss specificity? 
On the basis of the results obtained in this research, it is necessary to reconsider the catalytic 
activity rather than the binding as the major factor in the restricted selectivity of Lss to 
Staphylococcal species.  Firstly, CSP analyses of the SH3-PG interactions showed that, although 
the SH3 domain displays similarly weak affinities to simpler G5 and P4 peptides, fewer 
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interactions occurred at the G5 site as the complexity of the ligands increased. These results 
suggest that SH3_5 proteins display weaker interactions with ligands comprised of a more cell 
wall-like structure at the G5 site. Furthermore, the CSP analyses of the titrations with the single-
site mutant domains revealed that the residues involved in the interaction with P4 exhibited the 
most pronounced decrease in binding affinities, as compared to the wild-type SH3_5. These 
results were also consistent when assessing binding to purified PG sacculi and the enzymatic 
activity. We hypothesized that the SH3_5 domain from Lss has evolved to favour binding to P4 
peptide stems to allow for the catalytic domain to cleave its substrate (G5) as long as it still 
recognised both ligands and does not bind too tightly to either so it can remain attached to the 
PG lattice.  
 
As previously mentioned for the moderate selectivity of the Lss SH3_5 domain, most of the 
studied SH3_5 mutations had a limited impact on binding to S. aureus WT PG, similar to that seen 
for the WT SH3_5-mNG fusion to the PG fem B [GGG] mutant. In S. carnosus, the fem B mutation 
confers high resistance to the Lss enzyme with a 3000-fold increase in the MIC values from 0.01 
to 32 µg-mL-1 (Nega, 2015). Furthermore, the WT SH3_5-mNG fusion still bound in a dose-
dependent manner to the PG fem AB [G] mutant.  
 
Site-directed mutagenesis of three key amino acid residues of the Lss catalytic domain 
(H33,N37,H116) were shown to inhibit endopeptidase activity in turbidity assays (Bardelang, 
2009; Sabała, 2014). Additionally, using modified fluorescence resonance energy transfer (FRET) 
substrates, the catalytic domain was not capable of cleaving fragments with an any amino acid 
substitution at position 3 of the pentaglycine peptide (GGXGG). However, a competition FRET 
assay showed that binding to a modified substrate (GGSGG) was not affected in the full-length 
Lss (Bardelang, 2009).  
 
Altogether, these observations suggest that the restricted lytic activity of the Lss enzyme is 
conferred by its catalytic domain. However, previous experimental approaches using synthesized 
FRET peptides have highlighted the complexity of generating soluble complex fragments and the 
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need for more sensitive assays that lead to shorter experimental times to avoid the precipitation 
of substrates.  The low affinities of Lss to its substrates have required the use of high 
concentrations of ligands leading to a significant decrease in fluorescent emissions caused by the 
inner filter effect. Although different strategies have been applied to compensate for these 
problems, the search for peptides with lower Km values should be further studied (Bardelang, 
2009). 
 
7.7 Future work 
 
7.7.1 Substrate specificity across SH3_5 domains  
SH3_5 domains are made by bacteria producing PG with distinct compositions. Two major 
questions remain to be answered: how conserved is the recognition mechanism described for 
the Lss SH3_5 domain? Do all SH3_5 domains recognise both the peptide stem and the 
crosslinks? Sequence and structure alignments of the SH3_5 family suggests the existence of 
conserved features necessary for the recognition of canonical ligand binding moieties (Fig 1.14, 
Chapter 1). Residues identified to interact with P4 are conserved across SH3_5 domains present 
in the Protein Data Bank (PDB) despite their low sequence similarity (e.g. 32% similarity with E. 
faecalis  BacL1  or 30% similarity with Streptococcus pyogenes Plypy). The recognition of the 
pentaglycine crossbridge in the Lss SH3_5 domain is mediated via the N-terminal extension that 
does not appear to be conserved in other domains. Although we cannot exclude that some 
residues upstream of the SH3_5 consensus are involved in the recognition of the lateral chain in 
Gram-positive cocci, it is possible that the only PG motif recognised is the pentapeptide stem. 
Further structural and functional studies are required to explore the binding mechanism of SH3_5 
from bacteria with distinct PG structures. Towards the end of my PhD, I have started to 
investigate the recognition of E. faecalis PG by the SH3_5 domain of the bacteriocin BacL1. 
Unfortunately, I have not been able to carry out the NMR experiments planned to test if these 
SH3-5 domains were recognising the pentapeptide stem and the L-Ala-L-Ala crossbridges via 
distinct binding sites.  
 
254 
 
7.7.2 What is the role of the modularity of SH3_5 domains?  
As mentioned previously, the majority of SH3-5 domains are made of a single binding module but 
several proteins (55 in total) contain up to five modules.  It will be important to investigate the 
binding properties of proteins with a distinct number of modules to explore if, like with the LysM 
domains, the diversity in the modularity of the SH3-5 domain reflects the diversity of binding 
mechanisms. It has been shown that other SH3 domains can undergo homodimerization (IB1 
protein) (Kristensen, 2006). As previously mentioned, homodimerization is important for the 
binding activity of another binding domain, LysM (Sánchez-Vallet, 2020). An interesting model 
system will be the BacL1 domain which contains three SH3_5 binding modules. One of my 
objectives was to compare the binding activity of domains containing a variable number of 
repeats to PG fragments and whole sacculi. My preliminary results indicate that combination of 
BacL1 SH3_5 domains can be expressed at high levels and as soluble polypeptides (single 
domains, tandem domains) so it is tempting to assume that the three modules are not required 
to form a quaternary structure and are therefore likely to bind independently to PG.  
 
7.7.3 Could other properties regulate peptidoglycan recognition by SH3_5 domains? 
Several properties of SH3 domains have been shown to modulate the recognition of their ligands. 
SH3 proteins regulate distinct processes by associating with other proteins, through 
phosphorylation (WW2, SH3, SH2, and PDZ) (Akiva, 2012), heterodimerization (VAV N-terminal 
and GRB2 C-terminal SH3 domains complex) (Nishida, 2001), and cis-trans isomerization (Sarkar, 
2011). None of these processes have been investigated in prokaryotic domains and it would 
therefore be interesting to investigate whether these modifications modulate PG recognition by 
SH3_5 domains.  
 
7.7.4 Harnessing SH3_5 domains to generate antimicrobials  
The concept of exploiting bacteriolytic enzymes as therapeutic agents to eradicate pathogens has 
been contemplated for decades. The presence of serine amino acid substitutions in the 
interpeptide bridge prevents autolysis in the Lss producing staphylococci (Thumm, 1997; 
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Tschierske, 1997). This work showed that the Lss SH3_5 domain can recognise staphylococcal 
PGs which do not have a pentaglycine crossbridge. To target all staphylococci, including those 
with modified pentaglycine crossbridges in their PG, we could therefore use the Lss SH3_5 
domain as a binding module, fusing it to a catalytic domain able to cleave a broader range of PG 
structures. To explore this possibility, the Lss SH3_5 domain was fused to the catalytic domain of 
the E. faecalis EnpA (EnpAc) endopeptidase which can cleave a wide range of bacterial species 
harbouring distinct interpeptide bridges  (Reste de Roca, 2010). EnpAc  cleaves between the 
fourth D-Ala of the donor stem and the N-terminal L-Ala residue of the sidechain of the acceptor 
stem. So long as the PG is not directly crosslinked it can cleave different chemotypes irrespective 
of their length and amino acid sequence (Reste de Roca, 2010). EnpAc has been shown to be 
poorly active against intact PG and requires low ionic strength conditions (I. Sabala, personal 
communication).  Previous work indicated that EnpAc has no detectable lytic activity against S. 
aureus (M. Molloy and S. Mesnage, unpublished). When fused to the Lss SH3_5 domain, the 
EnpAc-SH3_5 fusion protein displayed a clear lytic activity against S. aureus (Fig. 7.1). These 
preliminary results indicate that fusing the Lss SH3 domain to the catalytic domain of PG 
hydrolases could lead to chimeric proteins with potent antimicrobial activity. 
Understanding the mechanisms underpinning ligand recognition by the SH3_5 domains serves as 
a framework for deciphering the evolutionary strategies adopted by distinct cell wall binding 
domains and facilitates the development of future antimicrobial approaches. Our work raises 
questions about the significance of protein specificity for meaningful biological outputs. 
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Figure 7.1 Zymogram analysis of the lytic activity of EnpAc and EnpAc-SH3_5 fusion against S. 
aureus peptidoglycan. (A) SDS-PAGE analysis of the EnpAc and EnpAc-SH3_5 proteins and (B) 
zymogram analysis of their lytic activity against S. aureus PG. The blue and red arrows indicate 
the bands corresponding to the EnpAc-SH3_5 fusion (27 kDa) and the EnpAc domain (15.1 kDa), 
respectively. Lane 1, (MWM), molecular weight makers from the SDS-PAGE Coomassie stained 
gel; lane 2-5, four serial dilutions with a mixture of the EnpA
c
 and EnpA
c
-SH3_5 proteins were 
loaded and separated by SDS-PAGE; lane 6-9, zymography of the four serial dilutions of the EnpAc 
and EnpAc-SH3_5 proteins separated by SDS-PAGE using gels with S. aureus PG. The haloes 
indicate the lysis of intact PG substrate by the enzyme on the zymogram (lane 6-9) located at the 
same position of the over-expressed protein bands (lane 2-5).  
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Appendix A 
 
Characterisation of synthetic PG ligands 
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Figure 1A. LC-MS of tetrasaccharide [GM-GM] ligand. 
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Figure 2A. Characterisation of pentaglycine [G5] ligand. 
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Figure 3A. Characterisation of pentaglycine derivative with an extra tyrosine residue at the N-
terminus [YG5] ligand. 
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Figure 4A. Characterisation of pentaglycine derivative with an extra tyrosine residue at the C-
terminus [G5Y] ligand. 
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Figure 5A. Characterisation of tetrapeptide stem with a lactyl group [P4] ligand. 
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Figure 6A. Characterisation of tetrapeptide stem with no lactyl group linked to a pentaglycine 
peptide as a lateral chain [P4-G5] ligand. 
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Figure 7A. Characterisation of pentapeptide stem crosslinked to a tetrapeptide stem through a 
pentaglycine bridge [P5-G5-P4]  ligand.  
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Appendix B 
 
Presented here is the accepted manuscript “Two-site recognition of Staphylococcus 
aureus peptidoglycan by lysostaphin SH3_5” deposited in White Rose Research Online (WRRO) 
open access repository (04 Nov 2019) originally published in Nature Chemical Biology.  
 
 
 
 
 
 
 
